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ABSTRACT 
The enzyme dihydropteridine reductase (DHPR) plays the crucial role of recycling 
quinonoid dihydropterins to tetrahydropterins, which are cofactors for the aromatic amino 
acid hydroxylases. DHPR from Escherichia coli Kl2, first reported in this study, was 
investigated so that it could be used as a good model system for revealing alternative 
role(s) of this ubiquitous reductase in a cell that is devoid of aromatic amino acid 
hydroxy lases. 
The reducase from E coli was initially purified to apparent homogeneity in four 
steps by ammonium sulfate fractionation, followed by anion exchange chromatography 
through DE52 DEAE-cellulose and f.p.l.c Mono-Q columns, and finally by 
chromofocusing with a f.p.l.c Mono-P column. The protocol was developed based on 
experiences of other workers in purifications of DHPRs from several sources. The yield 
and stability of this bacterial reductase was conciderably improved by replacing Tris 
buffer with Hepes buffer at pH 7 .4 and using a three-step purification method involving a 
flat bed isoelectric focusing step. 
Unlike the reductases from other sources, the native enzyme from E. coli is a 
monomer with a molecular weight of about 27 000. The purified enzyme is a flavoprotein 
containing tightly bound (non-covalent) FAD, which endows the protein a yellow colour 
when concentrated. This is the first report of a DHPR with a prosthetic group. 
Consequently, artificial electron acceptors such as K3Fe(CN)6 tetrazolium-MTT are 
substrates, in a non-pterin dependent oxido-reductase reaction catalysed by the protein. 
The compound K3Fe(CN)6 exhibits saturation kinetics. In addition, the bacterial enzyme 
can also reduce 7, 8-dihydrofolate, a function that is normally unique to dihydrofolate 
reductases (DHFRs) and some bifunctional enzymes that possess both DHFR and 
thymidylate synthase activities. The enzymes DHPR and DHFR catalyse superficially 
similar reactions; the former reduces the pterin ring by transferring the hydride from the 
. 
IX 
pyridine nucleotide cofactor to position N-5, whereas in the latter case the hydride is 
transferred to position C-6. The ability to transfer the hydride to both positions is unique 
to the reductase from this study. This apparent lack of discrimination between N-5 and C-
6 of the pterin ring suggests that the FAD prosthetic gioup may mediate the transfer of 
hydride. Preliminary kinetic data and the use of a site-specific inhibitor of FAD, support 
the veiw that FAD is involved in the catalysis. Hence it is proposed that the reaction 
catalysed by the enzyme may occur by the "ping-pong" mechanism. 
The reductase from E coli has an isoelectric point of 5.3, an unprotected amino 
terminus and a pterin-binding site that is recognised by an anti-idiotype (pterin) antibody. 
It is also established that L-threo neopterin (monapterin) is the most abundant naturally-
occurring pterin in the organism. 
The cosmid cloning approach was explored in attempts to isolate the gene that 
encodes E coli DHPR. A clone (WA266) that exhibited a six-fold increase of DHPR 
specific activity compared to the background (wild-type) strain was investigated further. 
Two soluble proteins with molecular weights of about 45 000 and 47 000 were expressed 
in high levels under the direction of the plasmids p WA 266 (from the primary clone) and 
pWA 406 (subclone). The two proteins were partially purified and identified by N-
terminal amino acid sequencing in order to investigate the suspicion that a fusion protein 
was inadvertently formed. The larger protein was serine hydroxymethyl transferase 
(SHMT) which was encoded by the glyA gene (Plamann et al., 1983). The smaller 
protein was the previously described product of an unnamed gene which was adjacent to 
the glyA gene, but transcribed in the opposite direction (Plamann and Stauffer, 1983). 
The N-terminal sequence of the smaller protein showed extensive homology with that of 
haemoglobin from the filamentous myxobacterium Vitreoscilla, which has molecular 
weight of about 18 000 (Wakabayashi et al., 1986). 
X 
The visible absorption spectra of the 45-kD protein are characteristic of a CO-
binding b-type haem containing protein, that is high-spin in the reduced state. The gene 
that codes for the 45-kD protein is designated as hmp (for haemonrotein) and is located 
near the 55-min region of the Escherichia coli linkage map. The in vivo function of this 
soluble haemoprotein is not clear but based on the indirect evidence obtained from 
immunochemical investigations, this newly identified protein has a pterin binding site and 
is probably responsible for the six-fold increase in DHPR specific activity in the cosmid 
clone. 
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1 DISCOVERY OF DIHYDROPTERIDINE REDUCT ASE 
The conversion of phenylalanine into tyrosine was demonstrated in vitro as early 
as 1913 (Embden and Baldes, 1913) but the details of the reaction remained obscure for a 
further half a century. Except for the brief respite where it was wrongly shown that the 
soluble rat-liver extract contained an enzyme that carried out the conversion of 
phenylalanine into tyrosine in the presence of NAD+ and an alcohol or aldehyde 
(Udendfriend and Cooper, 1952); the classic work describing the hydroxylation of 
phenylalanine into tyrosine which ultimately led to the discovery of dihydropteridine 
reductase (DHPR; Enzyme commission number, EC 1.6.99.7) was carried out in the 
laboratory of Seymour Kaufman. Kaufman (1957) showed that the conversion of 
phenylalanine into tyrosine required two separate ammonium sulfate aggregated fractions 
from the rat-liver extract, neither of which was active on its own and that the system 
required a reduced pyridine nucleotide to donate electrons. Fortunately the sheep-liver 
extract unlike the sheep-liver homogenate could not carry out the conversion of 
phenylalanine into tyrosine. This was because one of the components of the 
hydroxylating system which was present in the sheep-liver homogenate was not readily 
solubilized. The sheep-liver extract replaced the activity of the higher ammonium sulfate 
fraction from the rat-liver extract. In the system where the extracts from two animal 
sources were used to convert phenylalanine into tyrosine, NADPH was found to be the 
preferred pyridine nucleotide. With the information that phenylalanine stimulated the 
oxygen uptake of a dog-liver extract (Lang and Westphal, 1942) in hand, an overall 
equation for the conversion of phenyalanine into tyrosine was postulated; 
NADPH + H+ + 02 + phenylalanine ----~ NADP+ + H20 + tyrosine 
1 
The demonstrated requirement of 02 and NADPH in the hydroxylation reaction 
indicated that the hydroxylase is a mixed-function oxidase and that the phenolic oxygen in 
tyrosine was probably derived from molecular oxygen. Evidence for this came from 
carrying out the hydroxylation in the presence of 0218 or H20l8, where tyrosine was 
only labelled in the presence of the former. During preliminary kinetic analysis of the 
hydroxylase it became evident that another factor that could be oxidized by air was also 
required for the conversion of phenylalanine into tyrosine. Direct evidence for the 
involvement of a cofator other than NADPH was gleaned during attempts to further 
purify the rat liver enzyme. The hydroxylase activity was completely lost and was only 
restored when boiled rat-liver extract was included in the assay. Early chemical evidence 
suggested that the non-protein component in the boiled rat-liver extract might be a 
pteridine. The well known pteridine cofactor in several biological reactions, 5,6,7 ,8-
tetrahydrofolate (1) exhibited cofactor activity when included in the assay, whereas folic 
acid, 5-formyltetrahydrofolate and 7,8-dihydrofolate were inactive. Chemical studies of 
0 H H Nr: 10 5 6. N 
1 H 8 
N 
H (1) 
H ,COOH 0 ,/.~ ~ 
C-N/~COOH 
H 
the natural cofactor indicated that it did not contain the p-aminobenzoylglutamate side 
chain. By a series of elegant experimental studies it was showed that the 'labile' rat-liver 
enzyme was phenylalnine hydroxylase (PAH), the 'stable' sheep-liver enzyme was 
dihydropteridine reductase (DHPR) and the cofactor in the boiled extract was the 
unconjugated pteridine 5,6,7,8-tetrahydrobiopterin (2). The last of these discoveries was 
significant because it was the first report of a Liochemical role for an unconjugated 
pteridine (Kaufman, 1957,1958 a,b, 1959, 1961, 1963; Kaufman et al., 1962). 
2 
0 
7 
8 
N 
H 
(2) 
OH 
. 
. 
-
-OH 
Several tautomers of dihydropteridine were postulated as possible oxidation products of 
the phenylalanine hydroxylase catalysed reaction, hence substrates for DHPR (3-5). 
0 
HN..JyNyR 
A .. Jls~H 
H2N N N H 
H 
(3) (4) 
Structures (3) and (4) were eliminated on the basis of chemical studies, and it was 
realised that the sheep-liver enzyme was contaminated with dihydrofotate reductase 
(DHFR, EC 1.5.1.3) which can reduce the more stable 7 ,8-dihydropteridines. Structure 
(5) was favoured as the cofactor for DHPR (Kaufman, 1961). Later, Hemmerich (1963) 
presented evidence for the existence of the p-quinonoid tautomer of dihydropteridine (6) 
by analogy with the structure of oxidized lumazines. Further studies involving tritium 
labelling experiments enabled Kaufman (1964) to show that the dihydropteridine product 
of the hydroxylase reaction and hence the substrate for DHPR, was a p-quinonoid 
dihydropteridine ( 6). 
0 
N . 
HN ~ 5 6. 
HNAN~ N 
7 
H 
(6) 
OH 
. 
. 
-
OH 
3 
Work with purer preparations of DHPR indicated that NADH was the preferred 
pyridine nucleotide cofactor (Nielsen et al., 1969; Cheema et al., 1973). The earlier 
observation that NADPH was a better substrate was due to contamination by DHFR in 
the enzyme preparations (Craine et al., 1972). These data culminated in the proposition 
of Scheme 1.1 for the complex phenylalanine hydroxylation system and the discovery of 
dihydropteridine reductase .. 
Phenylalanine hydroxylase 
Phenylalanine Tyrosine 
NADH + H+ 
Dihydropteridine reductase 
Scheme 1.1 The phenylalanine hydroxylation system (Craine et al., 1972) 
1.2 ASPECTS OF PTERIDINE CHEMISTRY AND BIOLOGY 
Pteridines (7) are fused pyrazino-pyrimidine ring systems and pteridines with 2-
amino and 4-oxo substitutions are called pterins (8) after Pfleiderer's suggestion 
(Pfleiderer, 1964). Conjugated pterins are members of the folate series (9) that contain 
the p-aminobenzoylglutamate side chain at C-6 of the pterin nucleus; all other pterins are 
referred to as "unconjugated pterins" (reviewed in Kaufman, 1967a). Since biological 
roles for conjugated pterins have been known and studied for a long time, this class of 
pterins is still referred to as the folates. The biologically active tetrahydrofolates exist in 
4 
several oxidation levels by substitutions at N-5 and/or N-10 so that they can carry out 
their crucial role in several biosynthetic pathways by donating a carbon atom, including in 
the de novo biosynthesis of purines and thymidine (reviewed in Benkovic, 1980). 
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The use of the term 'unconjugated pterin' to describe non-folate type pterins was 
ambiguous at the beginning but it took on a biological meaning when it was discovered 
that the trypanosomid flagellate Crithidia fasciculata required both conjugated and 
unconjugated pterins for growth. The growth p 1ttem of this organism with different 
types of pterins has become a sensitive assay for identification of naturally occurring 
pterins (e.g., L-erythrobiopterin, D-erythroneopte1in, L-threobiopterin). The structure of 
the phenylalanine hydroxylase cofactor, L-erythro-tetrahydrobiopterin (2) was identified, 
after oxidation, by the Crithidia assay. This assay still remains as one of the most 
sensitive assays for biopterin, albeit the most time consuming (Dewey and Kidder, 
1971). 
1.3 THE AROMATIC AMINO ACID HYDROXYLATION PATHWAY 
The discovery that phenylalanine hydroxylase required a pterin cofactor was 
thought to be a strange phenomenon especially since it was an oxygen-activated system. 
The purification and characterisation of tyro sire and tryptophan hydroxy lases gave 
further evidence that oxygen-activated aromatic. amino acid hydroxylases required a 
tetrahydropterin cofactor (N agatsu et al., 1964; Friedman et al., 1972). 
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Scheme 1.2 The Aromatic amino acid hydroxylation pathway. 
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Tetrahydrobiopterin was also the natural cofactor for tyrosine and tryptophan 
hydroxylases (see Scheme 1.2). The reactions catalysed by these two aromatic amino 
acid hydroxylases are important because they are the rate-limiting steps in the 
biosynthesis of neurotransmitters such as dopamine, norepinephrine, serotonin and 
indolamine. 
13c NMR studies of the pterin cofactor during the conversion of phenylalanine 
into tyrosine indicated that when 90% of tyrosine was formed, the predominant pterin 
was a 4a-carbinolamine which readily loses a molecule of water non-enzymatically 
(Lazarus et al., 1982) to form the quinonoid dihydropterin which is the substrate for 
DHPR. Further evidence favouring the quinonoid dihydropterin structure as substrate for 
DHPR includes the preservation of the chiral centre* at C-6 of the pterin nucleus during 
the in situ oxidation of tetrahydropterin ( 10) and the subsequent reduction of the oxidized 
dihydropterin (11) by DHPR in the presence of NADH (Hasegawa et al., 1979). The 
fact that quinonoid 6,6-dimethyldihydropterin (12) was a substrate for DHPR, provided 
added proof for the quinonoid species (Armarego and Waring, 1983). 
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The removal of H20 from the primary product formed during the hydroxylase 
reaction to give the quinonoid dihydrobiopterin can also be catalysed by a dehydratase 
enzyme found in liver (Huang et al., 1973 and Lazarus et al., 1983; see Scheme 1.2). 
The natural tetrahydropterin cofactor for the aromatic amino acid hydroxylases can be 
biosynthesized in several organisms including man by apparently similar routes (Curtius 
et al., 1985; Nichol et al., 1985). The confirmation that the primary precursor for 
tetrahydrobiopterin biosynthesis is guanosine triphosphate (GTP) was evidenced by the 
ability of several organisms to convert [14C] guanosine into [14C] tetrahydrobiopterin, 
whereas [2-14C] folic acid was not converted into [14C] tetrahydrobiopterin. The first 
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step towards the synthesis of tetrahydrobiopterin involves a complex ring opening of the 
guanosine ring, elimination of C-8 and a ring closing reaction that can be catalysed by the 
enzyme GTP-cyclohydrolase (Fan and Brown, 1976; Blau and Niederwiesser, 1983). 
The product of this reaction is dihydroneopterin triphosphate and the mechanism of its 
subsequent conversion to tetrahydrobiopterin by a series of intramolecular 
rearrangements, elimination and reduction reactions, is still not completely clear. 
However, the involvement of DHFR in the biosynthesis was precluded because 
tetrahydrobiopterin synthesis was demonstrated in vivo when the reductase activity was 
inhibited by methotrexate (Duch et al., 1983). 
1.4 CLINICAL SIGNIFICANCE 
The observation by Folling (1934) that urine samples of mentally retarded patients 
had high levels of phenylpyruvate, which is a breakdown product of phenylalanine, 
marked the discovery of the metabolic disorder Phenylketonuria (PKU). The cause of 
this genetic disorder which is transmitted in an autosomal recessive manner is the 
deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; see Scheme 1.2). 
Lesions at the PAH gene locus which causes the deficiency of the hydroxylase result in 
the build up of high phenylalanine levels in the blood and tissues of the patient. PKU is 
common in Caucasians and occurs with a frequency of about 1 in 10,000 births. In some 
communities the ratio can be as high as 1 in 6,000, e.g. in Ireland (Tourian and Sidbury, 
1983). The wide range of elevated levels of phenylalanine in the blood of PKU sufferers 
(from 2.5 mg to 60 mg/100 ml) indicated the heterogenous nature of the disease (Trefz et 
al., 1985). The complexity of the phenylalanine hydroxylation system also indicated the 
possibility of several biochemical lesions that could result in PKU-like symptoms (see the 
Block sites in Scheme 1.2). It is now known that the lesion of PAH results in classical 
PKU and lesion of DHPR or the enzymes involved in biosynthesis of tetrahydrobiopterin 
results in PKU variants known as malignant hyperphenylalaninaemia (MHP A; Blocks 2,3 
etc. in Scheme 1.2). 
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1.4.1 Classical PKU 
Since 1965 most western countries have used a routine assay known as the 
Guthrie inhibition assay (Guthrie and Susie, 1963) to screen newborn infants for 
increased phenylalanine levels (>2.5 mg/100 ml blood). Guthrie-positive newborn 
infants are further investigated by direct determination of the level of serum phenylalanine 
and a phenylalanine load test (reviewed by Cotton, 1985). Very little was known about 
PKU at the molecular level because phenylalanine hydroxylase is quite labile and hence 
difficult to isolate and study. However, the cloning and sequencing of the full-length 
human PAH cDNA (Kwok et al., 1985) has contributed immensely to the understanding 
of classical PKU. Restriction fragment linked polymorphism (RFLP) analysis of a PKU 
population identified twelve RFLP haplotypes, of which four mutations accounted for 
90% of PKU cases in a sample population (Konecki et al., 1988). This finding readily 
explains the reasons for the wide range of elevated levels of phenylalanine in blood and 
serum of positive PKU cases and also can serve as an excellent complement to confirm 
PKU positives that are identified by the Guthrie test. RFLP haplotype information has 
the potential of being used for neonatal screening of high risk groups and also for the 
purpose of identifying 'carriers' in the general population. A further development in this 
direction has been made by the demonstration that subnanogram quantities of DNA can be 
amplified by the Polymerase Chain Reaction and analysed for RFLP haplotypes (DiLella 
et al., 1988). 
The clinical symptoms as a result of high levels of phenylalanine in blood and 
tissues of classical PKU sufferers range from the impairment of their mental ability, by 
lowering the level of other aromatic amino acids available for the normal development of 
the brain, to inhibition of protein synthesis, especially of those proteins involved in 
myelination, hence causing disruption of the whole neuronal circuitry (Davison, 1973). 
Classical PKU has been controlled to a large extent by placing the affected infant on a 
strict phenylalanine-free diet (Bickel et al., 1953). When the dietary treatment is 
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commenced before the affected infant is 3 weeks of age and continued for at least the first 
decade of its life, brain damage and other associated symptoms are effectively prevented 
(reviewed in Cotton, 1985). 
1.4.2 Malignant hyperphenylalaninaemia (MHPA) 
When all the components of the phenylalanine hydroxylating system were 
elucidated (Kaufman, 1967b), it became apparent that other forms of PKU that are not 
due to lesions of PAH can exist,. However, it was not until 1974-75 that several reports 
about PKU variants that were not responding to dietary treatment started to appear in the 
literature (Bartholome, 197 4 ). The first confirmed report of MHP A was a patient lacking 
in DHPR (Kaufman et al., 1975). This patient showed no DHPR activity when tissue 
samples were assayed under conditions that can detect 1 % of normal DHPR acitivity. 
Antibodies raised against sheep-liver DHPR which gave a precipitin line with control 
human-liver extracts did not give any precipitin line with the extract from the patient's 
liver (Milstein and Kaufman, 1975). In addition it was found that the phenylalanine 
hydroxylase activity in the cases where there were lesions in DHPR or the enzymes 
involved in biosynthesis of tetrahydrobiopterins was depressed to about 20% of the 
normal activity. Scheme 1.2 clearly shows that DHPR and tetrahydrobiopterin are 
involved in the reactions catalysed by tyrosine and tryptophan hydroxylases, which are 
rate limiting steps for the biosynthesis of the neurotransmitters. Therefore it is not 
surprising that biochemical lesions that cause MHP A result in severe neurological 
deterioration and death by the time the patient is 6-7 years of age (Danks et al., 1978). 
Several cases of MHP A due to tetrahydrobiopterin deficiency have been identified and in 
most cases the biochemical lesions have been related to deficiency of enzyme(s) involved 
in conversion of dihydroneopterin triphosphate to tetrahydrobiopterin (reviewed by 
Cotton, 1985). One case of tetrahydrobiopterin deficiency due to lack of GTP-
cyclohydrolase has also been identified (Niederwieser et al., 1984). 
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On the diagnosis front, Guthrie-positive infants that are suspected MHPA 
sufferers are further tested to establish the type of biochemical deficiency. The sensitivity 
of the DHPR assay has allowed direct measurement of the reductase activity in cultured 
skin fibroblasts, continuous lymphoid cells, erythrocytes and liver biopsies. This has 
been useful to determine if the patient suffers from MHP A due to DHPR deficiency. 
Levels of pterins in the serum of patients are also a good indicator of the type of 
biochemical defect. DHPR deficiency is normally characterised by high levels of 
dihydroxanthopterin, neopterin and biopterin with almost negligible levels of 
tetrahydrobiopterin. Defects in the biosynthesis of the pterin cofactor on the other hand 
result in a high neopterin to biopterin ratio in serum when the defect is due to enzyme(s) 
involved in converting dihydroneopterin triphosphate into tetrahydrobiopterin; and an 
overall decrease in levels of neopterin, biopterin and other pterins when the defect is due 
to deficiency in GTP-cyclohydrolase activity (reviewed by Cotton, 1985). The cloning 
and sequencing of the cDNA of human liver DHPR (Dahl et al., 1987; Lockyer et al., 
1987) and the RFLP haplotype analysis of mutant genes (Dahl et al., 1988) introduces the 
possibility of neonatal screening for DHPR deficiency in high-risk pregnancy cases. 
These new tools could also help in the early identification of the different MHP A types so 
that more progress could be made in the treatment of patients suffering from the 
syndrome. 
The treatment for MHPA involves the use of neurotransmitter replacement 
therapy, tetrahydrobiopterin therapy or the combination of both. The neurotransmitter 
replacement therapy using L-DOPA, L-5-hydroxytryptophan and carbidopa has been 
quite effective in conjunction with dietary restriction of phenylalanine to prevent 
symptoms caused by high phenylalanine levels in serum. Tetrahydrobiopterin treatment 
has been effective in several cases of MHP A but DHPR-deficient cases require higher 
doses of tetrahydrobiopterin because its effective concentration in cells and tissues is 
much lower than that predicted from the actual dose (reviewed by Armarego et al. , 1984; 
Cotton, 1985). The reason for this is the poor penetration of tetrahydrobiopterin across 
the blood-brain barrier. Synthetic tetrahydropterins such as 6-methyltetrahydropterin 
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cross the blood-brain barrier ten times better than tetrahydrobiopterin because of higher fat 
solubility arising from the lipophilic charateristic endowed by the methyl substituent at C-
6 (Kapatos and Kaufman, 1981). Since the available protocols for MHPA therapy can be 
improved, a fuller understanding of the unknown roles of tetrahydropterins and DHPR in 
vivo will be a definite advantage. 
1. 5 OCCURRENCE AND DISTRIBUTION OF DHPR 
DHPR is widely distributed in mammalian cells and has been purified from a wide 
variety of sources including a Pseudomonas species (reviewed by Armarego et al., 1984). 
The only well-characterised physiological role for DHPR is to recycle the pterin cofactor 
involved in the hydroxylation of the aromatic amino acids. However, DHPR is known to 
occur in higher levels than the aromatic amino acid hydroxylases in some tissues. The 
reductase also occurs in human cultured fibroblasts, continuous lymphoid cells, 
peripheral blood lymphocytes, granulocytes and platelet cells, all of which are known to 
lack the aromatic amino acid hydroxylases. Molecular and immunological comparison of 
purified human liver DHPR with DHPR from human cultured fibroblasts and continuous 
lymphoid cells indicated that the same structural gene encoded DHPR irrespective of the 
tissue distribution and function (Firgaira et al., 1981b). Also tetrahydrobiopterin, whose 
only established physiological role is as the natural cofactor for the aromatic amino acid 
hydroxylases, is also present in some tissues which have almost no aromatic amino acid 
hydroxylase activities (Fukushima and Nixon, 1980). These observations indicate that 
DHPR and tetrahydrobiopterin may be involved in other biochemical reactions. The 
literature points to several systems where putative roles for DHPR and pterins have been 
implied. 
Alkylglycerols are glycerols that are attached to a fatty acid side chain by an ether 
bond and are known to be present as components of the myelin sheath and involved in 
haemopoeisis. The cleavage of the ether bond in alkylglycerols by the microsomal 
enzyme glyceryl etherase was shown to require molecular oxygen and tetrahydropterin. 
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Scheme 1.3 Proposed completely soluble electron transport chain (Rembold and Buff, 1972b). 
The activity of this enzyme was shown to be maximal when the soluble fraction and 
NADH were added to the assay. The etherase activity was also stimulated when 
tetrahydropterin was added to washed subcellular preparations (Tietz et al., 1964; Snyder 
et al., 1973). In the case of phenylalanine hydroxylase, the addition of the fraction that 
contained DHPR activity enhanced the hydroxylase activity. By analogy, since the 
glyceryl etherase activity was also enhanced by the addition of the soluble fraction, it is 
most likely that DHPR may be involved in recycling the pterin cofactor required for the 
etherase activity . 
The proline-rich collagen molecules are known to undergo processing by 
hydroxylation of proline residues while ther are still attached to the ribosomes. This 
reaction is catalyzed by proline hydroxylase, which requires molecular oxygen, a-
ketoglutarate and a reducing agent such as ascorbate. Tetrahydropterins, cysteine and 
dithiothreitol are also active as reducing agents. Although ascorbate is generally 
considered as the physiological reductant, Peterkofsky et al .. (1980) showed that proline 
hydroxylase was active in laboratory cultured L-929 cells which did not contain 
measurable ascorbate but contained pterins. The involvement of molecular oxygen and 
tetrahydropterin once again implies a possible role for DHPR. 
The quinonoid dihydropterin-tetrahydropterin couple has a lower reduction 
potential than the oxidized cytochrome c - reduced cytochrome c couple (see Scheme 1.3) 
and this fact has been used for the measurement of dihydropteridine reductase where 
oxidized cytochrome c generates the quinonoid dihydropterin in situ (Hasegawa, 1977). 
Rembold and Buff (1972a,b) demonstrated that the addition of tetrahydropterin to rat liver 
mitochondria resulted in an increase in the net substrate-dependent oxygen consumption 
without the concomitant production of ATP. Their evidence that the electrons from the 
pterin couple were being fed into the mitochondrial respiratory chain at the level of 
cytochrome c came from preliminary low-temperature-difference spectral studies which 
indicated that the pterins caused the reduction of cytochrome c but not cytochrome b. 
Based on these preliminary results, a possible mechanism by which the quinonoid 
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dihydropterin-tetrahydropterin couple may be involved in the mitochondrial electron 
transfer chain was postulated (see Scheme 1.3). A later study of the above phenomenon 
demonstrated that ATP production was coupled to the increase in respiration produced by 
tetrahydropterin with a P:O ratio of 0.85, as expected for reduction at the level of 
cytochrome c (Taylor and Hochstein, 1975). 
A previous study of the involvemant of pterins in electron transfer in the 
photosynthetic centre in postulation of an electron transfer mechanism which involved the 
quinonoid dihydropterin-tetrahydropterin couple (Fuller and Nugent, 1969). The recent 
identification of a pterin derivative as the second prosthetic group (flavin moeity was the 
first group that was identified) in Escherichia coli DNA photolyase, an enzyme that 
catalyses the monomerization of dimers formed between adjacent pyrimidine residues 
when DNA is exposed to ultraviolet light, has been hailed as the first positive implication 
pterin in photobiological processes (Wang et al., 1988). In all these cases where the 
quinonoid dihydropterin-tetrahydropterin couple is involved, DHPR has the putative role 
of recycling the oxidized quinonoid dihydropterin with NAD(P)H providing the reducing 
equivalent. 
Another function for DHPR became apparent when it was found that a patient 
suffering from MHPA due to DHPR deficiency had low levels of serum folate and the 
brain biopsy of this patient indicated deficiency in tetrahydrofolates (Pollock and 
Kaufman, 1978). Under physiological conditions, tetrahydrofolates can be oxidized to 
quinonoid dihydrofolate, and since the latter is a substrate for DHPR (Waring and 
Armarego, 1987), its role in maintenance of tetrahydrofolate levels becomes clear. For 
this reason, DHPR-deficient patients have been treated with folinic acid in conjunction 
with other treatment protocols (reviewed by Cotton, 1985). 
Apart from the wide cellular distribution of DHPR and pterins in mammals, they 
are also known to be widely distributed throughout the living system. The need for good 
experimental models of PKU and MHPA has led to the study of DHPR in the ciliated 
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protozoan Tetrahymena (Sanford and Orias, 1981), the trypanosomid flagellate Crithidia 
fasciculata (Kidder and Nolan, 1973) and a Pseudomonas species (Williams et al., 1976). 
1. 6 ASSAYS FOR DHPR 
Since DHPR was first discovered in conjunction with the phenylalanine 
hydroxylating system, the early assay for DHPR used the coupled enzyme approach 
where the reductase reaction was coupled to the hydroxylase reaction and the rate of 
tyrosine formation was monitored (Craine et al., 1972). The identification of the reduced 
pterin cofactor for phenylalanine hydroxylase activity, and the eventual elucidation that the 
oxidized pterin product of the hydroxylase reactions was the transiently-stable quinonoid 
dihydropterin species which was the substrate for DHPR led to the development of 
several direct enzymic assays. These direct DHPR assays ensured the accuracy of the 
kinetic parameters obtained for the DHPR-catalysed reaction because it became the rate-
limiting step. The reduction of one mole of quinonoid dihydropterin requires one mole of 
NAD(P)H, therefore the initial rates of the enzymic reaction can be determined by 
following the rate of oxidation of NAD(P)H at 340 nm and using 6200 M-lcm-1 as its 
molar extinction coefficient. 
The unstable nature of the quinonoid species (e.g. tv2 of -20 min for quinonoid 
6-methyl-dihydropterin; Armarego, 1984) required that the pterin substrate for DHPR be 
produced rapidly and quantitatively in situ. Several oxidants have been reported in the 
literature but the most commonly employed method uses peroxidase-hydrogen peroxide 
as the oxidant (Nielsen et al., 1969). Peroxidase alone under aerobic conditions can 
rapidly oxidize tetrahydropterin to the quinonoid species (Armarego et al., 1983). It was 
suggested that hydrogen peroxide keeps the peroxidase in the right oxidation state to carry 
out the initiation of oxidation to produce the C-4a radical (13) which could lose an 
electron to produce the quinonoid species (14) as in Scheme 1.4 (Armarego, 1984). The 
other oxidants that have been used include bromine (Benkovic et al., 1985), 2,6-
dichlorophenolindophenol (Craine et al., 1972), ferric iron (Archer et al., 1972), 
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potassium ferricyanide (Nielsen et al., 1969; Archer et al., 1972) and ferri-cytochrome c 
(Hasegawa, 1977). 
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Scheme 1.4 Generation of quinonoid dihydropterin in situ 
In all the cases, the oxidant is used in excess so that the tetrahydropterins are 
quantitatively oxidized to the quinonoid species and rapidly reoxidize the tetrahydropterins 
regenerated by DHPR during the enzymic assay. Thus, it can be assumed that the 
concentration of the quinonoid species during the first few minutes of the assay is equal to 
the concentration of tetrahydropterin that was added in the reaction cuvette for in situ 
oxidation. In most of the studies on DHPR reported in the literature the pterin substrate is 
often a synthetic analog of tetrahydrobiopterin. This is because synthetic pterin analogs 
with substitutions in the 6 and/or 7 positions of the pterin nucleus are often cheaper and 
more widely available. The corresponding quinonoid dihydropterins prepared from the 
synthetic tetrahydropterin substrates often vary in their stability, hence it is often a good 
practice for their stability to be determined spectroscopically prior to their use as 
substrates in enzyme assays. The stability of the quinonoid species is pH-dependent and 
the maximum half-life has been observed at pH 7.4 + 1.0. Thus the optimal pH used for 
DHPR assay is within the range of 7 .0 to 7 .5, where there is negligible auto-oxidation of 
NAD(P)H and maximum stability of the quinonoid dihydropterin. Rearrangement of the 
quinonoid dihydropterin to the 7 ,8 dihydropterin (which is not a substrate for DHPR) is 
slowest in Tris-HCl buffer, hence it is generally used in the assay of the enzyme (Archer 
and Scrimgeour, 1970). Since the DHPR activity is quantified by observing the rate of 
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oxidation of NAD(P)H at 340nm, it is important that the oxidants used to generate the 
quinonoid dihydropterins in situ are transparent at this wavelength. 
1. 7 SUBSTRATES FOR DHPR 
The previously unknown cofactor in the boiled rat-liver extract that was required 
for the conversion of phenylalanine into tyrosine by the phenylalanine hydroxylating 
system was shown to be 5,6,7 ,8-tetrahydrobiopterin and the unusual quinonoid species 
produced by this reaction is the substrate for DHPR (see Scheme 1.2). The Crithidia 
assay identified the configuration of the dihydroxypropyl side chain at C-6 to be L-erythro 
(Kaufman, 1963). Quinonoid 7 ,8-dihydrobiopterin is the natural substrate for all the 
dihydropteridine reductases reported in the literature except for the Pseudomonas species 
DHPR (Williams et al., 1976). The analysis of naturally-occurring pterins in 
Pseudomonas species clearly showed that the major component was 6-
trihydroxypropyl(L-threo)pterin or L-threo-neopterin (15). The evidence for this came 
from ultra-violet spectra, potassium permanganate (KMn04) oxidation and comparative 
paper chromatography. The Crithidia assay was consistent with the L-threo 
configuration and this substrate was about 150 times less effective when compared with 
L-erythro biopterin on a equimolar basis (Guroff and Rhoads, 1969). 
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Early evidence that NADPH was the preferred pyridine nucleotide was shown to 
be in error due to contamination by DHFR. Purified samples of dihydopteridine 
reductases from most sources use NADH about 15 to 45 times more effectively than 
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Table 1.1 Comparison of Km and Vmax values of the natural substrate (a) with synthetic quinonoid 
dihydropterin substrates (b - e) to show the minimum structine required for DHPR activity. 
(summarised by Armarego, 1987) 
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NADPH. However, there are reports in the literature of NADPH-specific 
dihydropteridine reductases with different molecular properties (Hasegawa, 1977). 
1.7.1 Structure-activity relationship of pterin cofactors 
The ambiguities with respect to the structure of the quinonoid dihydropterin 
substrate and the instability of tetrahydrobiopterin at physiological pH (t112 -3 min; 
Armarego, 1984) prompted several laboratories to synthesize more stable analogs and test 
their effectiveness as substrates with a view to using them for therapeutic purposes. 
The para quinonoid structure (6) that was initially proposed by analogy with 
oxidized flavins has an exocyclic double bond at C-2 (Kaufman, 1964). This 
representation of the quinonoid species indicates that the protonation step during the 
DHPR-catalysed reduction may occur at the imino group on C-2. Evidence against the 
para quinonoid structure has been accumulating from several studies. Substitutions of 
pterins at C-2 with 2-MeNH, 2-MeS or 2-Me did not eliminate the substrate activities of 
the corresponding quinonoid species with DHPR. A series of simple quinonoid 
pteridines without the NH2 group on C-2 were good substrates for DHPR and gave 
kinetic constants that were comparable with quinonoid 6-methyl dihydropterins 
(summarised in Table 1.1; Armarego and Waring, 1983; Armarego et al., 1986). 15N 
NMR studies of quinonoid 6,7-dimethyl-dihydropterin enriched at N-1, N-3, N-5 and 
NH2 on C-2 indicated that the endocyclic quinonoid structure ( 16) was the predominant 
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species in neutral aqueous buffer (Benkovic et l l., 1985). The results summarised in 
Table 1.1 show that the 2-NH2 group is not essential for substrate activity with DHPR 
and the endocyclic quinonoid species is the correct tautomeric structure that becomes 
reduced by the enzyme in the presence of NADH. 
A methyl group at N-8 makes the pterin an inefficient substrate for DHPR, and a 
methyl group at N-3 prevents the formation of significant quantities of the quinonoid 
species. The generation of a positive charge at N-3 subjects it to rearrangement by acid 
catalysis, resulting in rapid decomposition of the pterin molecule (Armarego and Waring, 
1982; Mager, 1975). During the search for the minimum structural requirement for the 
pterin cofactor, the simple pyrimidine, 2,5,6-triannno-4-oxopyrimidine (17), was found 
to be a substrate for phenylalanine hydroxy lase and its product 2,6-diamino-4-oxo-5-
iminopyrinridine (18) was a substrate for DHPR (Kaufman, 1979). This indicated that 
the ethylene bridge between N-5 and N-8 is not crucial for the hydroxylase or DHPR 
activity. 
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The endocyclic quinonoid structure of the natural substrate is retained in (18), 
which accounts for its favourable Km (76 µM) with human-liver DHPR (Armarego et al. , 
1983). Waring and Armarego (1987) synthesized the simple pyrimidine (19) so that the 
secondary propane will be somewhat analogous to the C-6 stereochemistry in the pterin 
moeity and might have given stronger binding. The corresponding quinonoid species 
however were not DHPR active and did not inhibit the enzyme activity even at 0.5 mM 
(Waring and Armarego, 1987). The inactivity was attributed to the formation of a 
structure such as (20) which would not bind tightl: , at the active site. The replacement of 
the 4-oxo group by 4-thioxo on the pterin nucleus was also tolerated by the enzyme, but 
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Table 1.2 Kinetic parameters of enantiomeric and racemic quinonoid 
dihydropterins with monkey-liver DHPRa 
Quinonoid dihydropterin substrate 
H2N~N~o 
N~~ y "NS 
H N 7 6 CH3 
H 
S(-) - 6 -methyl 
H2N"::N~o 
N,~ y 'Ns
HN 7 H 
6 
CH3 
R( +) - 6 -methyl 
RS(±) - 6 -methyl 
6,6-dimethyl 
Km(µM) Vmax 
15.9 55.6 
17.4 63.0 
15.0 47.0 
634 121 
a. The DHPR assay was carried out 250c at pH 7.5 (Armarego and Waring, 1982). 
quinonoid 6-methyl-7,8-dihydrolumazine (21) was DHPR inactive (Armarego et al., 
1986). This must be because the electronic properties of the lumazine moiety are different 
from those of the pterin moiety. 
(19) (20) 
Armarego (1979) measured the kinetic parameters of the optically pure 6-R and 6-
S enantiomers of quinonoid 6-methyl-dihydropterins with the view of obtaining some 
stereochemical information about the active site of DHPR. The enantiomers were equally 
effective as substrates. Interestingly, quinonoid 6,6-dimethyl-dihydropterin was a poorer 
substrate and bound some 30-fold less effectively than the quinonoid 6-methyl-
dihydropterins, assuming that Km = Kct (summarised in Table 1.2). The conclusion from 
these stereochemical studies was that the pterin-binding region at the active site of the 
enzyme does not discriminate between the 6-R and 6-S quinonoid 6-methyl-
dihydropterins presumably because the bulky methyl group can occupy the equatorial 
0 H 
N CH3 HN ~ 
OAN6 8 7 N H 
H H 
(21) 
plane in both S (-) and R( +) enantiomers. On the other hand, with quinonoid 6,6-
dimethyl-dihydropterin, one of the bulky methyl groups will always be in the axial plane, 
thus decreasing the binding efficiency due to steric hiderance. These results imply that the 
dihydroxypropyl side chain of quinonoid dihydrobiopterin at C-6 must occupy the 
equatorial plane when it is bound to the active site of the enzyme (see Table 1.2; 
Armarego, 1979; Armarego and Waring, 1982, 1983). 
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1.7.2 Pyridine nucleotide substrates for DHPR 
NADH is the favoured pyridine nucleotide in most of the dihydropteridine 
reductases and it is 15 to 45 times more effective than NADPH (for summary, see 
Armarego et al., 1984). Harono (1972) initially reported the partial purification of four 
different diaphorases from Bombyx silkworm and showed that three of them used 
NADPH more effectively than NADH. Quinonoid dihydrobiopterin was not a cofactor 
for these enzymes (up to a concentration of 0.7 mM), whereas the quinonoid dihydro 
forms of 6,7-dimethylpterin, 6-methylpterin and neopterin were all substrates (Harano, 
1972). There has been no further report of this observation, so the reason why the 
quinonoid dihydrobiopterin was not a substrate is not clear. This was followed by a 
report by Hasegawa (1977) on the existence of a NADPH-specific DHPR in bovine liver 
with different physicochemical properties. With this protein, purified to homogeneity, the 
Km values for NADH and NADPH with quinonoid 6-methyl dihydropterin as the second 
substrate were estimated to be 2900 µM and 1.4 µM respectively (Nakanishi et al., 
1986a). 
1.8 PHYSICAL PROPERTIES OF DHPR 
1. 8 .1 Molecular size and subunit structure 
Generally the native dihydropteridine reductases from most sources are dimers of 
identical subunits with molecular weight of 50 000 to 52 000 as determined by gel 
filtration chromatography, non-denaturing PAGE or analytical ultracentrifugation studies. 
Cross-linking studies using dimethyl suberimidate have been used to confirm that the 
native protein is dimeric (Firgaira et al.,1981a). A subunit molecular weight of 25 000 to 
27 000 as determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) is also a 
characteristic of the mammalian dihydropteridine reductases. These values are consistent 
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with the subunit molecular weights of human-liver DHPR (Dahl et al., 1987; Lockyer et 
al., 1987) and rat-liver DHPR (Shabaz et al., 1987), determined from the amino acid 
sequence deduced from the nucleotide sequences of their genes. SDS-PAGE of human 
DHPR sometimes showed two bands around 25 kD and this was probably due to the 
presence of strongly-bound NADH in some subuLits that retards its mobility (Firgaira et 
al., 1981a). The identical subunits are not covalently bound because they dissociate in the 
presence of SDS even in the absence of sulphychyl reagents. The DHPR isolated from 
Pseudomonas species has an estimated molecular weight of 44 000 for the native protein 
but this enzyme was not purified to homogeneity and denaturing PAGE analysis has not 
been carried out (Williams et al., 197 6). 
The NADPH-specific DHPR from bovine liver and human liver consist of two 
identical subunits that are 35 kD each. These reductases are also active as dimers 
(Nakanishi et al., 1986a,b). There is apparently no NADPH-specific DHPR in human 
brain (S.G.Vasudevan and W.L.F.Armarego, unpublished results). 
1.8.2 Isoelectric point 
The isoelectric points of some of the dihydropteridine reductases have been 
measured and they range from 7.0 for the human--liver DHPR (Firgaira et al., 1981a) to 
5.4 for the enzyme from sheep liver (Webber et al., 1978). Several reports of multiple 
bands during isoelectric focusing of purified dihydropteridine reductases have been 
attributed to tight nucleotide binding and other modifications that may arise during 
manipulations in the purification process. A detailed study of purified rat-liver DHPR 
indicated that three forms of the enzyme with approximate isoelectric points of 6.5, 5.9 
and 5.7 can exist. The three forms were isolated by preparative chromatofocusing and 
shown to exhibit similar kinetic parameters with q 1inonoid dihydrobiopterin and NADH. 
However two distinct subunits, a and ~' were identified when the different forms were 
subjected to denaturing isoelectric focusing in the presence of 6 M urea. The different 
forms of the enzyme represent the three possible combinations of the subunits, which are 
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aa, ap and pp. The aa form of the enzyme can be converted to the P subunit under 
acid conditions. Webber et al. (1986) suggest that differential hydrolysis of asparagine 
and glutamine residues may be responsible for the conversion of the a subunit (amide 
form) to the p subunit (carboxyl form). These amide to carboxyl changes probably occur 
during the purification manipulations. 
1.8.3 Amino acid composition 
The amino acid compositions of several dihydropteridine reductases have been 
reported and they show no unusual properties. The N-terminal amino acid residue of 
DHPR from mammalian sources is blocked by a covalent modification. N-Acetylation of 
isoleucine and cyclization of glutaminyl or glutamyl residues to give pyroglutamic acid 
were suggested as the possible nature of the N-blocked residue (Korri et al., 1977; 
Webber et al., 1987). The nucleotide sequence of the human-liver and rat-liver cDNAs 
coding for DHPR predict that the blocked residue may be N-acetylalanine (Dahl et al., 
1987; Shabaz et al., 1987). Positive identification of the N-terminal amino-acid residue 
would only be obtained from NMR or mass spectrometric studies. 
1.9 INHIBITORS OF DHPR 
The similarities of the pterin nucleus of the natural cofactors for DHPR and DHFR 
led to the well-known inhibitors of the latter being investigated as inhibitors of the former. 
Most dihydropteridine reductases are inhibited by aminopterin, amethopterin 
(methotrexate) and other folate analogs, but the inhibition constants are several hundred-
fold higher than those for DHFR. The mechanism of inhibition by aminopterin and 
amethopterin is competitive in most of the cases studies (for summary, see Armarego et 
al., 1984). The powerful anticancer drug methotrexate which inhibits DHFR strongly, is 
also an inhibitor of DHPR. The Pseudomonas enzyme shows competitive inhibition (Ki 
260 µM) by methotrexate with respect to pterin (Williams et al., 1976). DHPR also 
exhibits substrate inhibition by pterins at high concentrations. 
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Sulphydryl-specific reagents such as p-chloromercuribenzoate (PCMB), mercuric 
chloride (HgC!i) and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) were inhibitors of 
human-liver DHPR in the lower µM range, whereas N-ethylmaleimide (NEM) and 
iodoacetamide were inhibitors in the mM range. Pretreatment of the enzyme with NADH 
protected it totally from inactivation by these sulphydryl agents (Firgaira et al., 1981a). 
The reductase from Pseudomonas species was also inhibited by some of the above 
sulfhydryl reagents in the mM range. Webber and Whiteley (1981) titrated four cysteine 
residues per subunit for the rat-liver DHPR by using sulfhydryl reagents. They also 
showed that only six (three per subunit) thiol residues were accessible to PCMB. When 
the reductase was complexed with NADH (1 : 1), only four thiols were titrated with 
PCMB. This suggested that two thiol groups (one per subunit) are inaccessible to PCMB 
and a further two are either close to or at the nucleotide binding site. In a more recent 
study it was shown that platinum (II) complexes inactivated human-brain DHPR in a time-
dependent manner. Once again it was found that NADH could completely protect the 
enzyme from inactivation (Armarego and Ohnishi, 1987). These results indicate that thiol 
groups which are present at or close to the active site may be involved in catalysis. 
Metal ions such as of lead and aluminium have been shown to inhibit up to 50% of 
rat brain DHPR activity around 50 -100 µM levels (Purdy et al., 1981; Leeming and 
Blair, 1979). As an extension of that observation, Altmann et al. (1987) claimed that 
encephalopathy associated with aluminium intoxication in patients undergoing 
haemodialysis was due to inhibition of DHPR in erythrocytes and proposed that a similar 
reduction in activity may occur in the brain. They indicated that treatment of patients with 
the aluminium chelating agent desfereoxamine showed a doubling of DHPR activity in the 
erythrocytes. However, it was pointed out later that the serum aluminium concentration 
may not reflect the erythrocyte aluminium concentration and that a single dose of 
desfereoxamine results in doubling of erythrocyte DHPR activity for 28 days even though 
the aluminium levels have been reduced to normal (Sprague and Umans, 1987). In a 
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more direct criticism, Milstein and Kaufman ( 1987) alleged that the results of Altmann et 
al. were due to artefacts in their DHPR assay. 
Several aromatic amino acid metabolites and their derivatives inhibit DHPR. The 
aminochrome oxidation products of the catecholamines (dopamine, adrenalin and 
noradrenalin) are potent reversible inhibitors of human-brain DHPR. It was proposed that 
the inactivation was due to structural changes brought about by disulfide bond formation 
between two surface sulphydryl groups (Armarego and Waring, 1983; Waring, 1986). 
The nigrostriatal neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the 
compound present in "synthetic heroin" that causes Parkinsonian symptoms, does not 
inhibit DHPR in the lower millimolar range but its hydroxylated derivative can inhibit the 
enzyme at the micromolar range. However, hydroxylated versions of MPTP have not 
been identified in humans or experimental animals (Abell et al., 1984). 
The inhibition of DHPR by quinones was the basis for the development of the 
naphthoquinone affinity column to purify human liver DHPR and human brain DHPR 
(Cotton and Jennings, 1978). Pyridine nucleotide analogs such as NAD+, AMP, 
Cibacron Blue and Blue Dextran were all competitive inhibitors of bovine kidney DHPR 
with Ki values of 300 µM, 1 µM, 0.3 µMand 0.3 µM, respectively. These dyes have 
been used as affinity adsorbents for the purification of several mammalian 
dihydropteridine reductases (Korri et al., 1977; Chauvin et al., 1979). 
Antibodies raised against DHPR from several sources inhibited their enzymic 
activities to varying degrees. Polyclonal antibodies raised against the bovine-brain 
enzyme crossreacted with the reductase isolated from the brain, kidney and liver tissues of 
rat. The antiserum against sheep liver DHPR crossreacted with DHPR isolated from 
various human, rat and bovine tissues (Snady and Musacchio, 1978; Milstein and 
Kaufman, 1975). On the other hand, the antibodies raised against bovine-liver NADPH-
specific DHPR did not inhibit the NADH-specific DHPR and conversely, the antibodies 
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Scheme 1.5 The mechanism of transfer of the pro-S hydrogen from the B face of 
the nicotinamide ring (A) of the NADH to N-5 of the quinonoid dihydropterin 
(B) that results in the protonation of N-3 to give the tetrahydropterin (C). 
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Scheme 1.6 The reaction pathway for the DHPR catalysed reaction 
against the latter enzyme did not inhibit the former. This indicates that the structures of 
the two proteins may be very different (Nakanishi et al., 1986b). 
1.10 MECHANISM OF DHPR CATALYSIS 
The first committed step in the DHPR-catalysed reaction is the extremely tight 
binding to NADH which is only partially stable to exhaustive dialysis. The binding 
stoichiometry of NADH to the enzyme is 1: 1, i.e. 1 subunit binds 1 mol. of NADH 
(Webber and Whiteley, 1978; Chauvin et al., -979; Armarego and Ohnishi, 1987). 
Armarego (1979) showed that the pro-S hydrogen from the B-face of the nicotinamide 
ring of NADH is transferred to N-5 on the pterin nucleus during the DHPR-catalysed 
reaction. The mechanism of the hydride trartsfer from NADH to the quinonoid 
dihydropterin (q-PH2) is presented in Scheme 1.5. A comparison of deuterated NADH 
(NADD) with NADH as substrate for DI-IPR with quinonoid 6,7-dimethyl 
tetrahydropterin as the second substrate showed that there was no significant difference in 
Km and V max, implying that the rate-limiting step does not involve C - H bond breaking 
(C - D bond energy > C - H bond energy; Ferscht, 1985a). Therefore the rate 
determining step must occur before or after hy,ifogen transfer (Poddar and Henkin, 
1984). Further studies using stopped-flow, rapid quench and temperature-jump 
techniques indicated that the kinetic mechanism involves non-equilibrium ordered binding 
of substrates, where the rate determining step may be the isomerization of the ternary 
complex which precedes hydride transfer (see Scheme 1.6; Poddar and Henkin, 1984; 
Randles, 1986). 
1.11 DIHYDROFOLATE REDUCTASE (DHFR) 
A brief introduction of DHFR is necessary because several references have been 
made to it either to distinguish it from or compare it with some of the features of DHPR, 
which is the main topic of this thesis. 
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DHFR catalyses the reduction of 7 ,8-dihydrofolate to 5,6,7 ,8-tetrahydrofolate, 
7,8-Dihydrofolate + NADPH + H+ • 5,6,7,8-Teterahydrofolate + NADP+ 
and the enzyme from various sources can catalyse the reduction of folate to 7 ,8-
dihydrofolate. However, since the rate of the former reaction is much faster than the 
latter, the enzyme is commonly referred to as dihydrofolate reductase (Blakley, 1984). 
DHFR plays a crucial role in the biosynthesis of the building blocks of DNA. Therefore, 
it was chosen as a target for the anti-cancer drugs which are designed to challenge the 
uncontrolled proliferation of cells (McCormack, 1981). Methotrexate is the most potent 
inhibitor of this enzyme with an inhibition constant (Ki) in the lower nanomolar range. A 
multitude of reviews and monographs cover the avalanche of articles describing various 
aspects of DHFR, ranging from X-ray crystallographic analysis, site-directed 
mutagenesis and detailed kinetic analysis (for a recent review see Morrison, 1988) 
DHFR from most bacterial sources is monomeric with a molecular weight of about 
18 000 and the mammalian enzymes are about 22 kD (Blakley, 1984). The Type I and II 
R-plasmid encoded DHFRs (trimethoprim resistant) are an exception because they have 
subunits with molecular weight of about 8 000-11 000 and are active either as dimers or 
tetramers (Matthews et al., 1986). The superficial relationship between DHPR and 
DHFR that is often referred to is the fact that both the enzymes catalyse the reduction of 
dihydropterins to tetrahydropterins. In both cases ::he chemistry of the enzymatic reaction 
is confined to the pyrazine ring of the pterin r ucleus. However, the dihydropterin 
substrate for DHPR is the transiently stable quinonoid dihydropterin (22) and that for 
DHFR is the more stable 7 ,8-dihydropterin (23) tautomer. NADPH is the preferred 
nucleotide cofactor for DHFR from all the sources and it is clear that the hydride is 
transferred onto C-6 of the pterin moeity as N-5 becomes protonated. In the case of 
E.coli DHFR, the protonation is carried out by an aspartate residue at position 27 (Howell 
et al., 1986). In contrast, in the DHPR-catalysed reaction, the hydride is transferred from 
NADH to N-5 of the pterin moiety and protonation occurs at N-3. The substrate 
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(22) (23) 
specificity range for DHFRs is narrow. Even in the case of the R-plasmid encoded 
DHFR, which bears no homology with other DHFRs, the requirement for 7 ,8-
dihydropterin is absolute and it is completely inactive towards quinonoid 6-methyl-
dihydropterin (S.G. Vasudevan and J.F. Morrison, unpublished results). 
1.12 STRUCTURE OF DHPR 
Primary structural data for DHPR has been long overdue and the main reason for 
this may be that the N-terminal amino acid residue is blocked. Recently, there have been 
three reports of the complete amino acid sequence deduced from the nucleotide sequence 
of cDNA clones from human liver (Dahl et al., 1987; Lockyer et al., 1987) and rat liver 
(Shabaz et al., 1987). The human-liver cDNA clones were identified by screening in one 
case with antibodies raised against human-liver DHPR (Dahl et al., 1987) and in another, 
by using antibodies raised against sheep-liver DHPR (Lockyer et al., 1987). The two 
human-liver sequences were identical except for a serine to threonine change at amino acid 
residue 51 (counting the methionine start codon as position 1) which may be due to 
polymorphism. However, an error in reading the nucleotide sequence cannot be ruled out 
because polymorphic sites usually arise from single nucleotide changes in the sequence, 
whereas in this case it is a GC inversion (AGC for serine to ACG for threonine) . 
Moreover, one of the human-liver DHPR sequences (Dahl et al., 1987) is identical with 
the rat-liver DHPR sequence at position 51 (see Figure 1.1). The rat-liver cDNA was 
obtained by hybridization screening using a low-degeneracy radiolabelled oligonucleotide 
probe predicted to encode a short internal peptide sequence of a cyanogen bromide 
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Figure 1.1 The amino acid sequence of human-liver DI-IPR predicted from the open reading frame in the nucleotide 
sequence of cDNA (Dahl et al., 1987). (*) Position 51 is a threonine residue in the human-liver DHPR sequence obtained by 
Lockyer et al. (1987). The residues typed in bold are substitutions that occur in the rat-liver DHPR sequence (Shahbaz et al., 
1987). The boxed sequence indicate the human-brain DHPR peptides that were independently obtained in this laboratory 
(A. Ohnishi, S.G.Vasudevan and W.L.F. Armarego, unpublished results). 
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cleavage fragment. The rat sequence differs from the human-liver DHPR sequence of 
Dahl et al. (1987) by 10 residues. The changes in most instances are conservative but the 
most significant difference is around the N-terminal region where the human liver enzyme 
has a string of three additional alanines and a serine to alanine replacement (see Figure 
1.1 ). The high conservation of sequence between rat and human reductases is astounding 
and implies that the structure of the protein is very tightly linked with its function. 
The DHPR sequences have been compared with the DHFR sequence to determine 
regions of homology since the two enzymes carry out superficially similar reactions. 
Only a small region of homology was observed between the human DHPR and the human 
DHFR around Cys104 for the former and Gly20 for the latter (Dahl et al., 1987). This 
region in DHFR is known to be involved in the binding of the pyridine nucleotide. 
Several DHFRs have been crystallised and subjected to high resolution X-ray structural 
analysis. Thus crystal structure of DHPR will be desirable to indicate if the tertiary 
structure of these two related proteins have any resemblance that is pertinent to their 
function. Preliminary X-ray diffraction data of rat-liver DHPR that crystallised in the 
monoclinic system with a C2 space group has been reported (Matthews et al., 1986). 
AIM OF THIS RESEARCH PROGRAMME 
In the light of the rapidly accumulating data that uncongugated pterins and DHPR 
are distributed widely even in cells that do not contain aromatic amino acid hydroxylases, 
further investigations are necessary to identify alternative functions. Since it is well 
known that in Escherichia coli the aromatic amino acids phenylalanine, tyrosine and 
tryptophan are synthesized from a common precursor, chorismate via the shikimate 
pathway (Umbarger and Davis, 1962; Gibson and Pittard, 1968), the organism will be a 
good model system to investigate alternative role(s) for DHPR. As there are no aromatic 
amino acid hydroxylases in E.coli, and there is no information available on the presence 
of a dihydropteridine reductase in the organism, the primary tasks of this study are as 
follows: 
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a) Show the presence of DHPR in the organism. 
b) Isolate and purify E.coli DHPR to electrophoretic homogeneity. 
c) Characterise the protein and compare it with other known DHPRs. 
d) Investigate other enzymic activities for the purified DHPR. 
e) Obtain N-terminal sequence data for the new protein. 
f) Determine kinetic constants for the various substrates and identify the natural 
substrates for the enzyme. 
f) Isolate the gene that encodes DHPR in the organism so that it will provide a 
genetic handle for the use of established mutagenesis methods to investigate 
effects of deletion of the gene from E. coli. The experimental approach to 
isolate the gene coding for DHPR would involve: 
i) Construction of a cosmid library containing large inserts of 
chromosomal DNA from Escherichia coli (,..,35-40 kb). 
ii) Transfection of a suitable strain and selection of clones by screening 
for increased DHPR specific activity. 
iii) Sub-cloning the DHPR gene and characterise the gene product to 
confirm that it is similar to the protein purified and characterised in 
the first instance. 
iv) Attempt to sequence the complete gene that encodes D HPR so 
it can be compared with the mammalian DHPR sequence and with 
the E.coli DHFR sequence to determine if there is any significant 
relationship. 
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CHAPTER 2 
PURIFICATION OF DIHYDROPTERIDINE REDUCTASE 
FROM ESCHERICHIA COLI 
2 .1 INTRODUCTION 
Dihydropteridine reductase has been isolated in a pure form from several 
mammalian tissues. The reductase has also been partially purified from other sources, 
e.g. from a P seudomonas species (reviewed by Armarego et al., 1984 and Shiman, 
1985). The only addition to the comprehensive list of sources from which DHPR has 
been purified, cited in the review by Armarego et al., 1984, is the NADPH-specific 
DHPR purified from bovine and human livers (Nakanishi et al., 1986a,b). The isolation 
of DHPR from these various sources was spurred on by the discovery of a variant form 
of phenylketonuria where the biochemical defect was in the reductase (reviewed by Danks 
et al., 1978) and also because little was known about the enzyme. The enzyme from 
sheep that was described by Kaufman (1959) was purified to apparent homogeneity for 
the first time from the liver tissue (Craine et al., 1972). Three fractionation steps 
(ammonium sulfate precipitation, zinc-ethanol fractionation and alkaline ammonium 
sulfate precipitation) followed by calcium phosphate gel elution, DEAE-cellulose 
chromatography and Sephadex G-100 gel filtration, were used to attain a 160-fold 
purified reductase with a final specific activity of 15.6 U/mg. Since then, a wide range of 
procedures have been used to purify DHPR from other sources. The use of affinity 
chromatography featured strongly in most of these new procedures. An affinity column 
based on the fact that the reductase is inhibited by methotrexate, which is a pterin 
analogue, has been used to purify the sheep and rat-liver enzyme (Webber et al., 1978) 
with methotrexate-aminohexyl Sepharose affinity adsorbent. This method has not been 
adopted in other laboratories and even the authors' laboratory has reported an alternate 
method (Webber et al., 1986). The main drawback with a methotrexate-based affinity 
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column, despite the fact that it somewhat speeded up the purification of DHPR, is the real 
problem of contamination by dihydrofolate reductase. 
The reductase from bovine liver has been shown to be strongly inhibited (Ki of 
0.3 µM for each) by Cibacron Blue (F3GA) and Blue Dextran (Chauvin et al., 1979). 
Binding of proteins to immobilized Cibacron Blue columns has been ascribed to the 
interaction between the nucleotide binding domain of the protein and the dye ligand. It is 
well known that this specific interaction is due to the similarity in the three-dimensional 
structure of NAD and Cibacron Blue F3GA (Thompson et al., 1975). Further evidence 
for this came from the X-ray crystallographic structure of Cibacron Blue F3GA bound to 
liver alcohol dehydrogenase, where the dye was clearly shown to be interacting with the 
nucleotide binding domain (Biellmann et al., 1979). This dye ligand-nucleotide binding 
domain interaction was exploited in the use of immobilized Cibacron Blue F3GA 
(Chauvin et al., 1979) and Matrex Gel Blue A (Shen and Abell, 1981; Webber et al., 
1986) to purify large quantities of the reductase from bovine kidney, human platelets and 
rat liver, respectively. 
However, by far the most successful affinity adsorbent available for the 
purification of DHPR is 1,2-napththoquinone-4-sulfonic acid coupled to aminohexyl-
Sepharose. The ligand, 1,2-napthoquinone-4-sulfonic acid is a potent inhibitor of 
phenylalanine hydroxylase and the affinity column was initially designed to purify that 
enzyme (R.G.H. Cotton, private communication). However the hydroxylase did not 
bind to the affinity column. It was suggested that the ligand may have undergone a 
physical change during the cross-linking reaction with the Sepharose, thus losing its 
capacity to interact with the hydroxylase. Fortunately the naphthoquinone column proved 
to be an excellent method for purifying DHPR (Cotton and Jennings, 1978). This 
method has been used to purify DHPR from human liver, fibroblasts and continuous 
lymphoid cells (Firgaira et al., 1981a,b), from human brain (Armarego and Waring, 
1983) and from rat liver (Purdy and Blair, 1980). Sheep-liver DHPR apparently did not 
bind to the naphthoquinone affinity column (W.L.F. Armarego and H. Taguchi, 
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unpublished results). In all cases, homogenous preparations were obtained after the 
passage of the affinity purified protein through at least one other chromatographic step. 
Bearing in mind the various methods that have been used to purify the reductase 
from other sources, the experimental approach described in this chapter was to explore the 
possibility of purifying the E. coli reductase by an affinity chromatographic procedure. 
This turned out to be unsuccessful and the procedure of Williams et al. (1976) which 
described the partial purification of the only other bacterial OHPR (from Pseudomonas 
species A TCC 11299a) was first adopted to purify the reductase from Eschericha coli. 
This method was not ideal but a new method developed around it allowed the purification 
of E. coli OHPR to apparent homogeneity. This successful attempt was considerably 
improved by employing a preparative flat bed isoelectric focusing step that increased the 
yield and speeded the isolation procedure. 
2.2 RESULTS AND DISCUSSION 
In the attempted purification using the naphthoquinone affinity column the E. coli 
OHPR activity (90%) appeared in the void volume, unlike the human liver and brain 
enzyme that were bound to the column and were eluted by the OTT-containing buffer (see 
section 2.5.1; ca. Firgaira et al., 1981a; Armarego and Waring, 1983). Normally, the 
OHPR-NAOH complex binds to the mahagony-coloured oxidized quinone form of the 
ligand and upon washing with the OTT-containing buffer the bound ligand becomes 
reduced to the green-coloured diol form, which causes a weakening in its affinity for the 
reductase complex (see Scheme 2.1). To confirm that the affinity adsorbent was 
functioning properly, 80 units (enzyme activity) of human brain OHPR were applied to 
the column and eluted as described in Section 2.5.1 . More that 90% of the human brain 
OHPR activity applied to the column was held and eluted by the OTT containing buffer, 
thus confirming that the naphthoquinone affinity adsorbent does not bind the E. coli 
OHPR-NADH complex. 
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Table 2.1 Trial purification using the Amicon Dye Matrex Kit 
Control BlueA RedA OrangeA GreenB BlueB 
% DHPR activity in void volume 98 84 70 80 90 100 
% DHPR activity in high salt eluate 5 20 5 
Assay: The DHPR assay was carried out as described in Section 2.5.1.1 at 25°C in Tris-HCl (pH7.4). 
0 
OH 
OTT OH 
so~I 
Sheme 2.1 The oxidised and reduced forms of the naphthoquinone ligand 
(Armarego et al., 1984) 
At this stage discovery of the inability of E.coli DHPR to bind the naphthoqu 
inone Sepharose column was not surprising because not all dihydropteridine reductases 
are held by this column. Armarego and Taguchi (unpublished results) indicated that 
sheep-liver DHPR did not bind to it. However, the high homology between the predicted 
(from nucleotide sequence) amino acid sequences of rat-liver DHPR (Shabaz et al., 1987) 
and human-liver DHPR (Dahl et al., 1987), as well as the extensive homology between 
the available amino acid sequence of sheep-liver DHPR and the predicted amino acid 
sequence of human-liver DHPR (Lockyer et al., 1987), indicates that mammalian DHPR 
structures are highly conserved. In this light, th( lack of binding of sheep liver DHPR 
needs to be re-evaluated. In that particular case it is possible that deterioration of the 
affinity ligand may have been the reason. Although the reasons for the binding of DHPR 
to the naphthoquinone column are not very clear, the fact that the NADH-bound 
mammalian dihydropteridine reductases are held on the column suggests that the pterin 
binding domain may be the site of interaction. The lack of binding of E.coli DHPR may 
be due to lack of structural homology with the mammalian enzyme or the presence of 
some factor in the extract that inhibited the binding of this reductase, since it had been 
shown that the column was in working condition. 
The commercially available Dye Matrex columns (Amicon Corporation) were 
surveyed to identify a suitable dye affinity colurnn that would bind the reductase from 
E.coli and provide a good first step in purification. However the results in Table 2.1 
indicated that none of the dye columns were suitable for binding DHPR. The possibility 
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that one of the columns could have provided partial purification could not be ruled out 
because protein measurements were not carried out on the wash and eluate fractions since 
clearly the affinity columns did not bind E.coli DHPR strongly. 
The method of purification of DHPR from Pseudomonas species, the only other 
bacterial DHPR that had been reported (Williams et al., 1976), was followed. The 
fractions that were eluted from the DE52 column were assayed for DHPR activity using 
K 3Fe(CN)6 as the oxidant to generate the pterin substrate, quinonoid 6-methyl 7 ,8-
dihydropterin. Two fractions that exhibited consumption of NADH in the DHPR assay 
were isolated. At first it was thought that the two species were isoenzymes because the 
band that was eluted at 100 mM NaCl (band I in Figure 2.1) had 50% of the reductase 
activity with NADPH as cofactor compared to that with NADH as the cofactor. The 
second band (band II in Figure 2.1) that was eluted at about 200 mM NaCl, on the other 
hand, was totally NADH-dependent and did not oxidise NADPH. However, upon 
further investigation of the two active bands using peroxidase/H202 as the oxidant to 
generate the quinonoid dihydropterin cofactor in situ, it was found that only band I 
exhibited pterin-dependent oxidation of NADH, whereas band II was completely inactive. 
This result indicated that both bands I and II had NADH oxido-reductase activity (with 
ferricyanide as the electron acceptor; Dixon and Webb, 1979), but only band I had DHPR 
activity. NADH oxido-reductases had been isolated and characterised from several 
sources and they are mostly involved in electron transport processes. More recently, a 
H20-forming NADH oxidase from Streptococcusfaecalis was isolated and found to be a 
flavoprotein. This enzyme was also specific for NADH and completely inactive towards 
NADPH (Schmidt et al., 1985). It is supected that the protein in band I may be similar to 
the S. f aecalis enzyme because their natural molecular weights appeared to be the same 
(about 50 Kd). The general caution that ferricyanide should not be used as an oxidant to 
generate the quinonoid pterin substrate when studying DHPR in bacterial extracts should 
be raised. The cell-free extract from human brain did not exhibit pterin-independent 
NADH oxido-reductase activity when K3Fe(CN)6 was used as substrate (S.G. 
Vasudevan and W.L.F. Armarego, unpublished results). 
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Figure 2.1 DE-52 union exchange chro1natogruphy of /1.,'. coli dihydroptcridinc rcduct.u~c 
as described in Section 2.6.3 
Key to symbols : ~ conductivity; 6,. protein concentration; Q dihydroplericline reductase 
activity, assayed as described in Section 2.5.1.1; D oxido-reductase activity, assayed as decribed in 
Section 2.5.1.2 
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Table 2.2 Requirements of pterin-dependent and pterin-independent NADH oxidation in Tris-HCI (pH7 .4) at 25°C 
Omission Pterin-dependenta N AD H oxidationc Pterin-independent b NADH oxidationc 
None 4.58 5.16 
Enzyme 0.42 0.38 
6-Me thy ltetrahydropterin 0.23 4.52 
NADH 0.00 0.00 
Peroxidase/peroxide 0.48 ------
K3Fe(CN)6 ------ 0.45 
a. DHPR assay carried out as described in Section 2.4.1.1 
b. Oxidoreductase assay carried out as described in Section 2.4.2.2 
c. µmoles NADH oxidized per min per ml of enzyme 
The requirements for pterin-dependent and pterin-independent NADH oxidase 
activities were investigated and are summarised in Table 2.2. Clearly, quinonoid 
dihydropterin is the substrate for the pterin-dependent oxidation of NADH because when 
the constituents of the assay mixture such as the enzyme or the substrate (6-methyl-
tetrahydropterin) or the oxidant (peroxidase/H202) were individually omitted, the level of 
NADH oxidation was <10% of that when all the requirements for the pterin-dependent 
reaction were present. The small level of NADH oxidation in the reactions without all the 
requirements for the DHPR assay can be ascribed to non-enzymic aerobic oxidation. In 
the pterin-independent oxido-reductase activity, the rate of oxidation of NADH in the 
absence of 6-methyl-tetrahydropterin was about 90% of that when the pterin subtrate was 
present. The requirement of K3Fe(CN)6 for NADH oxidation in the pterin-independent 
reaction was clearly demonstrated. In summary, although both peroxidase/H202 and 
K3Fe(CN)6 have been used as oxidants for assaying DHPR activity of mammalian 
enzymes, use in the purification of DHPR from E.coli is limited to the former. From this 
point on, the pterin-dependent NADH oxidation will be referred to as DHPR activity and 
the pterin-independent NADH oxidation will be known as NADH oxido-reductase 
activity. 
The presence of both DHPR activity and NADH oxido-reductase activity in the 
partially purified band I, thought to be due to contamination by another protein with the 
latter activity. The DHPR-active band I lost >80% of the reductase activity that was 
applied to the Ultragel AcA 33 gel filtration column despite the presence of 2mM DTT and 
20 µM NADH throughout the separation. The long separation time (>24 h) involved in 
the AcA.33 gel filtration was not suitable for the purification of E. coli DHPR. The 
Pseudomonas enzyme also lost >50% of the activity that was applied to each gel-filtration 
chromatography (Williams et al., 1976). 
The fast protein liquid chromatography (f.p.l.c.) system allowed rapid trials of 
various columns. The enzyme from the DE52 column was subjected to gel filtration (60 
35 
min) at 150c on a Superose 6 column that had a separation range of 5 to 5 000 kD 
followed by a second gel filtration on Superose 12 column that had a separation range of 
1000 to 3 000 kD. When the active fractions after the gel filtration purification were 
finally purified through a Mono-Q anion exchange column (see Figure 2.2) the resulting 
DHPR-active fraction also contained NADH oxido-reductase activity. Analysis of the 
active fractions by SDS/P AGE revealed two protein bands with Mr values of 20 000 and 
27 kD (see Figure 2.3). The two protein bands were not separated after an additional step 
of f.p.l.c. Mono-S cation-exchange chromatography was introduced. Non-denaturing 
PAGE of this mixture gave one band when stained for protein. The same band also 
stained for DHPR activity. When the band corresponding to the protein and activity stain 
was cut out and extracted into 50 mM Tris/HCl p--I 7.4 (500 µl), it was found to possess 
both DHPR activity and NADH oxido-reductase activities (see Figure 2.4). 
At this stage it was suspected that the protein could be a dimer with subunits of 
unequal Mr values, where one subunit was responsible for the DHPR activity and the 
second subunit was responsible for the NADH oxido-reductase activity. Further evidence 
that a single protein had both the activities came from looking at the ratios of the two 
activities during purification, which remained unchanged (see also the inset in Figure 
2.2). Finally, when the two activities were mea~.ured in the presence of methotrexate, 
which was known to inhibit DHPR activity, beth the DHPR and the NADH oxido-
reductase activities were inhibited (see Figure 2.5). The concomitant loss of the two 
enzymic activities in the presence of an inhibitor which is a pterin analogue was taken as 
an indication that their active sites must be closely ~,.ituated or identical. 
However, when this apparently pure heterodimer was subjected to non-denaturing 
isoelectric focusing and stained for protein, two bands that were close to the anode were 
apparent. A second dimension (SDS-PAGE) of the isoelectric focused disc gel clearly 
showed that these were two different proteins (see Figure 2.6). If the protein was a true 
heterodimer, then non-denaturing isoelectric focusing should not have separated the 
subunits. The protein mixture was finally purified to apparent homogeneity by f.p.l.c. 
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Figure 2.2 Mono-Q anion exchange chromatography of E. coli DHPR 
Partially purified DHPR (after chromatography through Superoses 6 and 12, gel 
filtration columns) was chromatographed on a Mono-Q column, essentially as 
described in Section 2.6.6. Buffer A was 50 mM Tris/HCl (pH7.4) and Buffer B 
contained 200 mM NaCl (in Buffer A). The column was eluted with a linear 
gradient of NaCl (0 to 100 mM) at a flow rate of 1 ml/min for 5 min, followed by 
isocratic elution at 100 mM NaCl at the same flow rate for 3 min and 0.5 ml 
fractions were collected. The linear gradient elution was then continued for a 
further 12 min. The DHPR and the oxido-reductase (oxidase) activities 
co-eluted between fractions 4 and 6 (Inset: Histogram shows the levels of the two 
enzymatic activities measured as described in Sections 2.5.1.1 and 2.5.1.2, 
respectively. 
Figure 2.2 SDS-PAGE of samples from fractions 4, 5 and 6 after Mono-Q 
anion exchange chromatography. 
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Figure 2.4 No~-denaturing-PAGE of dihydropteridine reductase 
The partially-purified protein (2 µg per track) was subjected to non-denaturing-PAGE as described in Section 2.5.3.2. 
The gel was cut into three sections (a, band c). Section (a) was stained for protein using Coomassie Blue (see Section 
2.5.3.1). The shaded portion in Section (b) was cut out with a scalpel and extracted into 50 mM Tris/HCl (pH7.4). The 
extracted protein contained both DHPR and oxido-reductase activities when measured spectrophotometrically, as described 
in Sections 2.5.1.1 and 2.5.1.2, respectively. Section (c) was stained for DHPR activity as described in Section 2.5.3.2. 
The broad band was attributed to diffusion of DHPR in the gel during the staining. 
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Figure 2.5 Effect of methotrexate on E. coli DH PR 
(a) Percentage loss of pterin-independent NADH oxido-reductase activity [assay 
described in Section 2.5.1.2]. (b) Percentage loss of DHPR activity [assay 
described in Section 2.5.1.1]. 
Figure 2.6 Two-dimensional gel electrophoresis of apparently-pure heterodimer 
, ... -5 µg of apparently-pure E.coli DHPR (consisting of 27-kD and 20-kD subunits) was electrophoresed in the first 
dimension by non-denaturing IEF (Section 2.5.3.3) followed by a second dimension separation on a 12% (w/v) 
SDS-PA gel. The arrowhead 'a' indicates the 27-kD E.coli DHPR and the arrowhead 'b' indicates the contaminating 
protein (20 kD; discussed in text). 
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Table 2.3 Purification of dihydropteridine reductase from Escherichia coli 
Purification stepa 
Cell-free extract 
Ammonium sulfate fraction b 
DE 52 anion exchange 
Mono-Q anion exchangec 
Mono-P chromatof ocusingc,d 
Volume 
(ml) 
300 
80 
8 
6 
3 
Total activity 
(U) 
632 
355 
80 
50 
31 
Total protein 
(mg) 
15800 
4300 
160 
5.2 
1.5 
Specific activity 
(U/mg) 
0.04 
0.08 
0.50 
8.64 
20.7 
Purification 
fold 
1 
2 
12 
216 
517 
a. The ratio of DHPR and NADH oxido-reductase activity remained constant after the ammonium sulfate fractionation step. 
b. The 35-50% ammonium sulfate saturation fraction was used. 
c. Carried out using a complete Pharmacia f.p.l.c. system. 
d. The pH range of 5.5 to 4.5 was used. 
% yield 
55 
14 
8 
5 
Mono-P chromatofocusing. A narrow pH range (between pH 4.5 and 5.5) was used 
after an unsuccessful attempt to separate them using a broad pH range (between pH 3 and 
10 with the same column). The purified protein that migrated as a single band at Mr 25 
000 on SDS-PAGE, contained both the DHPR and NADH oxido-reductase activies. The 
20-kD band, on the other hand, did not contain either of these activities. 
With this information at hand, the E.coli DHPR was purified to apparent 
homogeneity as judged by SDS-PAGE (Figure 2. 7) and N-terminal amino acid 
sequencing (to be discussed in Chapter 3). A summary of the purification steps and the 
yields at each step is presented in Table 2.3. Gel filtration chromatography was omitted 
because a second anion exchange chromatography in Bistris buffer achieved a much better 
result as it gave a better separation at this stage and also obviated the need for additional 
purification steps. The two bands co-eluted through the Mono-P chromatofocusing 
column when a pH gradient of 3 to 10 was used. The pl values of the contaminating 
protein and the reductase were very close; therefore a narrow pH range chromatofocusing 
step was employed for the final purification. The enzyme was stable in the buffers used 
for chromatofocusing during the period of the separation. The pH was adjusted tp 7 .0 
immediately after purification and the fractions were rapidly dialysed against 50 mM Tris-
HCl (pH 7.4) containing 2 mM DTI and 20 µM NADH. The purified enzyme lost 50% 
of its reductase activity at -700c in - 3 months. 
The reductases from mammalian sources are stable in the presence of NADH and 
DTT at -20°C for several years (for example human-brain DHPR that was purified in 
1985 had not lost any activity in 1988). There has been no previous example to date of an 
unstable DHPR from any of the sources from which it has been purified (reviewed in 
Armarego et al., 1984). In all cases, the presence of 2mM DTT and 20 µM NADH 
stabilized the protein. It was suspected that the reductase from this study might have been 
cold-sensitive because it lost enzyme activity even at -70°C. Addition of glycerol (20% 
w/v) to the enzyme did not protect it from inactivation. Pascal et al. (1983) have observed 
that the flavoenzyme orotate dehydratase from the trypanosomid flagellate Crithidia 
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Figure 2.7 SDS-PAGE of samples taken at different stages of 
purification of DHPR using the protocol summarised 
in Table 2.3 
Lane (1) is the Pharmacia low molecular weight proteins (standard), ran concurrently 
with; (2) cell-free extract from strain H 712; (3) after DE-52 anion exchange 
chromatography; (4) after Mono-Q anion exchange (following the buffer exchange 
from Tris/HCl (pH 7 .5) to Bistris/HCl (pH 6.5) and (5) after Mono-P 
chromatofocusing 
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Table 2.4 Survey of the stability of dihydropteridine reductase from E.coli a 
Condition 
DHPR without any addition 
DHPR + DTI (2mM) 
DHPR + DTI (2mM) 
DHPR + NADH (20µM) 
DHPR + NADH (20µM) 
DHPR + DTI (2mM) + NADH (20µM) 
DHPR + DTI (2mM) + NADH (20µM) 
DHPR + Glycerol (20% w/v) 
DHPR + BSA (1 % w/v) 
Temperature 
(OC) 
-20 
-20 
25 
-20 
25 
-20 
25 
25 
25 
a. DHPR assay was carried out as described in Section 2.4.1.1 
OhC 
7.8 
5.3 
5.3 
6.9 
6.5 
5.8 
5.8 
5.4 
6.7 
b. Activity units are expressed as µmoles NADH consumed per min per ml of enzyme. 
DHPR activityh after 
24 h 48 h 
6.9 7.3 
3.7 2.8 
1.2 0.3 
7 .1 7 .1 
7.2 6.8 
5.7 5.4 
5.3 4.6 
6.2 5.2 
6.3 5.2 
c. The activity at time = 0 h was carried out to correct for reduction of activity due to volume changes. 
72h 
6.8 
2.3 
0.0 
7 .1 
6.5 
4.7 
3.8 
4.8 
4.3 
fasciculata was more stable in Hepes-KOH pH 7.4 than in Tris-HCl pH 7.4. Since it 
was obvious by this stage that the reductase from E.coli may contain a flavin prosthetic 
group that gives rise to the NADH oxido-reductase activity (discussed in Chapter 3), the 
Tris-HCl buffer was replaced with Hepes buffer throughout all the purification steps. 
The fractionation with ammonium sulfate was much better in Hepes buffer and 
more than 80% of the DHPR activity was in the 35-45% saturation fraction compared 
with 55% of the starting activity that was obtained in the 35-50% saturation fraction in 50 
mM Tris-HCl pH 7.4 (compare Table 2.3 with Table 2.5). Furthermore, the high yield 
of DHPR activity in the 35-45% saturation fraction essentially excluded the protein 
responsible for the NADH specific oxido-reductase activity that was present in band II 
(discussed earlier) because it aggregates at a higher ammonium sulfate concentration 
(>45%, saturation). The DEAE-Fractogel chromatography gave a 30-fold purification 
with an overall activity yield of 70% which was better than the corresponding step using 
DEAE-cellulose DE-52 chromatography. When the fractions from the anion-exchange 
column that contained DHPR activity were pooled, it had a tinge of yellow colour. The 
colour disappeared upon addition of NADH and DTT to final concentrations of 20 µM 
and 2 mM, respectively. This observation was investigated further by adding NADH or 
DTI separately to partially-purified fractions that did not contain the two componds. The 
addition of NADH to a final concentration of 20 µM caused the immediate disappearence 
of the yellow colour but there was no change in DHPR activity. The loss of colour upon 
addition of NADH indicates that the flavin group must be in the oxidized form in the 
resting stage (this is shown spectroscopically in Chapter 3). There was no visible change 
in colour upon the addition of DTI to the solution, although about 20% of the total DHPR 
activity present at the start was lost when the reductase activity was measured 10 min after 
the addition of the thiol reagent. 
The stability of the reductase from E.coli under various conditions was surveyed 
(see Table 2.4). It is clear that the DHPR activity was being affected by the presence of 
DTI. The loss of activity at 25°C in the presence of DTT is more rapid than that at 200c. 
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Table 2.5 Purification of dihydropteridine reductasea from Escherichia coli 
Purification stepa 
Cell free extract 
Ammonium sulfate fractionb 
DEAE anion exchangec 
Preparative bed isoelectric f ocusingd 
Volume 
(ml.) 
100 
40 
26 
9 
Total activity 
(U) 
303 
256 
210 
120 
Total protein 
(mg) 
5830 
1350 
142 
4.4 
Specific activity 
(U/mg) 
0.05 
0.19 
1.48 
26.7 
a. Hepes-KOH (pH 7.4) was used throughout the purification in replacement of Tris-HCl (pH 7.4) 
b. A 35-45% ammonium sulfate saturation fraction was used. 
c. The DEAE-Fractogel (Merck) resin was used in replacement of DE-52 (Whatman). 
d. Using the Bio-Phoresis system (Bio-Rad) with a pH gradient of 4.5 to 7.5. 
Purification fold 
1 
4 
30 
534 
o/o yield 
84.5 
63.3 
39.6 
NADH did slow down the inactivation by DTT but it did not afford total protection. 
Perhaps the slow air oxidation of the pyridine nucleotide might have removed its 
protecting ability. There are two possible reasons for inactivation of the reductase by 
DTT. There may be a crucial disulfide bond in the protein that is cleaved by the thiol 
reagent thus causing it to unfold and become inactivated. Also it is known that thiol 
reagents can reduce oxidized flavins and act as a substrate for some flavoproteins and the 
caveat has been raised, "that the general practice of enzymologists to add some DTT to 
stablize soluble proteins needs to be reconsidered for flavoenzymes" (Desa, 1976). The 
reason for inactivation by DTT is not clear, but the reagent was omitted from all buffers 
used during the purification in later preparations and no loss of enzyme activity was 
apparent. 
A further modification to the purification protocol summarised in Table 2.3 was 
the replacement of the f.p.l.c. Mono P chromatofocusing step with preparative granulated 
flat-bed isoelectric focusing, because of several disadvantages in using the former. The 
major disadvantage was that to obtain reproducible results, the Mono-P column required 
time-consuming stringent washing procedures: also the capacity and the volume of sample 
that could be applied to the column was low. Preparative flat-bed isoelectric focusing, on 
the other hand, allowed sample applications of up to 200 mg protein in a large sample 
volume (-10 ml) and required no operator attention once the separation was started. The 
yellow colour of the flavin prosthetic group allowed ready visualization of the required 
protein band. The three-step purification (see Figure 2.8) was rapid and reproducible. 
The yield of activity after final purification was almost 8-fold better than that summarised 
in Table 2.3 ( compare with Table 2.5). 
It is interesting to note that the final specific activities of the enzyme purified by the 
methods summarised in Tables 2.3 and 2.5 were of the same order despite the very low 
yield of activity in the former method. The low recovery by the first method may be due 
to the inactivation of the enzyme by DTT and Tris. The physico-chemical properties of 
the denatured DHPR must be different to those of the native protein during purification 
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Figure 2.8 SDS-PAGE of samples taken at different stages of purification of DHPR using the 
protocol summarised in Table 2.5 
In the Coomassie blue-stained gel (a): lane (1) is the Pharmacia low molecular weight standard; lane (2) the 
cell-free extract; lane (3) the greater than 35-45% ammonium sulfate fraction; lane (4) the 35-45% ammonium 
sulfate fraction that contains about 80o/o of DHPR activity; lane (5) a sample after DEAE-Fractogel 
chromatography and lanes (6 & 7) are fractions after preparative flat-bed isoelectric focusing. 
In the silver-stained gel (b): lane (4) clearly shows a single band at about 27 kD for DHPR after preparative 
bed isoelectric focusing. 
a 
94K ~ 
67. K ~ 
43K ~ 
30K ~ 
21K ..... 
14K ~ 
1 2 3 4 5 6 7 
b 
1 
r 
94K ~ ,,, c 
67K ~ l1a 
43K ....... 
30K ....... 
21K ~ 
2 3 4 5 
• 
,, 
because if it were not, then the specific activity cf the reductase purified by the former 
method (that summarised in Table 2.3) would have been considerably lower due to the 
presence of inactive enzyme. The reductase tha: was purified by preparative flat-bed 
isoelectric focusing was stable to storage in 50 mM Hepes-KOH (pH 7.4) containing 20 
µM NADH at -2ooc. 
2.3 SUMMARY 
After unsuccessful attempts using previously published methods, the Escherichia 
coli DHPR was purified to apparent homogeneity by two methods summarised in Tables 
2.3 and 2.5. The latter method was rapid and gave a higher yield. The enzyme was more 
stable in Hepes-KOH buffer (pH 7 .4) at every s::age in the purification. Unlike other 
dihydropteridine reductases that have been described in the literature, the E. coli DHPR 
contains a tightly-bound prosthetic group (see Chaper 3). The presence of the prosthetic 
group enabled the E. coli reductase to carry out pterin-independent oxidation of NADH 
or NADPH when an artificial electron acceptor :;uch as K3Fe(CN)6 was present. The 
susceptibility of the reductase from E.coli to inactivation by DTT is another feature that 
has not been encountered previously. 
2.4 MATERIALS 
The E.coli strains used for purification of DHPR: H712 (F-, guaB22 xyl-7 
rpsLJ 25) and D3-157 (F-, as H712 fol200 xyl+) were generous gifts from Dr Sara 
Singer of Burroughs Wellcome Research Laboratories, Research Triangle Park, NC, 
U.S.A. (Singer et al., 1985). All the 5,6,7,8-t·:trahydropterins used in the enzyme 
assays throughout this work were prepared by standard procedures (Armarego and 
Schou, 1978) and were kind gifts from Dr Armarego. The human-brain DHPR used in 
this study was purified in this work using the naphthoquinone affinity column procedure 
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(Firgaira et al., 1981a) and DEAE-Fractogel chrornatography. The water used throughout 
this work was either glass distilled or Milli-Q reagent water (Millipore). 
2. 5 EXPERIMENT AL METHODS 
2. 5 .1 Measurement of enzyme activity 
Assays of DHPR activity (pterin-dependent oxidation of NADH or NADPH) and 
oxido-reductase activity (pterin-independent oxidation of NADH or NADPH) were 
carried out spectrophotometrically at 25°C on a Cary 219 or a Unicam SP 1800 double-
beam spectrophotometer. 
2.5.1.1 The DHPR assay 
The stock solutions of pterin substrate (8-10 mM in 4 mM HCl) and NADH or 
NADPH (8-10 mM in 0.1 M Tris-HCl, pH 7.4) were stable for at least two months when 
stored frozen. The solutions for the assay were diluted appropriately to -2 mM when 
required and these were stable at 40c for several hours. The standard reaction mixture 
for the measurement of DHPR activity contained Tris-HCl, pH 7 .4 (0.1 M), peroxidase 
(11 µg), H202 (5 µM), 6-methyl-5,6,7 ,8-tetrahyclropterin (0.1 mM in 4 mM HCl) and 
NADH or NADPH (0.1 mM in 0.1 M Tris/HCl pl-I 7.4) in a total volume of 1 ml in each 
of two cuvettes. The substrates (pterin and NADH or NADPH) were kept on ice and 
added 2-3 minutes before the initiation of the reaction in small volumes (50 µl) so that the 
temperature can equilibrate rapidly and the quinonoid dihydropterin can be formed in situ. 
The DHPR reaction was initiated by injecting the ·~nzyme solution (5-10 µl, 0.25-0.5 µg) 
' 
into one cuvette only and the rate of change in ahsorbance at 340 nm due to the pterin-
dependent oxidation of NADH or NADPH was recorded. The enzyme activity was 
calculated by using the molar absorption coefficient at 340nm of 6220 M-lcm-1 for 
NADH or NADPH. 
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2.5.1.2 The Oxido-reductase assay 
The standard reaction mixture for the oxido-reductase activity (pterin-independent 
activity) contained Tris-HCl, pH 7 .4 (0.1 M), K3Fe(CN)6 (0.3 mM) and NADH or 
NADPH (0.1 mM) in a total of 1 ml in each of two cuvettes. The assay was initiated by 
injecting the enzyme solution into one cuvette only and the rate of oxidation of the 
pyridine nucleotide was used to calculate the oxido-reductase activity, as described in 
Section 2.5.1.1. 
One unit of enzyme activity for DHPR or oxido-reductase activities was defined as 
the amount of enzyme that caused the oxidation of 1 µmole of NAD(P)H per minute 
under the conditions described for the above assays. 
2. 5. 2. Protein determination 
Protein concentration was determined essentially by the method of Bradford 
(1976) using the Bio-Rad protein assay kit with bovine serum albumin as a standard. To 
800 µl of bovine serum albumin in clean 1 ml plastic cuvettes (Sarstedt, W.Germany) at a 
series of concentrations between 2 and 20 µg/ml, was added 200 µl of the Bio-Rad 
cocktail. The solutions were mixed well by inverting the cuvette after sealing with 
parafilm. The absorbance at 595 nm was measured with a Perkin-Elmer Lambda 1 single 
beam spectrometer after the mixture had been standing at room temperature for about 10 
minutes. The blank solution contained 800 µl of the buffer without bovine serum 
albumin and a standard curve was plotted. Sample protein solutions were diluted until the 
absorbance reading was in the middle range of the bovine serum albumin standard curve. 
Routine protein measurement of fractions eluted from columns were estimated by 
absorbance at 280 nm where it was assumed that an absorbance of 1.0 at 280 nm was 
equivalent to a protein concentration of 1 mg/ml. 
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2.5.3 Electrophoretic methods 
2.5.3.1 SDS-PAGE 
Unless otherwise stated SDS-PAGE (Weber and Osborn, 1969) was carried out 
on slab gels 100 mm high by 150 mm wide by 1.5 mm thick. The separating gel 
contained 12% (w/v) acrylamide (from a stock solution containing 30% (w/v) acrylamide 
and 0.8% (w/v) bisacrylamide). 0.375 M Tris-HCI (pH 8.8) and 0.1 % (w/v) SDS, in a 
final volume of 15 ml. (The mixture was degassed under a water pump for five minutes 
before the SDS was added). The polymerization was initiated by adding 50 µI of 10% 
(w/v) ammonium persulfate and 5 µI of TEMED. The stacking gel contained 5% (w/v) 
acrylamide (from the above 30:0.8 stock solution), 125 mM Tris-HCI (pH 6.8) and 0.1 % 
SDS in a final volume of 5 mls. Ammonium persulfate (40 µI of 10% stock solution) and 
TEMED (4 µ!)were added to polymerize the stacking gel. Sample wells 15 mm deep and 
4 mm wide were made by inserting a comb into the stacking gel prior to polymerization. 
The separating gel was sometimes left standing overnight at 40c with a 0.2% SDS 
overlay, but the stacking gel was always prepared 1-2 h before use. The sample was 
diluted (1:1) in the sample loading buffer (containing 0.08% (w/v) bromophenol blue, 
25% (w/v) glycerol, 0.4 M Tris base, 67 mM DTT and 2% SDS) and heated at 1000c for 
2 mins. After the samples were loaded into the sample wells, they were subjected to 
electrophoresis at a constant voltage of 60 V for 1 h, then at a constant voltage of 120 V 
for 3 h in a running buffer that contained 50 mM Tris, 385 mM glycine and 0.1 % (w/v) 
SDS. The gel was fixed and stained simultaneously in solution that contained 0.25% 
(w/v) Coomassie Brilliant Blue G-250, 50% (v/v) methanol and 9% (v/v) acetic acid. 
Destaining of the gel was carried out in 10% (v/v) isopropanol and 10% (v/v) acetic acid. 
The fixing/staining and destaining steps were carried out at room temperature. The 
destained gel was stored in 7% acetic acid with 5% glycerol until it was photographed. 
2.5.3.2 Non-denaturing-PAGE and DIIPR activity stain 
Non-denaturing-PAGE (Ornstein, 1964; Davis, 1964) was carried out in slab 
gels. The separating gel contained 6% (w/v) acrylamide (from the 30:0.8 stock solution) 
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and 0.375 M Tris-HCl (pH 8.8) in a total volume of 15 ml and polymerized with 40 µl of 
10% (w/v) ammonium persulfate and 5 µl of TEMED. The stacking gel contained 2.5% 
acrylamide (from the above 30:0.8 stock solution) and 125 mM Tris-HCl (pH 6.8) in a 
total volume 5 rnls. Polymerization was initiated with 40 µl of 0.04% (w/v) riboflavin 
and 4 µl TEMED. The gel was cooled to 4°C before loading the samples which were 
prepared by diluting the protein sample (1: 1) in the loading buffer [ which contained 
0.08% (v/v) bromophenol blue, 25% (w/v) glycerol and 50 mM Tris-HCl (pH 8.8)]. 
Electrophoresis was carried out at a constant voltage of 30 V for 15 hat 4°C. The gel 
was cut into three sections and used for protein staining, enzyme activity measurement 
and DHPR activity stain, respectively. The DHPR activity stain was essentially as 
described by Cotton and Jennings (1978). The stain solution contained 1 mM NADH, 1 
mM tetrazolium MTT (Sigma), and 50 mM Tris-HCl (pH 7.4) in a total of 9 ml at 37°C. 
The substrate, 1 mM quinonoid 6-methyl 7 ,8-dihydropterin was generated using 
dichlorophenolindophenol as the oxidant according to the method developed by Kaufman 
(1961). This was added to the above mixture and the gel was immersed in the solution 
with gentle rocking for five minutes. The stained gel was washed with two changes of 
distilled H20 (200 ml) and photographed immediately. (Note that the free acid of 
dichlorophenolindophenol should be used to generate the quinonoid dihydropterin 
substrate and not the sodium salt). 
2.5.3.3 Two-dimensional gel electrophoresis 
Two dimensional gel electrophoresis was carried out using the method of 
O'Farrell (1975). In the first dimension, isoelectric focusing in tube gels separated 
proteins on the basis of their isoelectric points. The cylindrical gels (5 mm diameter x 130 
mm long) consisted of 6% (w/v) acrylamide:bisacrylamide [from a 30% (w/v) stock 
solution containing 28.4% (w/v) acrylamide and 1.6% (w/v) bisacrylamide], 10% (v/v) 
glycerol and 2% (w/v) ampholines [a mixture of 1.6% (w/v) ampholines with a pH range 
of 5-7 and 0.4% (w/v) ampholines with a pH range of 3.5-10 from Pharmacia] in a total 
volume of 15 ml. The mixture was polymerized by adding 35 µl of 10% (w/v) 
ammonium persulfate and 7 µl of TEMED. The gel was overlaid with 200 µl of 10% 
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(v/v) glycerol containing 2% (w/v) ampholines. Samples (200-300 µl) were loaded and 
subjected to electrophoresis for 4 h starting at 180 V and maintaining constant current 
until the voltage reached 800 V for the remainder of the run. The cathode solution (20 
mM NaOH) was in the top tank and the anode solution (10 mM phosphoric acid) was in 
the bottom tank. After electrophoresis the disc-gels were placed in SDS sample buffer 
(2% SDS, 62.5 mM Tris-HCl, 50 mM DTT, 10% glycerol, pH 6.9) and frozen at -2ooc. 
The second dimension SDS-PAGE was set up and run essentially as described in section 
2.5.3.1. The stacking gel did not contain sample wells. The first dimension disc-gel 
(from IEF) was placed carefully along a groove between the two glass plates and 
immobilized with 1 % (w/v) agarose. 
2.5.3.4 Silver stain of protein gels. 
In cases where a sensitive staining procedure was required to visualise protein 
bands on a PA gel, silver staining was carried out essentially as described by Oakley et al. 
(1980). Gloves were worn throughout the procedure because fingerprints otherwise 
showed up. The gel was prefixed in a solution containing 50% methanol and 10% acetic 
acid (500 ml) for 30 min. This was followed by a wash in a solution (500 ml) containing 
5% methanol and 7% acetic acid for 2 h or more. The gel was then soaked in 10% 
glutaraldehyde (80 ml of reagent stock + 120 ml water) for 30 min with gentle agitation 
on a gyratory shaker. After this the gel was rinsed in four changes of water (30 min each 
change), with agitation. While the gel was being rinsed, fresh ammoniacal silver solution 
was made as follows; to a stirred mixture of 2.8 ml of 23% NfL+OH solution and 42 ml 
of 0.36% NaOH was added 8 ml of 19.4% AgN03 dropwise. The solution was then 
made up to 200 ml with water. The gel was stained in the ammoniacal solution for 15 
min with agitation. This was followed by a wash in water for 2 min with agitation and 
then the gel was developed in a dish containing freshly made reducer solution (0.2 ml 5% 
citric acid and 0.1 ml 37% formaldehyde made up to 200 ml) for about 5 min. The gel 
was then washed with three changes of water (30 min each time) and stored in 5 % acetic 
acid until it was photographed. 
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2.5.4 Growth of Cells 
LB (Luria-Bertani) medium containing the appropriate supplements was used to 
culture the bacterial strains used in this study. LB contained (per litre): 
Tryptone 10 g 
Yeast Extract 5 g 
NaCl 5 g 
NaOH (lN) 2.5 ml 
The pH of the medium was,.., 7.4 before sterilization by autoclaving. All media used for 
culturing bacteria were sterilised by autoclaving at 121 °c for 30-45 min. Escherichia coli 
strains H712 and D3-157 were routinely cultured in LB medium supplemented with 0.2% 
(w/v) glucose (from a 20% w/v stock solution) and 50 µg/ml thymine (from a 2.5 mg/ml 
stock solution). The supplementations were more crucial for thefo!A strain D3-157. 
Large quantities of strains H712 and D3-157 for isolation of DHPR were prepared 
using the following procedure: The strains were streaked onto a LB agar plate (1.5% 
(w/v) agar in LB) and incubated at 370c for 15 h. Single colonies from the plate were 
used to inoculate 10 ml LB media containing appropriate supplements in a 150-ml 
capacity Erlenmeyer flask and cultured with aeration at 37°C for 10 h in a shaker 
waterbath. This culture (5 ml each) was used to inoculate two 2-L capacity Erlenmeyer 
flasks each containing 1 L of LB medium containing supplements and cultured with 
aeration at 370c for 15 h in a gyratory environmental shaker. The cell suspension was in 
turn used to inoculate 38 L of sterile growth medium (1 % (w/v) yeast extract, 0.9% (w/v) 
glucose*, 1 % (w/v) K2HP04, 0.18% (w/v) KH2P04 and 5 x 10-5% (w/v) thymine) in a 
40 L fermenter (New Brunswick Scientific). The culture was incubated at 37°C with 
stirring and 30-50 mls were removed aseptically every 1 hr to determine the growth rate 
by measuring the turbidity at OD595. The cells were normally harvested at the end of the 
log phase of growth (,..,5 h) and sedimented in a Sharpels continuous-flow centrifuge. 
The wet weight of cells obtained was between 100 and 130 g. 
*Glucose (20% w/v) stock was sterilised separately and added aseptically. 
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2.5.5. Preparation of cell-free extract 
The procedure for the lysis of cells and preparation of cell-free extract was 
essentially as described by Fuller and Kornberg (1983). Briefly, the cells from the large-
scale growth were washed twice with 50 mM Tris/HCl (pH 7.4) containing 1 mM EDTA, 
200 mM KCl and 2 mM DTT (buffer A) and suspended in the same buffer (2 ml/g of 
cells). This cell suspension was divided into 20-ml portions into 60Ti Beckman 
centrifuge tubes. Chicken egg-white lysozyme (Sigma, 50 mg/ml in buffer A) was added 
to the cell suspension to a final concentration of 5-10 mg/ml and the suspension 
wasshaken vigorously. The suspension was incubated at ooc for 30 min, frozen in 
liquid nitrogen and thawed at ooc to produce a gelatinous suspension. This was 
centrifuged at 150,000 g for 1 hat 40c to give the cell-free extracts that were used for 
purification of the reductase. The protease inhibitor PMSF (Sigma) was added routinely 
to cell free extracts at this stage to a final concentration of 0.5 mM. This method of 
preparation of cell-free extract had the advantage that contamination by nucleic acids was 
minimal, thus obviating the need for an additional step in streptomycin sulfate 
precipitation. Note: The Tris/HCl was replaced with Hepes/KOH in later preparations. 
2.5.6 Ammonium sulfate fractionation 
Ground solid ammonium sulfate was added slowly over 30 min to bring the 
extracts to the required saturation (see Scopes, 1982), and stirred for a further 1 h to 
allow complete equilibration to take place between the dissolved and aggregated proteins. 
The aggregated protein was separated by centrifugation at 6000 x g for 20 min at 4°C. 
When the cell-free extract was in Tris buffer, a 35-50% ammonium sulfate saturation 
fraction contained about 60% of the total DHPR activity present in the starting extract and 
when it was in Hepes buffer, a 35-45% ammonium sulfate cut contained about 80% of 
the starting activity. 
2.6 DEVELOPMENT OF PURIFICATION PROCEDURE 
Unless otherwise stated all the purification steps were carried out at 4°C. 
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2. 6 .1 Naphthoquinone affinity chromatography 
A sample (10 ml, 50 units of DHPR activity) of the 35-50% ammonium sulfate 
fraction in 50 mM Tris-HCl (pH 7.8) containing 0.8 MNaCl and 0.1 mM NADH, was 
applied to a naphthoquinone affinity column [5 cm x 1.5 cm; prepared by Mr Bella Paal 
using the method of Cotton and Jennings (1978)] that was previously equilibrated with 
the same buffer. After the passage of the extract, the column was washed successively 
with 40 ml of 50 mM Tris-HCl (pH 7.4), containing 0.8 M NaCl and 0.1 mM NADH 
(buffer B; the eluate was Fraction 1); 30 ml of 0.1 M Na2C03 (pH 10) containing 0.8 M 
NaCl and 0.1 mM NADH (buffer C; the eluate was fraction 2); 30 ml of buffer C without 
NADH (the eluate was fraction 3). After a wash with 20 ml of buffer B without NADH 
(this eluate was fraction 4), a final wash with 30 ml of buffer B without NADH but with 
5 mM DTT ( this eluate was fraction 5) was carried out. The column was regenerated as 
described by Cotton and Jennings (1978) after it was washed with 8 M urea (20 ml) 
followed by 50 mM Tris-HCl pH 7.4 (200 ml). 
2. 6. 2 Screening with dye Matrex columns. 
The dye Matrex kit (Amicon) consisted of 6 polypropylene columns (9mm x 32 
mm), each containing Matrex Gel Blue A, Matrex Gel Red A, Matrex Gel Orange A, 
Matrex Gel Green A, Matrex Gel Blue Band Matrex Gel control (without ligand). The 
columns were washed with 12 ml each of 8 M urea in 0.5 M NaOH (buffer D) to remove 
any free dye that may have resulted from very slow hydrolysis of the dye-agarose 
linkage. After draining buffer D the columns were washed with 30 ml each of 50 mM 
Tris-HCl (pH 7.4; buffer E). The dialysis residue of the 35-45% ammonium sulfate 
saturation fraction (0.5 ml, 10 units of DHPR activity) in buffer E was applied to each 
column, allowed to drain, and left standing for 0.5 h to allow binding equilibration which 
otherwise might not have occurred because of high flow rate. The columns were each 
washed with 10 ml of buffer E and the eluate was collected (void volume fraction). The 
bound proteins were eluted with 10 ml each of buffer E containing 1 to 5 M NaCl (high 
salt eluate fraction). 
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2.6.3 DE-52 anion exchange chromatography 
The dialysis residue of the 35-50% ammonium sulfate saturation fraction in 50 
mM Tris-HCl (pH 7.4; 100 ml; buffer E) was applied to a DEAE-cellulose DE-52 column 
(2.0 cm x 15 cm; Whatman) which was previously equilibrated with buffer E. The 
column was eluted with this buffer at a flow rate of 1 ml/min until the u.v. absorbance of 
the effluent at 280 nm was less than 0.1. A linear gradient between 250 ml of buffer E 
and 250 ml of buffer E containing 250 mM Na Cl (formed with a Gradient mixer; 
Pharmacia) was used to elute the enzyme, which appeared at about 100 mM NaCL 
Fractions of the eluate (8 ml) were collected in tubes containing DTT and NADH to give 
final concentrations of 2 mM and 20 µM respectively. The active fractions were pooled 
and concentrated to 8 ml in an ultrafiltration stirrer cell (Amicon) using a PM-10 
membrane (10,000 MW cut-off) at a N2 pressure of 45 psi. The concentrate was 
centrifuged (3000 x g) to remove some precipitated protein and the supernatant was stored 
in glass vials (1 ml aliquots) at -700C. 
2.6.4 Ultragel AcA-34 gel filtration 
A sample of the enzyme (1 ml) from Section 2.6.3 was applied to a column of 
Ultragel AcA 34 (2.5 cm x 80 cm; LKB) that had been previously equiliberated with 50 
mM Tris-HCl containing 2 mM DTT and 20 µM NADH (pH 7.4, buffer F). The 
fractionation range of Ultragel AcA 34 was 20,000-400,000 and when the column was 
run isocratically with buffer F at a flow rate of 20 ml/h, the DHPR activity appeared 
between 340-360 ml (void volume). 
2. 6. 5 F.p.l.c Superose 12 gel filtration 
The partially-purified sample (500 µl, after DE52-chromatography) was applied to 
a Superose 12 HR 10130 column (Pharmacia; a complete f.p.l.c. system was used) that 
was previously equilibrated with 50 mM Tris-HCl containing 2 mM DTT, 20 µM NADH 
and 200 mM NaCl (pH 7.4; buffer G, 30 ml). The enzyme was eluted with buffer Gata 
flow rate of 0.25-0.5 ml per min. The enzyme activity appeared between 18-20 ml. 
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2.6.6 F.p.I.c. Mono-Q anion-exchange chromatography 
A sample (1 ml, after DE-52 chromatography) was dialysed against 50 mM 
Bistris/HCl pH 6.5, containing 2 mM DTT and 20 µM NADH (buffer H, 2 x 500 ml) 
using a Spectrapor (Spectrum Medical Industries, LA, U.S.A.) dialysis tube. The 
dialysis residue (1 ml) was applied to the Mono-Q HR 5;5 column (Pharmacia). After a 
5-min wash with buffer H at flow rate of 1 ml/min, a linear gradient of O to 200 mM NaCl 
in the same buffer (30 ml) was applied. The enzyme was eluted around 100 mM NaCl 
and the active fractions (3 ml) were stored at -700C. 
2.6.7 F.p.l.c. Mono-P chromatography 
The active fraction (3 ml) after f.p.l.c. Mono-Q chromatography was dialysed 
against 25 mM piperazine-HCl (pH 6.3; 2 x 500 ml). The sample (1 ml) was then applied 
to a Mono-P HR 5120 column (Pharmacia), which had been treated and pre-equilibrated as 
specified by the manufacturers. The column was eluted with 10% (v/v) Polybuffer 74-
HCl (Pharmacia, pH 4.5, 30 ml) at a flowrate of 1 ml/min to form a pH gradient between 
5.5 and 4.5. The reductase activity was eluted at a pH of 5.3. The active fractions were 
adjusted to pH 7.4 with 50 mM Tris-HCl containing 2 mM DTI and 20 µM NADH and 
dialysed against the same buffer (2 x 500 ml). The purified active fractions were stored in 
500 µl aliquots at -700c. 
2.6.8 DEAE-Fractogel chromatography 
The 35-45% ammonium sulfate precipitate which contained 80% of the DHPR 
activity was suspended in 50 mM Hepes/KOH pH 7 .4 (buffer I) and dialysed against the 
same buffer (3 x 2 L). The sample (100 ml) was applied to a DEAE-Fractogel column (2 
cm by 15 cm, Merck) which was previously equilibrated with buffer I at a flow rate of 
2.5 ml/min. The column was washed with about 10 column volumes of the same buffer. 
A linear gradient formed with 250 ml of buffer I and 250 ml of buffer I containing 200 
mM NaCl was used to elute the enzyme activity around 100 mM NaCl. The active 
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Figure 2.9 The steps involved in setting up and carrying out the flat bed 
isoelectric focusing procedure is presented pictorially 
(reproduced with kind permission from Bio-Rad Laboratories) 
In (a) the gel+ ampholyte slurry is being poured into the gel tray with wet 
electrofocusing wicks at either ends of it; (b) the excess moisture from the slurry is 
removed by the wicking method; ( c) the sample is applied in the middle of the gel; ( d) 
the uppermost wicks on either sides are replaced with wicks that are wet with the anodic 
and cathodic buffers; ( e) the tray is placed on the cooled, wet stage and focused as 
required and in (f) it can be clearly seen that coloured proteins can be readily identified 
and isolated after placing a grid over the electrofocused gel and harvesting the band of 
interest. 
a b 
d 
e · 
fractions were pooled and the total protein was precipitated with ammonium sulfate (80% 
w/v) and separated by centrifugation (6000 g). If not used directly for the next step, the 
pellet was suspended in buffer I and dialysed against it (3 x 500 ml) and stored in the 
presence of 20 mM N ADH at -2ooc. 
2.6.9 Preparative granulated bed isoelectric focusing 
The ammonium sulfate precipitate (80% w/v) of the pooled active fractions from 
the DEAE-Fractogel step was dissolved in 5 ml of Milli Q water. The enzyme (2.5 ml) 
was immediately loaded on two PD-10 columns (Sephadex 025, Pharmacia) that were 
pre-equilibrated with Milli Q water. The columns were eluted with Milli Q water (3.5 ml 
each) and the eluate (pooled total of 7 ml) was made to 4% w/v in ampholines (0.15 ml of 
40 w/v Biolyte 3/io and 0.35 ml of 40% w/v Biolyte 517; LKB). This sample was applied 
onto a preparative granulated flat-bed isoelectric focusing slab gel (20 by 11 by 0.8 cm) as 
described by the manufacturer (Bio-Rad: Bio-Phoresis Instruction Manual, 1985; see 
Figure 2.9 reproduced with permission from Bio-Rad Laboratories). 
Pre-swollen Bio-Lyte electrofocusing gel (150 ml, Bio-Rad) made 4% in 
ampholine (6 mls of 40% w/v Biolyte 3/io and 9 ml of 40% w/v Biolyte 517) was set in a 
gel tray (20 x 11 x 0.8 cm) by wicking off the excess liquid from both ends of the tray. 
The sample was applied in two additions ( -4 ml each) in the middle of the gel bed and 
dried by wicking at the ends until the gel bed was firm upon tilting the tray to 45° 
inclination. The anode (1 N H3P04) and cathode (1 N NaOH) were applied on thin filter 
strips and placed at each end of the tray. Electrofocusing was carried out in Biophoresis 
cell (Bio-Rad) with a stage cooled to 40c at a constant voltage of 250 V for 2 h, followed 
by 18 hat 700 V. The stage was wet with 1 % Triton X-100 solution so that it would be 
in even contact with the tray. The gel containing the protein (a sharp yellow band near the 
anodic end) was removed with a spatula, extracted with 50 mM Hepes-KOH pH 7.4 
(Buffer I) containing 200 mM NaCl (by centrifugation) and dialysed against buffer I (2 x 
500 ml). The enzyme was stored in 1-ml aliquots with 20 µM NADH at -2ooc. 
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CHAPTER 3 
PROPERTIES OF ESCHERICHIA COLI DHPR 
3 .1 INTRODUCTION 
The properties of the dihydropteridine reductases from various sources that have 
been reported in the literature have been reviewed in Chapter 1. It is common practice to 
characterise a new protein once it has been isolated and purified to homogeneity. I will 
endeavour in this chapter to describe some of the properties of the reductase from E.coli 
so that it will serve as an useful preamble in the investigation of 'role(s)' of the enzyme in 
an organism that is devoid of aromatic amino acid hydroxylases. During the purification 
of this enzyme it became evident that it differed from dihydropteridine reductases from 
other sources in several respects. The most important difference is the NADH oxido-
reductase activity in the absence of the pterin substrate when an artificial electron acceptor 
such as K3Fe(CN)6 is present. By analogy with other enzymes that exhibit NADH 
oxido-reductase activity, it was suspected that the reductase might contain a prosthetic 
group. The prosthetic group was isolated and identified as FAD. This is the first report 
of a DHPR with a prosthetic group, hence attempts have been made to relate its presence 
in the protein to the catalytic activity, especially the reduction of quinonoid dihydropterin. 
Another novel feature of this reductase that is revealed by the investigations 
reported in this chapter is that E.coli DHPR can function as a dihydrofolate reductase 
(DHFR) in vitro; i.e., it can reduce 7,8 dihydrofolate, albeit at a much slower rate than E. 
coli DHFR. The superficial similarity in the chemistry of the reactions catalysed by the 
two enzymes had led to the general belief that the primary structure of DHPR may have a 
high homology with that of DHFR. However this belief was quashed when the predicted 
primary structures of the human-liver DHPR (Dahl et al., 1987; Lockyer et al., 1987) and 
rat-liver DHPR (Shahbaz et al., 1987) were compared with that of human DHFR 
(Masters and Attardi, 1983). There was no extensive similarity between the two 
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Table 3.1 The three different enzyme activities of purified E. coli DHPR in Tris/HCI buffer pH 7 .4 at 2S°C 
Enzyme activity 
DHPRa 
Oxido-reductasea 
DHFRa 
Specific activity 
(U/mg) 
25.5 
110. 
1.25 
a. NADH (100 µm) was used as the nucleotide cofactor. 
Substrate 
quinonoid 6-methyl-dihydropterin (100 µM) 
K3 Fe(CN)6 
7 ,8-dihydrofolate 
(300 µM) 
(100 µM) 
sequences except for a small region around the proposed nicotinamide binding region of 
human DHFR (Dahl et al., 1987). In this light, the discovery that the reductase from 
E.coli possesses both DHPR and DHFR activities reopens the question of the nature of 
evolution of these two proteins in higher organisms. 
3.2 RESULTS AND DISCUSSION 
3. 2 .1 Enzyme activities of purified E. coli D HPR 
The results summarised in Table 2.2 established the in vitro assay requirements 
for E. coli DHPR. Unlike the reductases from the other sources, this enzyme is able to 
oxidize both NADH and NADPH independently of the quinonoid dihydropterin cofactor. 
More remarkably, the homogenous preparation of DHPR from E.coli can also reduce 
7 ,8-dihydrofolate; a catalytic function that is normally exclusive to DHFR. The chemistry 
of DHFR- and DHPR-catalysed reactions bear one crucial similarity in that both enzymes 
are involved in the reduction of the pterin nucleus of two tautomers of 7 ,8-dihydropterin. 
None of the DHPRs reported in the literature can reduce 7 ,8-dihydro(3H)pterins 
(conjugated or unconjugated) and conversely none of the DHFRs can reduce quinonoid 
7 ,8-dihydro(6H)pterins. In the DHFR-catalysed reaction the hydride is transferred from 
NADPH onto position C-6 of the pterin nucleus and protonation occurs at N-5. In 
contrast, in the DHPR reaction the hydride is transferred from NADH to N-5 of the pterin 
nucleus with protonation taking place at N-3 (see Scheme 1.5). The three different 
enzyme activities of E.coli DHPR are summarised in Table 3.1 and the ratio of the three 
specific activities is 1 : 4.4 : 0.05 (for DHPR, oxido-reductase and DHFR respectively). 
These results with the protein purified from the wild type E. coli imply that the 
DHFR-deficient mutant of E.coli (strain D3-157) isolated by Singer et al. (1985) must 
be a double mutant, i.e. DHFR- and DHPR-. This was hypothesized on the basis that if 
DHPR was present in the mutant strain, then its ability to recycle 7 ,8-dihydrofolate ought 
to complement the DHFR deficiency of the strain. This is however not true because in 
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Table 3.2 Comparison of DHFRa activity with NADPHh and NADHh in Tris/HCI buffer pH 7.4 at 2soc 
Strain 
H712 
JFM228 
D3-157 
DHFR Source 
wild type 
overproducer 
mutant 
a. DHFR activity was assayed as described in Section 3.4.1 
b. [NADPH] or [NADH] was 100 µM 
DHFR activity (mU/mg protein) 
NADPH NADH 
28.8 
729 
2.55 
6.27 
24.3 
7 .19 
this work it is found that the strain D3-157 exhibits almost the normal level of DHPR 
activity that is present in the wild-type strain H712 from which the former was derived by 
mutagenesis with ethyl methane sulfonate. The reason for the inabilty of DHPR to 
complement the lack of DHFR activity in the strain D3-157 is not clear, but one 
possibility is that the catalytic efficiency of the enzyme is too low in vivo. Apart from the 
direct evidence that the purified DHPR from E.coli can reduce 7 ,8-dihydrofolate, further 
evidence that a protein other than the well-characterised DHFR can carry out a similar 
function comes from the comparison of DHFR activity in the cell-free extracts prepared 
from strains D3-157, H712 or JFM228 (an overproducer of chromosomal DHFR) using 
NADH or NADPH as the pyridine nucleotide cofactor. The DHFR specific activities in 
cell free extracts from H712 and JFM228 are higher when NADPH is the electron donor 
compared with NADH. This is consistent with the fact that the Km values for NADPH 
are more favourable than those for NADH in all DHFRs, and in most cases the Vmax 
values with NADH are only 10-30% of those for NADPH (reviewed by Blakley, 1984). 
In contrast, the DHFR specific activity in the cell-free extract from strain D3-157 is higher 
with NADH than with NADPH (see Table 3.2). Most DHPRs, on the other hand (with 
the exception of the physically distinct NADPH-specific DHPR), show more favourable 
Michaelis constants with NADH than with NADPH (reviewed by Shiman, 1985). Based 
on this, it is argued that the DHFR activity observed in the extract from strain D3-157 
must be due to DHPR. 
Singer et al. (1985) used antisera competition experiments to show that there was 
no significant amount of inactive DHFR in the extract from strain D3-157. They used an 
assay where active chromosomal DHFR incubated with DHFR antisera gave 57% 
inhibition of activity, and when 0.5 mg of extract from D3-157 was added the percentage 
inhibition was not changed. It can be inferred from this that the higher DHFR activity of 
the extract from D3-157 with NADH is not due to partial revertants which may have 
mutations that result in a more favourable binding site for NADH. Attempts were made in 
this work to investigate the presence of catalytically-inactive protein by comparing the 2D-
electrophoretic (first dimension was IEF and the second dimension was 12% SDS PAGE 
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as described in Section 2.5.3) separation of the cell-free extract from JFM 228 with that 
from the strain D3-157. The rationale was that JFM 228 overproduces DHFR, hence the 
protein may be identified on the 2D gel by using its molecular weight (18 000) and 
isoelectric point (pl 4.5). A band that fitted the criteria for wild-type DHFR was 
identified on the 2D gel of the extract from JFM 228 visualised by silver staining. The 
corresponding region on the 2D gel of the extract from D3-157 showed no protein band 
(data not shown). However, a mutation that may cause changes in the total number of 
charged amino acid residues may have considerably altered the mobility of the protein in a 
2D gel (for example, when Asp-27 of wild type E. coli DHFR was altered by site-
directed mutagenesis to Asn, the pl value of the mutant was 4.8; Villafranca et al., 1983). 
The most persuasive evidence that E. coli DHPR can reduce 7 ,8-dihydrofolate comes 
from the presence of DHFR activity in the apparently homogenous preparation, and also 
that in the extract from strain D3-157 the DHFR specific activity is higher with NADH 
than NADPH as the pyridine nucleotide cofactor. 
Enzyme activity staining of a sample of partially purified DHPR from E. coli was 
presented in Chapter 2 to demonstrate the presence of DHPR activity in a native PA gel. 
The basis of the activity stain method is that tetrahydropterins, which are products of both 
the DHPR- and DHFR-catalysed reactions, can reduce the soluble tetrazolium MTI to 
yield the insoluble blue coloured formazan (Gunlak et al., 1966). In an endeavour to 
further demonstrate the presence of both DHPR and DHFR activity of E. coli DHPR, the 
tetrazolium MTI activity stain approach was examined in this study. During preliminary 
investigations it became evident the tetrazolium-MTT could also be used to indicate the 
NADH oxido-reductase activity of E.coli DHPR. Using apparently homogeneous E.coli 
DHFR (kind gift from Dr. J. Morrison) and human-brain DHPR as standards, the three 
different activities of E. coli DHPR were demonstrated by enzyme activity staining (see 
Figure 3. lA) on a single slab PA gel. This was achieved by using a simple modification 
of the published assay methods (Nixon and Blakley, 1968; Hasegawa, 1977; Cotton and 
Jennings, 1978) whereby the reactants for each of the three enzymic activites are 
overlayered on the PA gel in 0.3% agarose so that they become immobilised. 
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Figure 3.1 Activity staining of wild type E. coli DHFR(18-kD), E. coli 
DHPR (27-kD) and human brain DHPR (50-kD), for DHFR, 
oxido-reductase and DHPR activities, respectively. 
a. Detection of the three enzyme activities by staining was carried out as described in 
Sections 2.5.3.2 and 3.4.12. The lanes marked '1' contain human brain DHPR (5 
µg) each; the lanes marked '2' and '3' contain purified E.coli DHPR (0.75 µg and 2 
µg respectively); and the lanes marked '4' contain E. coli DHFR (3µg) 
b. The activity-stained gel (without complete destaining to remove the formazan) 
was stained with Coomassie Blue and destained as described in Section 2.5.3. L 
a DHFR activity OR activity l)HPR activity 
... . ... .. 
1 2341234123 4 
• 
• 
b 
123 4 1234 1 2 3 4 
/ 
• - ., • • 1 
NAJ)+ E-FADH2 [tetrazoliun1-M11]Br 
NADH+H+ 
---E-FAD f ormazan + HBr 
E0 (volts) - 0.32 - 0.22 - 0.16 
Schcn1e 3.1 Mechanism of oxido-rednctase activity with tetrazolium - MIT as substrate. 
The DHFR-stained section showed that E. coli DHPR and E. coli DHFR reduced 
7 ,8-dihydrofolate to tetrahydrofolate which in turn was oxidized by tetrazolium MTT, 
whereas DHPR from human brain was completely inactive. Conversely quinonoid 6-
methyl-7 ,8-dihydropterin which was used in the DHPR-stained section was reduced by 
human-brain DHPR and E. coli DHPR, and gave a blue colour which is due to the 
insoluble formazan. Authentic E.coli DHFR was completely inactive towards the DHPR 
stain reaction. In the oxido-reductase stain the pterin substrate was excluded, but the 
formazan formation around the E. coli DHPR spot suggested that the reduced flavin 
prosthetic group can reduce the tetrazolium to the formazan. 
The reason for formazan formation around the E.coli DHPR spot was not obvious 
in the beginning, but upon further deliberation it became clear that a tightly-bound flavin 
prosthetic group upon reduction by NADH could serve as an electron donor to 
tetrazolium-MTT. The flow of electrons from NADH through to tetrazolium-MTT is 
favoured by the reduction potentials of the three oxidized-reduced couples that are 
involved (see Scheme 3.1). This result indicates that the formazan formation by E.coli 
DHPR due to the oxido-reductase activity must occur in the sections stained for DHFR 
and DHPR. However it is argued that the intensity of the activity stain is greater for the 
DHPR and DHFR activities compared with the oxido-reductase activity in this apparently 
multifunctional enzyme. (Note that the three staining reactions were carried out for the 
same length of time). This indirectly shows that 7 ,8-dihydrofolate and quinonoid 6-
methyl-7 ,8-dihydropterin are reduced by E. coli DHPR. The relatively faster rates of 
enzymatic reactions near the centre of the spot compared with the tetrahydropterin-
dependent reduction of tetrazolium-MTT at the periphery of the spots may possibly 
account for the colourless region within the respective protein spots (compare with Figure 
3.lB). 
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3.2.2 Molecular weight of the reductase 
The molecular weight of native E. coli DHPR as determined by gel-filtration 
chromatography was 54 000. This value was comparable with values obtained for other 
reductases from mammalian sources (reviewed by Armarego et al. , 1984). The 
molecular weight reported in the literature for the partially-purified P seudomonas 
reductase was about 44 000 with no reference to the nature of its subunits (Williams et 
al., 1976). The NADPH-dependent reductase from bovine liver however had a molecular 
weight of about 72 000 and consisted of two identical subunits (Nakanishi et al., 1986a). 
The subunit molecular weight value of about 27 000 for the E. coli reductase as 
determined by SDS-PAGE (see Figure 2.8) was in good agreement with values reported 
for other dihydropteridine reductases. The mammalian reductases are presumed all to be 
active in the dimeric form by analogy with human-liver DHPR which was shown to be 
active after covalent linking of the subunits by cross-linking with suberimidate (Firgaira et 
al., 198 la). 
The subunits in most of the dihydropteridine reductases are held together by non-
covalent bonds because treatment in 2% SDS without heating is sufficient to denature 
them to the monomeric form in the absence of DTI (reviewed by Armarego et al., 1984). 
Since the native molecular weight and subunit molecular weight of E.coli DHPR were in 
good agreement with the reported reductases, it was at first assumed that the new protein 
could be similar to known reductases in that it would be active as a dimer and perhaps 
inactive as a monomer. The loss of 80% of DHPR activity when the enzyme assay was 
carried out in the presence of 0.2% SDS was erroneously taken as further evidence that 
the E. coli enzyme was similar to the other dihydropteridine reductases. In contrast to the 
previous results, the enzyme activity stain of E. coli DHPR on a non-denaturing PA slab 
gel (see Figure 3.lA) when compared with native human-brain DHPR (Mr 54 000) and 
native E.coli DHFR (Mr 18 000) indicated that E.coli DHPR was active as a monomer 
(Mr 27 000); the band at 27 000 was stained. 
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Table 3.3 N-terminal amino acid sequence of E.coli DHPRa,b,c compared with those of related proteins 
Protein Sequence of the first 20 residues 
E.coli DHPRa M D I I C V A L K C I V X X A F D A M K 
E.coli DHPR b M A I I C V A L K C I V T K A F D A M K 
E.coli DHPRC M D I I C V A L K C T V T K A F D A M K 
E.coli DHFRd M I s L I A A L A V D R V I G M E N A M 
Sfaecium DHFRd M F I s MW A Q D K N G L I G L D G L L 
Human liver DHPRe M A A A A A A G E A R R V L V y G G R G 
Rat liver DHPRf M - - - A A s G E A R R V L V y G G R G 
a . Sequence obtained from a Beckman model 890M2 spinning cup sequencer. 
b.& C. Sequence obtained from an Applied Biosystems 477 A Pulse-Liquid Phase Sequencer 
C. The protein sample was transblotted from SDS-PA gel onto Polybrene coated glass fibre sheet as described in Section 3.4.13 
e. Obtained from review by Blakley, (1985) 
f. Predicted sequence from Dahl et al., (1987) 
g. Predicted sequence from Shahbaz et al., (1987) 
To resolve the conflicting results, a sample of E.coli DHPR (purified preparative 
isoelectric focussing in the presence of ampholines) was examined in a meniscus-
depletion sedimentation equilibrium experiment (Yphantis, 1964). The molecular weight 
of the protein, after allowing for the presence of ampholines, was found to be 25.7 00. 
There was no indication of any other species in the specimen that was examined. (The 
sedimentation equilibrium experiment and the analysis was kindly carried out by Dr. Peter 
Jeffrey, JCSMR). The protein sample had not lost its DHPR activity at the completion of 
the sedimentaion equilibrium experiment. This confirmed that E. coli DHPR to be a 
monomer in its native state. The gel-filtration chromatography of E. coli DHPR along 
with the molecular weight standards, described at the beginning of this section (which 
indicated a Mr of 54 000) were carried out in the presence of 0.2 M NaCl to minimise 
hydrophobic interactions. In hindsight it seems possible that the presence of DTT in the 
elution buffer may have caused the protein to dimerise because less than 40% of the total 
activity that was applied to the column appeared in the peak fraction that indicated a 
molecular weight of about 54 000. 
3.2.3 N-Terminal sequence of the reductase 
The N-terminal amino acid of the E. coli reductase is not protected. This is in 
contrast with the N-terminal amino acid residues of several mammalian dihydropteridine 
reductases (reviewed by Armarego et al., 1984) and human-brain DHPR (S.G. 
Vasudevan and W.L.F. Armarego, unpublished work), which are irreversibly blocked by 
acylation. The E. coli reductase was subjected to amino-acid sequence analysis on a 
Beckman model 890 M2 spinning cup sequencer and the resulting PTH derivatives, 
which were analysed as described in Section 3, readily gave a short sequence (Sequence 
A in Table 3.3). At the time this sequence was obtained, there was no sequence 
information in the literature about other dihydropteridine reductases. This sequence 
showed no significant homology with other proteins in the National Biomedical Research 
Foundation Protein Data Bank. Although N-terminal amino acid-protected proteins are 
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rare in E. coli, the possibility that there may have been an N-protected protein in the 
sample that co-purified with the unprotected protein to yield sequence A was ruled out 
because sequencing of the cyanogen bromidecleaved reaction mixture (without separation 
of polypeptides) gave recoveries of additional amino acids that were comparable with 
those obtained for the native protein. Also, the number of extra sequences obtained was 
reasonably consistent with the methionine content of the protein (see Table 3.4). In 
addition to giving the N-terminal sequence of E. coli DHPR, data from the above 
experiments clearly indicated that the protein was essentially pure. 
The N-terminal amino acid sequence of E. coli DHPR was also obtained using the 
Applied Biosystems 477 A Pulse-Liquid Phase Sequencer with samples purified from 
preparative flat-bed isoelectric focusing. Whereas sequence B was obtained after direct 
application of the appropriately-treated sample, sequence C was obtained by 
electroblotting E. coli DHPR separated on a (12%) SDS-PA gel (method of 
Vandekerckhove et al., 1985) onto a Polybrene -coated glass fibre sheet and sequencing 
of the appropriate band (see Section 3). This last method was very convenient and its full 
potential was realised when N-terminal amino acid sequences of partially-purified proteins 
were obtained (see Chapter 5). There were small differences in assignment of residues 
between the three sequences but residues 12-20 were consistent in sequences B and C 
(see Table 3.3). 
Although the first 20 residues of E.coli DHPR did not show any significant 
homology with those of E.coli DHFR, S.faecium DHFR (reviewed by Blakley, 1984), 
human-liver DHPR (Dahl et al., 1987) and rat-liver DHPR (Shahbaz et al., 1987), they 
share a common feature in that their N-terminal regions are mainly composed of 
hydrophobic residues. The secondary structure prediction for human liver DHPR using 
the Chou-Fasman rules concurs with this observation (Cotton et al., 1987). The amino 
acid at position 17 in all the bacterial dihydrofolate reductases is an aspartate or glutamate. 
Although there are presently no known functions for this residue, it is interesting that E. 
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Table 3$4 Amino acid composition (calculated for a 27-kD protein) 
Amino acid E. coliDHPR 
Lysine 17 
Histidine 5 
Arginine 7 
Cysteine 3c 
Aspartic acid 
124 
Asparagine 
Threonine 11 
Serine 11 
Glutamic acid } 27 
Glutamine 
Praline 8 
Glycine 24 
Alanine 29 
Valine 23 
Methionine 5(6) 
Isoleucine 12 
Leucine 19 
Tyrosine 3 
Phenylalanine 7 
Tryptophan N.Dd. 
a From Shabaz et al., 1987. 
b From Dahl et al., 1987. 
c Determined as cysteic acid in this work. 
d Not determined 
RatDHPRa HumanDHPRb 
15 14 
4 4 
8 8 
4 4 
} 19 
9 
7 
17 17 
20 19 
j 19 14 
7 
8 9 
25 25 
29 33 
18 18 
8 7 
9 9 
21 21 
3 3 
7 7 
7 7 
ii I 
. I 
ii I I ! 
.! ! 
ii I 
! 
coli DHPR also had an aspartate at this position, whereas the human and rat proteins 
have glycine residues in this position. 
3.2.4 Amino acid analysis 
The amino acid composition of the reductase was determined by the method of 
Spackman et al. (1958). Cysteine was determined as cysteic acid following oxidation of 
the protein with performic acid prior to hydrolysis. The amino acid ratios were obtained 
based on the determined concentration of phenylalanine, as it is one of the more stable 
amino acids in the analysis procedure, and the composition was calculated for a 27-kD 
protein (see Table 3.4). The sequence determination of cyanogen bromide-cleaved 
fragments of the reductase indicated at least six fragments whereas the analysis indicates 
five residues. However, considering that methionine residues can be oxidized to 
methionine sulfone under conditions used for amino acid analysis (Glazer et al., 1976), 
the number of methionine residues in the protein is probably six. The amino acid 
compositions of human-liver DHPR (Dahl et al., 1987) and rat-liver DHPR (Shahbaz et 
al., 1987) deduced from the nucleotide sequences of their respective genesare also 
presented for comparison. The lower threonine and serine content and the higher 
asparagine/aspartate and glutamine/glutamate content are the main differences between E. 
coli DHPR and the two mammalian enzymes. The higher content of the latter residues 
indicates that there may be more acidic residues in the bacterial reductase. This may 
account for its isoelectric point of 5.3 which is lower than that for human-liver DHPR (pl 
= 7.0; Firgaira et al., 1981a) and rat-liver DHPR (pl= 6.4; Webber et al., 1978). 
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3.2.5 Identification of prosthetic group 
The possibility that E. coli DHPR had a tightly-bound prosthetic group became 
clear early in this work when it was noticed that the reductase consumed NADH in the 
absence of the pterin cofactor and the nature of its u.v.-visible absorption spectrum (see 
below). This pterin-independent consumption of NADH was elicited only when the 
assay mixture contained K3Fe(CN)6 which is normally present to oxidize tetrahydropterin 
to the quinonoid dihydropterin form in situ (see Table 2.2). This ferricyanide-mediated 
NADH oxidation by the enzyme was quite well known among flavoproteins (Dixon and 
Webb, 1979), which led to the early belief that the reductase contained a flavin prosthetic 
group. Since quinonoid dihydropterin is unstable and needs to be generated in situ for 
measurement of enzyme activity, the peroxide-peroxidase method was used for its 
generation. Peroxide-peroxidase did not oxidize NADH or NADPH in the absence of the 
pterin cofactor or enzyme at any appreciable rate ( <5% ). 
The purified reductase was yellow in colour when concentrated. The yellow 
colour was used in the prepartive flat-bed isoelectric focusing step to visualise and obtain 
high yields of apparently pure E. coli DHPR (see Chapter 2). The u.v.-visible absorption 
spectrum of the pure protein exhibited a maximum at 449 nm, with a shoulder at about 
475 nm (see Figure 3.2). This is characteristic of an oxidized flavin tightly bound to 
protein. When NADH was added to the enzyme, the peak at 449 nm and the shoulder at 
47 5 nm disappeared. After about 5-10 min in air, the original spectrum of the protein was 
restored except that the intensity of the peak at 449 nm was reduced slightly, probably due 
to the presence of NAD+ in the enzyme solution (see Figure 3.2). This result clearly 
suggested the flavin prosthetic group in the enzyme to be in the oxidized form. When 
NADH was added, the oxidized flavin became reduced to FADH2 which does not absorb 
' 
in the visible region. The prosthetic group was isolated by trichloroacetic acid 
denaturation of the protein. This method of freeing the prosthetic group ruled out any 
strong covalent association between the flavin moiety and the protein. The isolated 
prosthetic group gave a u.v.-visible absorption spectrum that was similar to authentic free 
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Figure 3.2 U.v.-visible absorption spectra of purified E. coli DHPR 
(A) spectrum of protein (15 µM) in 50 mM Hepes buffer at pH 7.4 and 
250c; (B) as in (A) - 1 min after adding 100 µM NADH; (C), (D) and (E) 
spectra after standing in air for about 10 min after addition of NADH 
(100 µM); (F) base linewith 50 mM Hepes buffer (pH 7.4) at 25°C. 
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Figure 3.3 U.v.-visible absorption spectrum of the prosthetic group 
isolated from purified E. coli DHPR 
(A) is the spectrum of the prosthetic group isolated from 400 µg of purified 
protein, in 50 mM Hepes buffer at pH 7.4 and 25°C; (B) is the spectrum 
of authentic FAD (20 µM) in 50 mM Hepes buffer at pH 7.4 and 25°C. 
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2Fe(CN)62+ FAD- NADH + tt+ 
2Fe(CN)63+. ---FADH2 NAD+ 
Scheme 3.2 Stoichiometry of the NADH oxido-reductase activity. 
FAD (see Figure 3.3). The fluorescence emission spectrum of the isolated prosthetic 
group had a maximum at 530 nm ( data not shown) when the excitation wavelength was 
fixed at 450, nm which is the same as that observed for free flavins (Morton, 1975). 
However, the spectroscopic data did not distinguish between FAD and FMN. 
Unequivocal evidence that the flavin was FAD was obtained by t.l.c. The Rp value of the 
isolated fluorescent cofactor relative to riboflavin was 0.16 and that for authentic free 
FAD was also 0.16. In contrast, the RF value for FMN with respect to riboflavin was 
0.31 (cf. Spitzer and Weiss, 1985). The possibility that oxygen or superoxide may be 
involved in the oxido-reductase reaction was also investigated. The NADH oxido-
reductase activity was not affected by bubbling nitrogen through the assay mixture for 10 
min prior to the assay. It was similarly shown that superoxide dismutase had no 
influence on the rate of the reaction. 
Theoretically the oxidation of one molecule of NADH requires two molecules of 
ferricyanide. The experimentally obtained stoichiometry in this study, as evidenced by 
the consumption of one mol. of NADH per mol. of ferricyanide, is in agreement with the 
theoretical value. The rate of oxidation of NADH (from the rate of change of absorbance 
at 340 nm) and the rate of reduction of ferricyanide (from the rate of change of absorbance 
at 420 nm) were the same and followed first order kinetics for more than 80% of the 
reaction. Rate constants of 8.8 x l0-3 s-1 for the former reaction and 8.6 x 10-3 s-1 for the 
latter reaction (at 25°C and Tris/HCl pH 7.4) were calculated. These data (almost 
identical rate constants) taken together with the fact that oxygen and/or superoxide are not 
involved in the NADH oxido-reductase reaction suggest that the enzymatic reactions 
presented in Scheme 3.2 are tightly coupled. 
3.2.6 Naturally occurring pterins in E. coli 
The absence of well-characterised reduced pterin-requiring enzymes such as 
phenylalanine hydroxylase in E. coli indicated the need to investigate the nature of the 
reduced pterins in this organism. The cell-free extract, deproteinized, oxidized and 
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Figure 3.4 The h.p.I.c. analysis of oxidized pterins from E. coli 
A is the blank h.p.l.c. elution profile of the Whatman ODS (0.46 cm x 25 
cm) column, eluted with 5o/o methanol in water at 0.5 ml/min and detected 
by fluorescence (arbitrary units). 
B is the elution profile of oxidized pterins from E. coli, obtained as 
described in Section 3.5.7, through the column as described above. 
C is the elution profile of a 3:1 mixture respectively, of oxidized pterins 
from E.coli and authentic monapterin (a), biopterin (c) and pterin (b). 
The peaks marked (a) and (b) in the elution profile of naturally-occurring 
pterins from E.coli were identified as monapteri".l (a) and pterin (b). 
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partially purified by passage through two Dowex columns, was analysed by h.p.l.c. The 
eluate was monitored by means of a Fluorichrome detector (see Figure 3.4). A mixture of 
synthetic pterin (24), biopterin (25) and monapterin (26) was used as marker to identify 
the types of pterins in the microorganism. Comparison of the elution time of pterins from 
the microorganism with the standards indicated that monapterin and unsubstituted pterin 
are the major pterin components. This was further confirmed by the elution profile of a 
mixture of standards and the unknown pterins. Monapterin was previously shown to be 
the major pterin of Pseudomonas species (ATCC 11299a) and that the tetrahydro 
derivative (27) is the natural cofactor for phenylalanine hydroxylase from that organism 
(Guroff and Rhoads, 1969). 
0 OH -
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:.XN 
. CH20H HN ~ 3' . 
H2NAN N6 
. 
:. 
OH 
(26) 
OH 
0 H OH H --. 
:J(N . HN 
H2NAN N 
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. 
-OH 
. 
. 
-
-OH 
CH20H 3' 
Although it is quite clear that monapterin is also the major pterin in E. coli examined in 
this work, the presence of small amounts of biopterin and other pterins cannot be ruled 
out because of the high level of unsubstituted pterin present. The latter may have resulted 
from loss of the side chain at C-6 during oxidation (Davis et al., 1988), although the use 
of acidified iodine should have minimised the oxidation process (Fukushima and Nixon, 
1980). 
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Figure 3.5 Dihydropteridine reductase activity of 
E.coli DHPR as a function of [NADH]. 
DHPR activity was determined as described in Section 
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Table 3.5 Kinetic data for E. coli DHPR in Tris-HCI pH 7.4, at 25 oc 
Substrate 
NADH 
NADPH 
quinonoid dihydrobiopterin 
quinonoid dihydroneopterin 
quinonoid dihydromonapterin 
quinonoid 6-methyl DHP 
quinonoid 6,7-dimethyl DHP 
a. Standard errors are within+ 5%. 
Apparent 
Km (µM)a 
91 (90)C 
290 
226 (160)C 
1050 
1320 (1450)C 
128 
523 (430)C 
b. µmole of NADH ( or NADPH) oxidized per min per 0.5 µg protein. 
c. Data for Pseudonwnas sp. DHPR (Williams et al., 1976) 
Apparent 
Vmaxa,b 
5.1 
5.2 
2.6 
10.1 
10.1 
4.1 
8.6 
·~ 
Second 
substrate (100 µM) 
quinonoid 6-methyl-DHP 
quinonoid 6-methyl-DHP 
NADI-I 
NADH 
NADH 
NADH 
NADH 
3.2.7 Activity of substrates 
The rate of DHPR activity in the enzyme from E. coli is dependent on the 
concentrations of both NADH and quinonoid dihydropterin, i.e. both substrates show 
Michaelis-Menten type saturation kinetics. When the concentration of quinonoid 6-
methyl-dihydropterin was 100 µM, increasing the concentration of NADH from 10 µM to 
100 µM resulted in increased DHPR activity (see Figure 3.5). Increasing the 
concentration above 100 µM NADH resulted in reduced DHPR activity. A similar 
phenomenon was observed with the Pseudomonas DHPR (Williams et al., 1976), and 
may be due to substrate inhibition. The Km value of 91 µM for NADH with respect to 
quinonoid 6-methyldihydropterin was calculated from a double reciprocal plot and using 
the computer programme of Comish-Bowden (Comish-Bowden and Edrenyi, 1981). 
This value compares favourably with the Km value of 90 µM for the above Pseudomonas 
enzyme. Mammalian dihydropteridine reductases generally have much lower Km values 
for NADH, and they range from 1-30 µM (reviewed by Armarego et al., 1984). The 
reductase from E. coli is active also with NADPH and the rates are about 50% of those 
with NADH under the same reaction conditions. The Km value for NADPH is 290 µM. 
Despite a three fold lower affinity (by comparing Km values, assuming that Km:::::: Kct) in 
binding by NADPH compared with NADH, their maximum velocities are the same (see 
Table 3.5). On the other hand, the reductase activity of the Pseudomonas enzyme with 
NADPH was less than 5% of that with NADH. It is interesting that NADPH and NADH 
were equally effective in protecting the Pseudomonas reductase from heat inactivation 
(Williams et al., 1976). The mammalian dihydropteridine reductases generally use 
NADPH about 15-fold less efficiently than NADH. The only exceptions to this are the 
NADPH-dependent dihydropteridine reductases isolated from bovine and human livers 
(Nakanishi et al., 1986a,b). In these examples, the Km values for NADPH and NADH 
were 1.4 µMand 2900 µM respectively, with quinonoid 6-methyldihydropterin as the 
second substrate. 
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The ability of a range of quinonoid pterins to act as subtrates was also examined in 
the present work and the kinetic parameters are p-esented in Table 3.5. Despite the fact 
that monapterin has been implicated as the predominant naturally occurring pterin in E. 
coli, its Km for quinonoid dihydromonapterin (1320 µM) is about six times higher than 
that for quinonoid dihydrobiopterin (226 µM). The Pseudomonas enzyme also had a 
lower Km value with quinonoid dihydrobiopterin (160 µM) compared with quinonoid 
dihydromonapterin (1450 µM) (Williams et al., 1976). The characteristic feature about 
the natural substrate for dihydropteridine reductascs from both bacterial sources is that its 
maximum velocity is higher than those of other substrates tested (see Table 3.5). 
However, the concentration of monapterin in Pseudomonas was estimated to be O. lmM 
(Williams et al., 1976) and at this level there is no apparent advantage to be gained by a 
high Km and favourable maximum velocity. The Km value for quinonoid 
dihydroneopterin (28) { stereoisomer of quinonoid dihydromonapterin (29)} is also in the 
mM range for the reductase from E. coli. Judging from the Km values for pterin 
substrates with various substitutions at C-6 (see Table 3.5), the active site of the enzyme 
seems to indicate tighter binding with pterins that contain a more hydrophobic sidechain 
(quinonoid dihydroneopterin and dihydromonapterin are the least hydrophobic because 
they contain a trihydroxypropyl group). This qualitative observation is supported by the 
lower Km values for quinonoid dihydrobiopterin and quinonoid 6-methyl and 6,7-
dimethyl dihydropterins. The three-fold higher value for the Km of quinonoid 6,7-
dimethyl-dihydropterin compared with that of quir.onoid 6-methyl-dihydropterin suggests 
that the methyl group at C-7 in the former may pre~ent some steric hindrance. 
OH 
-
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N N '7 
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3.2.8 Effect of methotrexate 
Methotrexate is successfully used in cancer chemotherapy because it inhibits 
DHFR (the essential enzyme in the biosynthesis of purines and thymine) at the pM level 
(Sather et al., 1979; Carter et al., 1981). It also inhibits dihydropteridine reductases from 
mammalian sources but at a much higher concentration (in the µM range; reviewed by 
Armarego et al., 1984). The inhibition of pterin-dependent DHPR and pterin-independent 
oxido-reductase activities by methotrexate has been discussed in Chapter 2 (see Figure 
2.5). The inhibition of both the activities was taken as evidence that the reductase from E. 
coli has more than one activity associated with it and that their active sites are either the 
same or contiguous. An apparent Ki of 0.26 mM at 25°C was calculated from the rate 
data for the pterin-dependent DHPR activity using the Cornish-Bowden programme 
(Cornish-Bowden and Endrenyi, 1981). Double-reciprocal plots of the data (see Figure 
3.6) gave a pattern of lines consistent with competitive inhibition with respect to 
quinonoid 6-methyl-dihydropterin. This type of inhibition was also observed for the 
Pseudomonas enzyme where an apparent Ki of 0.21mM was reported (Williams et al., 
1976) 
The hypothesis at that point in time was that the apparent Ki for methotrexate in 
the pterin-independent NADH oxido-reductase must be identical with that for the pterin-
dependent reductase reaction if the active site for the two activities are identical. The 
reason for the difference in slopes (Fig. 2.5) is probably because the binding abilities of 
the pterin substrate and potassium ferricyanide are different. An apparent Ki of 35 µM 
for methotrexate was calculated from the data for the pterin-independent oxido-reductase 
activity. In this case the pattern of inhibition was also competitive with respect to NADH 
(see Figure 3.7). The six-fold difference in apparent Ki for methotrexate may be due to 
the fact that its inhibition of DHPR activity is with respect to quinonoid 6-methyl-
dihydropterin whereas the inhibition of the oxido-reductase activity is with respect to 
NADH. The pattern of inhibition by methotrexate in the oxido-reductase reaction was 
expected to be a series of parallel lines with respect to NADH (when analysed graphically 
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Figure 3.6 Inhibition of E. coli DHPR activity by methotrexate 
A DHPR activity was determined as described in Section 2.5.1.1, in the absence of methotrexate (a); or in the presence of 
50 µM (b), 100 µM (c) and 150 µM (d) methotrexate, respectively. The concentration of quinonoid 6-methyl-dihydropterin 
was varied from 40 to 110 µM for each concentration of the inhibitor. 
B The double reciprocal plot of A. 
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The double reciprocal plot data on the inhibition of oxido-reductase activity by methotrexate Figure 3.7 
The oxido-reductase activity was measured essentially as described in Section 2.5.1.2 in the absence (I= 0 µM) or presence 
(I= 100 µMan I= 200 µM, respectively) of methotrexate, where 'I' is the concentration of methotrexate. The concetration 
of NADH was varied from Oto 150 µM, for each of the inhibitor concentration. 
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in a double reciprocal plot), by analogy with other flavoenzymes (W. W. Cleland, 
Wisconsin, USA, personal communication). The question that was being addressed 
when carrying out the inhibition studies was whether the flavin prosthetic group is 
involved in the reduction of quinonoid 7 ,8-dihydro(6H)pterins and 7 ,8-
dihydro(3H)pterin (eg. dihydrofolate). This was especially important because none of the 
other dihydropteridine reductases or dihydrofolate reductases reported in the literature 
were known to contain prosthetic groups. The hydride transfer in these enzymes occurs 
directly from the pyridine nucleotide onto N-5 in the case of DHPR catalysed reactions 
and C-6 for DHFR catalysed reactions. Since in the case of DHPR from E. coli the 
hydride can be transferred onto either N-5 or C-6, it was felt that the flavin prosthetic 
group might be mediating the hydride transfer. Although the kinetic data from this study 
do not support the hypothesis of a 'ping-pong' mechanism for the reductase and oxido-
reductase reactions, they are worthy of further investigation by more involved kinetic 
experiments. Time did not permit such a study in this work. 
The quickest way to find out if FAD is involved in the enzymic reaction would be 
to carry out the DHPR assay at 450 nm where the absorbance changes due to reduction of 
the FAD prosthetic group can be recorded. However the large amount of enzyme 
required for this experiment did not make it feasible. 
3.2.9 Potential substrates and the effects of pterins on oxido-reductase 
activity 
The presence of a flavin prosthetic group was an unusual occurrence in an enzyme 
that carried out pterin-dependent oxidation of NADH. Much effort was put into 
investigating if there may be a true substrate for this flavoprotein in E. coli and that 
perhaps the DHPR and DHFR activities were fortuitous in vitro reactions that do not take 
place in vivo. The literature was surveyed for known flavoproteins from any sources that 
had molecular weights of about 25 kD. Flavoproteins that used phenol, salicylate, 4-
hydroxybenzoate, 4-hydroxyphenylacetate, orcinol and 2,6-dihydroxypyridine were the 
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Figure 3.8 K3Fe(CN)6 is a substrate for the oxido-reductase reaction catalysed by E. coli DHPR, and shows 
saturation kinetics 
The oxido-reductase activity was carried out essentially as described in Section 2.5.1.2, except that the concentration of K3Fe(CN)6 
was varied from O to 300 µM. 
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Effect of 6-methyltetrahydropterin on the oxido-reductase reaction catalysed by E. coli DH PR Figure 3.9 
The oxido-reductase assay described in Section 2.5.1.2 was slightly modified, in that the visible wavelength of 420 nm was used 
to follow the loss of absorption, due to reduction of K3Fe(CN)6. The effect of the pterin substrate on the oxido-reductase activity was 
measured in the absence (a), or presence of 10 µM (b), 25 µM (c) and 100 µM (d) of 6-methyltetrahydropterin. 
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best candidates from the literature survey, so their substrate activity was examined 
individually with the enzyme purified in this study. None of the reactants listed above 
caused the oxidation of NADH in the presence of E.coli DHPR. 
The artificial electron acceptors K3Fe(CN)6 and tetrazolium MTI are substrates 
for the NADH oxido-reductase reaction with E. coli DHPR. K3Fe(CN)6 showed 
saturation kinetics in the oxido-reductase reaction of E.coli DHPR (see Figure 3.8) at pH 
7.4 and 300c. This was a surprising result since the saturation effect indicated that the 
reactant is binding to the enzyme to form an enzyme-substrate complex. This was further 
investigated by determining if pterins are inhibitors of the oxido-reductase activity. When 
6-methyl-tetrahydropterin (50 µl in 4 mM HCl) was added to a final concentration of 100 
µM to the oxido-reductase assay mixture containing 300 µM K3Fe(CN)6 and 102.5 µM 
NADH in a total volume of 1 ml of 0.1 M Tris/HCl at pH 7.4 and 30°C, the maximum 
velocity (measured by loss of absorption at 420 nm due to reduction of K3Fe(CN)6) 
dropped by about 40%. Since it was known that K3Fe(CN)6 was a good oxidant of 
tetrahydropterins to quinonoid dihydropterins and that 2 moles of the former are required 
to oxidize one mol. of the fully reduced pterins, then the addition of 100 µM 6-methyl-
tetrahydropterin in the reaction would have consumed 200 µM of K3Fe(CN)6 to oxidize 
the tetrahydropterin to quinonoid dihydropterin (compare with Armarego, 1984). Thus, 
some of the reduction in maximum rate was attributed to a lower concentration of 
K3Fe(CN)6 present. However, when 10 µM (final concentration) of 6-methyl-
tetrahydropterin was added, the maximum velocity dropped by about 20% and the 
addition of 25 µM (final concentration) of 6-methyl-tetrahydropterin also resulted in about 
40% reduction in maximum rate. When 6-methyl-tetrahydropterin was added to a final 
concentration of 10 or 25 µM, the effective concentration of K3Fe(CN)6 was 280 and 250 
µM respectively. However the data presented in Figure 3.8, shows that 150 µM 
K3Fe(CN)6 was sufficient to give the maximum rate for the defined assay. The 
suggestion from the qualitative results (see Figure 3.9) obtained by adding increasing 
amounts of 6-methyl-tetrahydropterin to the pterin-independent oxido-reductase assay is 
that the effective enzyme concentration is reduced, thereby causing the decrease of the 
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Table 3.6 Effect of N,N-dimethylpropargylamine (2.2mM) on the pterin-dependent oxidation of NADHa 
(DHPR activity) in 0.1 M Tris/HCI pH 7.4 at 2soc 
Time (min) . 
0 
5 
10 
15 
20 
25 
E. coli DHPR + inhibitor 
58 
74 
79 
89 
95 
% loss of DHPR activity 
E. coli DHPR (control) 
4 
7 
11 
13 
14 
a. The inhibition experiment was carried out as described in Section 3.4.10. 
II· I I I 
oxido-reductase activity. Since both 25 and 100 µM 6-methyl-tetrahydropterin caused the 
same level of inhibition, the hypothesis was that there may be two binding sites for 
K3Fe(CN)6 because when the enzyme is saturated with the pterin for which there is 
presumably only one binding site, the maximum velocity of the NADH oxido-reductase 
activity is more than 50%. (Note: K3Fe(CN)6 does not oxidize NADH non-enzymically). 
Another conclusion that may be drawn from this result is that the prosthetic group is not 
buried deeply in the protein, and could be reduced non-enzymically. 
3.2.10 An active site-directed suicide inhibitor 
Since the kinetic studies did showed no clear evidence of the involvement of the 
flavin prosthetic group in the DHPR reaction, attention was turned to the use of a suitable 
inhibitor. It is well known that several psychiatric and neurological diseases are depicted 
by imbalances in monamine oxidases (flavoproteins) which are involved in the 
deamination of substances such as dopamine and serotonin. Most of the drugs that are 
used to treat psychiatric and neurological diseases (e.g. Parkinson's disease) are based on 
acetylinic suicide inhibitors that inhibit the monamine oxidases by covalently binding to 
R 
H 
-::: H HC=C-C_.. 
' N, 
CH( CH3 
Enzyme Nll~Yo 
l~~NH 
0 
(30) (31) 
the flavin prosthetic group (Ferscht, 1885a; Youdim and Salach, 1978). N,N-
dimethylpropargylamine (30) is a well-known inhibitor of several flavoproteins (Maycock 
et al., 1976). The compound was prepared in this study and was >95% pure on the basis 
of 1 H NMR analysis. The data presented in Table 3.6 show that the pterin-dependent 
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NAD(P)H + H+ ______________ _ E.F AD ~ 1 ~ 6-Mc-PlI 4 
E.F AD- NAD(P)H + H+ E.F AD Hr q.6-Me-PH2 
NAD(P)+ -4 I ._ E.FADH2 q.6-Me-PH2 
Scheine 3.3 The proposed 'ping-pong' mechanism for DHPR from f. coli 
oxidation of NADH is inhibited by the acetylenic suicide inhibitor. This is direct evidence 
that the reduction of quinonoid 6-methyldihydropterin is mediated by the flavin prosthetic 
group. The loss of 50% of the enzyme activity after a five-minute treatment with the 
compound is evidence of its strong inhibitory action and almost all the DHPR activity was 
lost within 25 min at 25°C. The mechanism of inhibition, by analogy with other 
flavoproteins, involves alkylation of the flavin moiety (31) at N-5 (Maycock et al., 1976). 
The alkylation reaction probably occurs by a Michael addition reaction (Ferscht, 1985b). 
This is the first evidence that the flavin prosthetic group mediates the transfer of 
electrons from the pyridine nucleotide to the dihydropterin substrate. This then explains 
the reason why E. coli DHPR does not distinguish between positions N-5 and C-6 of the 
pyrazine ring of the pterin nucleus and can transfer a hydride to either of the positions, 
thus exhibiting both DHPR and DHFR activities. More evidence for this argument comes 
from the kinetic parameters for NADH and NADPH in the DHPR reaction for the E. coli 
enzyme presented in Table 3.5. Although the Km value for NADH was about 3-fold 
lower than for NADPH, the maximum velocities with both the pyridine nucleotide 
cofactors were identical. The DHPRs from most of the sources that have been studied 
use NADH in preference to NADPH, and the V max value with the former substrate is 
much higher than that with the latter. This is also true in the case of DHFRs from most 
sources which use NADPH in preference to NADH where the V max value with the 
former is higher. Therefore it may be reasoned that both NADH and NADPH exhibit 
identical apparent maximum velocities despite the 3-fold lower efficiency in the binding of 
the latter (which is probably due to lack of a site for the binding of the 2' phosphate group 
of NADPH) because their role in catalysis is mediated via the reduction of the flavin 
prosthetic group which in turn reduces the dihydropterins. These results are good 
support for the ping-pong mechanism of catalysis which is presented in Scheme 3.3. 
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3.2.11 Immunoreactivity of E. coli DH PR 
An ideal method of investigating structural relationships of enzymes that carry 
out a similar function and are separated by evolution (or by a creationist time-scale?) is to 
compare their cross-reactivity with antibodies rais,!d against either of the antigens. Since 
the results discussed in the preceding sections indicated that the physical and kinetic 
properties of E.coli DHPR are considerably different from those of mammalian DHPRs 
reported in the literature, it was felt that cross reactivity studies with antibodies raised 
against human DHPR should be investigated to determine if there are any surface 
structural similarities between them. The sensitive enzyme-linked immunosorbent assays 
(ELISA; Engvall, 1980) were carried out for E. coli DHPR, human-brain DHPR and 
human-liver DHPR with monoclonal antibodies raised against human liver DHPR 
(monoclonal and polyclonal antibodies against human liver DHPR were kindly supplied 
by Dr. R.G.H. Cotton, The Murdoch Institute, Iv1elbourne). Of the four monoclonal 
antibodies examined (#DHPR-1 to #DHPR-4) , three of them (#DHPR-1,2 and 3) 
recognised a conserved epitope present in the three reductases that were examined (see 
Figure 3.10). Judging from the versatility of the reductase from E. coli (i.e. its 
multifunctionality) and the single known function of recycling quinonoid dihydropterin 
for human DHPR, perhaps the epitope being recognised may be a pterin binding site. 
However, when the E.coli reductase was compared with the human reductases by a dot 
blot experiment probed with monoclonal antibody# DHPR-1, there was no indication of 
antigen-antibody reaction. This was not surprising because other workers have reported 
problems with reacting monoclonal antibodies wjth antigens blotted onto nitrocellulose 
(Szewczyk and Summers, 1987). It was felt tha' perhaps the monospecificity of these 
antibodies may be lost because the antigen may not be in its native conformation. 
E. coli DHPR and human D1-IPR were also examined by Western blots with 
polyclonal antibodies raised against human DHPR (see Figure 3.11). Human-brain 
DHPR showed a much stronger signal compared with that of the apparently homogenous 
preparation of E. coli DHPR. The absence of a signal from the E. coli DHPR band in the 
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Figure 3.10 Enzyme-linked immunosorbent assay of E.coli DHPR, 
human-brain DHPR and human-liver DHPR, using 
monoclonal antibodies (# DHPR-1, # DHPR-2 or 
# DHPR-3) 
The ELISA experiment was carried out as described in Section 3.4.14. 
0.5 
0 
a, 
~ 
< 0.4 
0.3 
0.2 
0.1 
0.12 
c:> 
Q\ 0.10 
~ 
~ 
0.08 
0.06 
0.04 
0.02 
# DHPR-1 
0.0 
# DHPR-2 
0. 1 
~ E.coli DHPR 
• Human brain DHPR 
• Human liver DHPR 
0 .2 0 .3 
MAb dilution 
-o-- E.coli DHPR 
• 
• 
Human brain DHPR 
Human liver DHPR 
0.00 -----.......-----------------....---
0. 0 0. 1 
# DHPR-3 
0.10 
0.06 
0.04 
0.02 
0.0 0 . 1 
0.2 0 .3 
MAb dilution 
-o-- E.coli DHPR 
• 
• 
0 .2 
Human brain DHPR 
Human liver DHPR 
0 .3 
MAb dilution 
l 
' 
Figure 3.11 Western blot analysis of purified human-brain DHPR (b), 
purified E. coli DHPR (c) and cell-free extract from strain 
H712 (d), using polyclonal antibodies to human-liver DHPR 
Human-brain DHPR (2 µg), E. coli DHPR (2 µg) and cell-free extract from strain 
H712 (100 µg) were run concurrently with Bio-Rad pre-stained molecular weight 
standards (a) on a 12% w/v SDS-PA gel, blotted onto a nitrocellulose filter and 
probed with polyclonal antibodies to human liver DHPR (1 in 2000 dilution of 
antiserum), as described in Section 3.4.16. 
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Table 3.7 Neutralisation of DI-IPR activity by polyclonal antibodies raised against E. coli DI-IPR 
Vol. of antiserum 
(µl) 
1 
2 
3 
4 
5 
E.coli DHPRa 
23 
48 
73 
92 
o/o loss of DlIPR activity 
Human-brain DHPRa 
4 
7 
8 
10 
a 0.5 µg of antigen was added in the assay together with the appropriate volume of antiserum in the enzyme assay 
carried out as described in Section 2.5.1.1, 
in the cell-free extract suggests that the antigenic properties of the two reductases are 
probably different. 
At a later stage in this work, polyclonal antibodies against E.coli DHPR were 
raised specifically to investigate if a fusion protein had been inadvertently formed during 
attempts to clone the gene that encoded the reductase ( discussed in the fallowing 
Chapters). The crude antiserum obtained after removal of the coagulated blood cells was 
used in a Western blot experiment, to indicate that antibodies raised were specific for E. 
coli DHPR. These polyclonal antibodies gave a strong signal with the apparently pure E. 
coli DHPR as well as with the reductase band in the cell-free extract. The human-brain 
DHPR however showed a weak signal (data not shown). Further evidence that the 
antibodies were specific for E.coli DHPR came from its abilty to neutralise the reductase 
activity. Under conditions where 2µ1 of antiserum gave about 50% inhibition of bacterial 
DHPR activity, only 4% of enzyme activity of human brain DHPR was lost (see Table 
3.7). It may be concluded from the above results that the mammalian and the bacterial 
reductases are antigenically diverse. However there are suggestions of a small degree of 
surface similarity which most probably is in the region of the pterin binding site. This 
notion also receives support from the preliminary studies with an anti-idiotype 
monoclonal antibody which behaves like a pterin substrate, which showed cross-
reactivity with the E. coli reductase (R.G.H. Cotton and I. Jennings, private 
communication). 
3.3 SUMMARY 
Dihydropteridine reductase from E. coli is different from all the previously 
characterised reductases from mammalian sources (reviewed by Armarego et al., 1984) 
and NADPH-specific DHPR from bovine and human liver (Nakanishi et al., 1986a,b) in 
several respects. The reductase from this study is a 27 kD protein which is active as a 
monomer. In addition to its ability to reduce quinonoid dihydropterins to the 
corresponding tetrahydropterins, the E. coli reductase can also reduce 7 ,8 dihydrofolate to 
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tetrahydrofolate. E. coli DHPR has FAD as prosthetic group which is non-covalently 
bound to the enzyme. The presence of the FAD prosthetic group gives rise to the non-
pterin dependent oxidase activity of NADH in the presence of artificial electron acceptors 
such as K3Fe(CN)6 and tetrazolium-MTT. The possibility that the protein from this work 
may have a major in vivo function which is unrelated to the in vitro activities was 
examined using phenol, salicylate, 4 hydroxybenzoate, 4-hydroxyphenylacetate, orcinol 
and 2,6-dihydroxypyridine as possible substrates, however none of them was active. 
Stoichiometric studies indicated that the pterin-independent oxidation of NADH in the 
presence of K3Fe(CN)6 is a tightly coupled reaction because 1 mole of NADH is 
oxidized when two moles of Fe(CN)63+ are reduced. The oxidation of NADH and the 
reduction of ferricyamide follow first-order kinetics. The reduction of quinonoid 6-
methyl-dihydropterin to the corresponding tetrahydropterin by E. coli DHPR is probably 
mediated by the FAD prosthetic group because the acetylenic inhibitor propargylamine 
inhibits the reaction. The enzymatic reaction is probably by the 'ping-pong' mechanism. 
The major naturally occurring pterin cofactor in E. coli is monapterin (L-threo-
neopterin). This pterin was previously identified as the cofactor for phenylalanine 
hydroxylase in Pseudomonas species (ATCC 11299a) (Guroff and Rhoades, 1969) and 
was the major pterin in that organism. The kinetic parameters for several quinonoid 
dihydropterins with respect to NADH as the second cofactor for E. coli DHPR compare 
well with those from the reductase from Pseudomonas (Williams et al., 1976). With both 
the bacterial reductases, quinonoid dihydrobiopterin has -6-fold lower Km value than the 
natural substrate quinonoid dihydromonapterin. The E.coli reductase prefers NADH as 
the pyridine nucleotide substrate but can also use NADPH to an equal maximum velocity, 
although the Km value is lower. The N -terminus of DHPR from E. coli is not blocked 
by acety lation and methionine is the first residue. The sequence of the first 20 amino-
acids of E. coli DHPR do not residues in common with the corresponding regions of 
human DHPR (Dahl et al., 1987) and rat DHPR (Shahbaz et al., 1987). The 
immunochemical studies may indicate that the bacterial reductase contain a pterin binding 
site. 
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3.4 MATERIAL AND METHODS 
3. 4 .1 Dihydrofolate reductase assay 
The DHFR activity assay, which measures the folate dependent oxidation of 
NADPH or NADH, was carried out spectrophotometrically on a Cary 219 double beam 
spectrophotometer (Wilmanns, 197 4 ). The stock solution of 7 ,8-dihydrofolate (DHF) in 
50 mM Tris-HCl pH 7.4 was made freshly on the day of the experiment. The standard 
reaction mixture contained Tris-HCl pH 7.4 (0.1 M), DHF (0.1 mM) and NADH or 
NADPH (0.1 mM) in a total volume of 1 ml each in two cuvettes. The enzyme activity 
was initiated by injecting the enzyme solution into one cuvette only. The enzyme activity 
was calculated by using the reaction molar absorption coefficient of 12,440 M-lcm-1 
(because molar absorption coefficient for NADH or NADPH is 6220 M-lcm-1 and that 
for DHF is also 6220M-1 cm-1) and the absorbances of both the substrates are decreased 
simultaneously in the enzyme reaction. 
3. 4. 2 Molecular weight determination 
3.4.2.1 Gel filtration method 
A Superose-12 gel filtration column with the f.p.l.c system (Pharmacia) and 
50 mM Tris-HCl pH 7 .5 containing 2 mM DTI and 20 µm NADH as solvent was used to 
determine the native molecular weight of the enzyme. The column was calibrated with a 
mixture (0.2 ml in the above buffer containing 100 µg of each protein) of phosphorylase 
b (94 000), bovine serum albumin (67 000), ovalbumin (43 000), carbonic anhydrase (30 
000), trypsin inhibitor (20 100) and a-lactalbumin (14 400), at a flow rate of 0.5 ml/min. 
The molecular weight of native DHPR (0.5 mg) was estimated from the calibration plot of 
logarithm of molecular weight versus elution volume, to be 54000+ 2000. SDS/P AGE 
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run concurrently with low molecular weight standards (Pharmacia) was carried out to 
estimate the molecular weight of the denatured enzyme. 
3.4.2.2 Analytical ultracentrifugation 
Analytical centrifugation of the purified protein was examined in a meniscus-
depletion sedimentation equilibrium experiment (Yphantis, 1964) by Dr Peter Jeffrey of 
the Protein Chemistry Group, JCSMR. DHPR purified by preparative bed isoelectric 
focusing (0.5 mg/ml) was dialysed against 50 mM Hepes pH 7 .5 (500 ml, 2 days). The 
speed of 40 000 rpm was calculated to be appropriate for a solute of molecular weight 25 
000. The experiment was performed in a double-sector aluminium-filled cpm cell with 
sapphire windows at a controlled temperature of 20 + 0.1 oc with the dialysed protein 
solution (0.10 ml) in one sector and its equilibrium dialysate (0.11 ml) in the other. A 
photograph was taken after sedimentation equilibrium had been attained ( 8 h) using 
refractometric optics of the Rayleigh interference fringe pattern. The fringe patterns were 
measured using a Nikon microcomparator and the results expressed as In (fringe 
displacement) vs. r2 where r is the distance from the axis of rotation. The weight average 
molecular weight was evaluated from the expression: 
where y 
R 
T 
'U 
p 
(l) 
2RT 
(1 - up) ol 
din y 
d (r 2) 
is the fringe displacement 
is the gas constant 
is the absolute temperature 
is the partial specific volume of the protein 
is the density of the solution 
is the angular velocity of rotation 
The partial specific volume was assumed to be 0.73 ml/g (for a normal soluble 
protein). The density was 1.001 g/ml. 
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3.4.3 N-terminal amino acid analyses 
The purified reductase (0.4 ml, 50 µg) was dialysed against 0.5% NR4HC03 
(w/v, 3 x 500 ml) and finally against MQ wate~ (Millipore, 500 ml). The sequence 
analyses were carried out by Dr Denis Shaw, Protein Chemistry Group, JCSMR. One 
half of the dialysis residue was applied directly on to a Beckman model 890M2 spinning-
cup sequencer, with automatic conversion to release the phenylthiohydantoin (PTH) 
derivative of the N-terminal amino acid after each cycle. The amino acid PTH derivatives 
were analysed on a du Pont PTH column (with elution by sodium acetate-acetonitrile) 
using a Hewlett-Packard 1084B h.p.l.c system with an Altex 165 variable-wavelength 
detector. The second half of the dialysis residu": was made 70% (v/v) in formic acid, 
treated with CNBr (200 µg) and analysed without separation of peptides. The reaction 
mixture was applied to the spinning cup and washed with ethyl acetate before the 
sequencing was commenced. 
3.4.4 Amino acid analysis 
E. coli DHPR(75 µg) in 1 ml of 50 m\/1 Hepes-KOH pH 7.4 was dialysed 
exhaustively against the same buffer (2 x 500 ml) followed by dialysis against water (2 x 
500 ml). The protein (dialysis residue) was aliquoted ( -0.4 ml) into three hydrolysis 
tubes and freeze dried. HCl (6 M, 1 ml) was added to each tube containing the freeze-
dried protein and degassed (using a freeze-thaw cycle) with an oil vacuum pump before 
sealing the tube. The protein was hydrolysed at 1100c for 24, 48 and 72 h. After the 
hydrolysis the seals were broken and the acid wa:; removed by rotary evaporation. The 
residue was taken up in 0.15 ml System 6300 Na-S™ buffer (Beckman) and applied to 
the Beckman System 6300 High Perfomance Analyzer by Mr L.B. James, Biochemistry 
Department, JCSMR. 
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The perfonnic acid oxidation of protein to obtain the analysis of cysteine as cysteic 
acid was carried out by adding 1 ml of perfonnic acid (prepared from 9 .5 ml of 90% 
formic acid and 0.5 ml of 30% hydrogen peroxide) to a hydrolysis tube containing 25 µg 
of protein treated as above. The oxidation was allowed to proceed for 6 hrs at o0 c and 
the solvent was removed by freeze drying. The oxidized protein was then hydrolysed and 
analysed as above. 
3.4.5 Identification of the prosthetic group 
The purified reductase (400 µg, 3 ml) in 50 mM Hepes-KOH pH 7.4 was 
denatured by the addition of trifluoroacetic acid (Aldrich; 90 µl of 99+% ), centrifuged 
(2000 x g, 30 min) and the supernatant and was filtered through a Centricon YMl 0 
(Amicon Mr cut-off 10000) by centrifugation (4000 x g, 30 min). The visible absorption 
spectrum of the filtrate (protein-free) was determined on a Cary 219 spectrophotometer, 
and the fluorescence spectrum was measured on a Perkin-Elmer 3000 fluorescence 
spectrometer with the excitation wavelength set at 450 nm. Authentic FAD (Sigma; 2 
µM) solution was used for comparison. The solution from the spectroscopic 
measurements was freeze-dried, dissolved in 20 µl of water and an aliquot was run on a 
silica-gel 60 (Merck) plate together with authentic FAD, FMN and riboflavin. The Rf 
values of the isolated fluorescent cofactor, and authentic FAD and authentic FMN, relative 
to riboflavin were 0.16, 0.16 and 0.31, respectively (cf. Spitzer and Weiss, 1985). 
3.4.6 Stoichiometry of NADH oxido-reductase activity 
The oxido-reductase activity assay (see Section 2.5.1.2) was used to investigate 
the stoichiometry. The enzyme (0.5 µg) was added to one of the cuvettes to start the 
reaction. The rate of decrease of absorbance at 340 nm (due to NADH oxidation) and the 
rate of decrease of absorbance at 420 nm (due to reduction of ferricyanide, £ 1050 cm-1 
M- 1) were recorded on a Cary 219 double-beam spectrometer driven by an Apple II-
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PLUS computer using a multiscan kinetic program. The absorbance readings were taken 
at 22 s intervals, and the readings at 340 nm were taken 11 s after the readings at 420 nm. 
Data were collected for 15 min. The infinity absorbance values for the two wavelengths 
were calculated by using the Curfit program provided by Dr David Randles (Department 
of Community Services and Health, Phillip, Canberra, A.C.T.). 
3.4.7 Analysis of naturally occurring pterins 
Escherichia coli strain H712 (20 g) cultured as described in Section 2.5.4 was 
suspended in 0.1 M H3P04 (40 ml) and lysed in a Sorvall Ribi cell smasher [290 kPa 
(2000 lb.in-2)]. The cell-free extract was obtained by centrifugation (2000 x g, 20 min) 
and concentrated (to 4 ml) by freeze drying. The sample was oxidized in a mixture of 
trichloroacetic acid (1 ml, 2 M) and acidified iodine (2 ml of 9 mg I2, 1.8 mg KI/ml 
solution in 0.1 M HCl) for 1 h at 25°C in subdued light. The suspension was centrifuged 
(2000 x g, 10 min) and the supernatant was concentrated to 2 ml by freeze-drying. The 
sample was applied to Dowex 50W x 4 (0.2 ml, 100-200 mesh, H+ form) resin in a 
Pasteur pipette. After washing with water (5 ml) the pteridines were eluted with 0.25 M 
NJ40H (6 ml) directly onto a Dowex 1 column (0.2 ml, 50-100 mesh, OH- form) also in 
a Pasteur pipette. This was washed with water (3 ml with suction) and the pterins were 
eluted with 1 M acetic acid (0.6 ml). The effluent was analysed for pterins on an ODS 
column (0.46 cm x 25 cm) fitted to a Varian 5000 h.p.l.c system with a Fluorichrome 
detector. Standard solutions of monapterin, biopterin, neopterin and pterin were used to 
identify the unknown pterins. 
3.4.8 Activity of substrate and kinetic analyses 
All the substrates examined in this work exhibited Michaelis-Menten type 
saturation kinetics. The kinetic parameters for the pyridine nucleotide substrate in the 
DHPR reaction were obtained by varying its concentration from 10 µM to 100 µM (at 
least five different concentrations, e.g. 10, 20, 40, 60, 80 µM) and keeping the 
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concentration of the pterin substrate constant at 100 µM. Conversely, the concentration 
of the pyridine nucleotide was kept constant 'Nhen kinetic parameters with pterin 
substrates were measured. The assays were carried out in duplicate for each 
concentration value. The velocities obtained were plotted graphically in the double 
reciprocal form (Lineweaver and Burk plot) to check for linearity before analysis with the 
computer programme of Comish-Bowden (Cornish-Bowden and Endrenyi, 1981). 
The inhibition constants with methotrexate were measured by keeping the 
concentration of one of the substrates constant (e.g. NADH = 100 µM) and varying the 
second substrate from 10 µM to 100 µM (at least five points), in the absence of 
methotrexate (I = 0) and repeated in the presence of 100 µM, 200 µM or 300 µM 
methotrexate respectively. (Note: The inhibitor was added in both cuvettes). The sets of 
data were graphically analysed by the double reciprocal plot (e.g. see Figure 3.8) and 
analysed by the computer programme of Comish-Bowden by fitting into appropriate rate 
equations to determine if the pattern of inhibition were linear competitive, non-competitive 
or uncompetitive. The pattern of inhibition obtained by computer analysis agreed with 
that determined graphically. All kinetic constants (Km, V max and Ki) had standard errors 
less than ± 5%. 
3.4.9 Synthesis of dimethylpropargylamine 
Dimethylamine (0.45 g, 1.36 ml in ethanol) was slowly added to a 50 ml round-
bottomed flask containing propargylbromide (1.11 g, 1.31 mls). The flask was 
stoppered after the white cloudiness disappear~d and the solution was left stirring 
overnight at room temperature. Ethanol (2 ml) w_as added to the reaction mixture and the 
product was crystallized by adding ether dropwis ~ and scratching the glass at 0°C. The 
crystals that were filtered were dissolved in the minimum volume of ethanol, 
recrystallized by addition of ether and washed with ether (3 x 10 mls) before drying over 
P205. The product dimethyl propargylamine was> 95% pure as determined by lH NMR 
(see spectrum in the Aldrich "NMR spectra" catalogue). 
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3.4.10 Inhibition by dimethylpropargylamine 
Dimethylpropargylamine (2 n1g) was dissolved in a mixture containing Tris/HCl 
(1 M, 0.6 ml), distilled water (5.9 ml) and E. coli DHPR (30 µg; 60 µl) at 25°C. The 
control experiment was carried out without the inhibitor. An aliquot (0.75 ml) was 
removed immediately after addition of enzyme and at five minute intervals thereafter. 
DHPR activity was determined from the change in absorbance at 340 nm 
followingaddition of peroxidase (20 µg; 100 µl), H202 (11 µmol; 50µ1), 6-
methyltetrahydropterin (100 µM; 50 µl) and NADH (100 µM; 50 µl) to start the reaction. 
3.4.11 Effect of tetrahydropterin on pterin-independent oxido-
reductase activity 
The pterin-independent oxido-reductase activity assay (Section 2.5.1.2) was 
carried out. The substrate 6-methyl-tetrahydropterin was added to give final 
concentrations of 0, 10, 25 or 75 µM to the sample and reference cuvettes. The enzyme 
was added to the sample cuvette to start the reaction. The rate of decrease of absorbance 
at 420 nm (due to the reduction of ferricyanide, E 1050 cm-1 M-1) was recorded on a Cary 
219 double-beam spectrophotometer. 
3.4.12 Non-denaturing PAGE and activity staining of gels 
The non-denaturing PAGE was carried out as described in Section 2.5.3.2. Since 
the reductase from E. coli possessed three different enzyme activities, a modified method 
of staining for all the activities on a single gel was used. Basically, it involved 
immobiliation of the constituents for a particular reaction in a gel medium so that it could 
be layered over the PA gel. When staining for 3 different activities on a single gel, 
spacers were used to guide the layering of the reaction mixture over a particular section. 
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For the DHPR stain, stock solutions of 10 mM NADH (1 ml), 10 mM tetrazolium 
MTT (1 ml), and 10 mM quinonoid 6-methyl-7 ,8-dihydropterin were warmed briefly to 
-37°C and added to molten agarose (0.3% w/v) in 7 ml of 140 mM Tris HCl (pH 7.4). 
The mixture was lukewarm when layered over the PA gel section that was analysed for 
DHPR activity. For the DHFR stain the reaction constituents were 10 mM NADPH (1 
ml), 10 mM tetrazolium MTT (1 ml) and 10 mM 7,8-dihydrofolate (1 ml), mixed with 
molten agarose prepared as above. For the pterin-independent NADH oxido-reductase 
activity the reaction mixture contained 10 mM NADH (1 ml), 10 mM tetrazolium MTT 
(1 ml), distilled water (1 ml), added with molten agarose as for the DHPR stain. 
The agarose gel overlay containing the reactants for the three enzymic reactions 
were allowed to be in contact with the PA gel for 5-10 min at room temperature. Once the 
bands were visualised, the overlay was removed and the gel was photographed 
immediately for record. The activity stained gels were stained for protein using the 
Coomassie G-250 method described in Section 2.5.3.1. 
3.4.13 Protein-blotting and N-terminal amino acid sequencing 
The Applied Biosystems 477 A gas-liquid phase sequencer was used for 
microsequencing kindly carried out by Dr Denis Shaw, JCSMR. 
The partially purified protein (-4 µg per track) was separated by SDS-PAGE on a 
12% gel as described in Section 2.5.3.1. Meanwhile, the sheets of glass microfiber 
(GF/C; Whatman, U.K.) were cut to the size of the PA gel and evenly wetted with 3 
ml/ml solution of Polybrene in water. The impregnated sheets were dried in air for 4 to 5 
hours. When the electrophoresis was completed, the glass plates were carefully 
separated. The stacking gel was removed with a scalpel and the separating gel was placed 
in a "sandwich" assembly (perspex sheet, Scotchbrite pad, 2 sheets of 3 MM paper cut to 
the size of the Scotchbrite pad, the PA gel, two sheets of Polybrene-coated GF/C placed 
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back to back, two sheets of 3 MM paper, one sheet of Scotchbrite pad and finally the 
perspex sheet). The Polybrene coated GF/C was washed in 100 ml water for 5 min to 
remove excess unimpregnated Polybrene before it was mounted in the "sandwich"). All 
the constituents of the "sandwich" were wetted with the transfer buffer (50 mM sodium 
borate, pH 8.0, 20% methanol and 0.02% 2-mercaptoethanol) and the bubbles from each 
layer of the "sandwich" were removed by rolling over it gently with a cylindrical tube. 
The "sandwich" was fastened by clips between the perspex sheets and immersed in an 
electro-blotting apparatus (Bio-Rad Trans-Blot Cell) containing the transfer buffer, and 
the electrophoretic transfer was carried out at room temperature for 15 h at 25 V 
(constant). Care was taken to ensure that the Polybrene coated GF/C within the sandwich 
was at the anodic end before the transfer was begun. After the transfer was completed, 
the constituents of the "sandwich" were carefully removed to expose the Polybrene coated 
GF/C. The sheets were marked so that the front and back sheets could be distinguished 
and superimposed after staining and drying. The sheets were subsequently washed for 
10 min with 150 ml of 25 mM NaCl, 10 mM sodium borate (repeated four times) and 
finally washed in water. They were then dried by being suspended in a clean cupboard 
for 3-4 h. The dried sheets were sprayed with a freshly-prepared acetone solution of 
fluorescamine (1 mg/300 ml acetone; Fluka A.G) and dried again (-30 min). Proteins 
were visualized under to u.v. illumination. The relevant bands were lightly outlined with 
a pencil and cut out with a clean scalpel. This was then mounted in the reaction chamber 
of the Applied Biosystems 477 A gas-liquid phase sequencer essentially as described by 
Hewick et al. (1981). The liberated PTH derivatives of amino acids were analysed on-
line in an Applied biosystems 120A h.p.l.c. fitted with a PTH-C18 reverse phase column 
using a gradient elution system essentially as described by Hunkapiller and Hood (1983). 
It should be stressed that gloves should be worn throughout and tall precautionary steps 
should be taken to prevent introduction of contaminating proteins. The dry GF/C 
membrane was has handled carefully because it was very brittle. 
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3.4.14 Enzyme-linked immunosorbent assay (ELISA) 
The purified E. coli DHPR, human-brain DHPR and human-liver DHPR (10 
µg/ml each in 0.05 M Na2C03, pH 9.6) were examined by ELISA using monoclonal 
antibodies raised against human-liver DHPR (kind gift of Dr R.G.H. Cotton). The 
monoclonal antibodies #DHPR 1, 2, 3 and 4 and the pre-immune control supernatant 
were examined. The protein antigens (50 µl) were placed in the appropriate wells of a 
microtitre plate (96 U shaped wells with cover; Linbro, U.S.A), allowed to stand 
overnight at 4°C and covered to prevent evaporation. The excess unbound antigen was 
removed and the wells were washed (twice) with phosphate buffered saline (PBS, pH 
7.2). The wells were blocked with 100 µl of 1 % BSA (Fraction V, 99% pure; 
Boehringer, Mannheim) for 1 hat 4°C. The excess was removed by tapping the plate. 
The monoclonal antibodies and the control were diluted (in PBS containing 1 % BSA) to 
form a range from neat to 1/50 and added to the appropriate wells. The plate was 
incubated for 1 h at 4°C. The excess antibody was then removed and the wells were 
washed (3 times) with PBS-Tween 20 (0.02%). The second antibody was peroxidase-
coupled goat antimouse IgG (diluted 1 in 2000 in PBS containing 1 % BSA; Sigma), 50 
µl of which was added to each well and left standing at 4°C for 1 h. This was removed 
and the wells were washed (twice) with PBS-Tween 20 and twice with water. 
The substrate for the perioxidase assay was prepared by dissolving 5 mg of o-
phenylenediamine in 0.25 ml of methanol followed, and just prior to addition to the wells, 
by addition of 12.25 ml of citrate-phosphate buffer, pH 5.4 (see later) and 1.25 µl of 
30% H2Di. This solution was added to each well and allowed to stand for 15 min at room 
temperature in the dark. The reaction was stopped with 50 µl of 8 N H2 S04 and the 
absorbance at 490 nm was read using the Titertek Multi-Scan spectrophotometer. 
Buffers: 0.05 M Na2C03, pH 9.6 contained 1.59 g Na2C03, 2.9 g NaHC03 made up to 
1 1 in water. Citrate-phosphate, pH 5.4 was made by adding 49.7 ml of phosphate 
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solution (17.8 g Na2HP04.2H20 in 500 ml of water) to 48.3 ml of citrate solution (10.5 g 
of citric acid in 500 ml of water). 
3.4.15 Raising polyclonal antibodies to E. coli DHPR 
Homogeneous E.coli DHPR (350 µg) in 0.5 ml of 50 mM Hepes-KOH (pH 7.4) 
was mixed with an equal volume of Freund's complete adjuvant (Commonwealth Serum 
Laboratories, Australia) and injected subcutaneously on the left thigh of a male rabbit. 
The rabbit had previously been bled from an ear vein to obtain pre-immune serum. Ten 
days later the rabbit was boosted with 200 µg of E. coli DHPR in 1 ml of Freund's 
incomplete adjuvant by subcutaneous injection on the right thigh. After a further 10 days, 
the rabbit was bled from an ear vein to give 30 ml of blood. The blood samples were 
allowed to clot overnight at 4°C and were then centrifuged at 25000 x g for 20 min at 
4°C. The antiserum was removed carefully with a Pasteur pipette into a fresh container 
and stored at -20°C until used. The pre-immune serum was obtained similarly. The 
presence of antibodies against E.coli DHPR in the antiserum was established by Western 
blot and neutralization of enzyme activity by antiserum in the DHPR assay. 
3.4.16 Western blot analysis 
Proteins were analysed by Western blot after separation on SDS-PA gel followed 
by electrophoretic transfer using the Bio-Rad Trans-Blot apparatus. The trans-blot buffer 
was 20 mM Tris, 150 mM glycine containing 20% methanol. The proteins were 
transferred onto a nitrocellulose membrane cut to the size of the gel and placed in a 
sandwich arrangement as described for protein blotting onto Polybrene coated GF/C. The 
electrophoretic transfer was carried out at 25 volts (constant) for 15 h. Pre-stained 
molecular weight markers (Bio-Rad) were transferred concurrently to indicate that the 
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transfer process was complete). The nitrocellui.ose filters containing the transferred 
proteins were sometimes stained with fluorescene isothiocyanate (FITC) as described by 
Szewazyk and Summers (1987) as this method 'did not affect the antibody reaction. 
[Nitrocellulose membranes to which antigens were applied by spotting (manually) or 
electroblotting were treated similarly from this step onwards]. The nitrocellulose 
membrane was immersed in the blocking solution (100 ml of 3% gelatin in 20 mM Tris-
HCl pH 7.5, 500 mM NaCl,; TBS) and agitated gently for 30 min to 1 h. The membrane 
was then transferred into a tray containing TTBS [Tween-20 (0.05%) in TBS] and 
washed (twice) for five minutes each. Following this the membrane was exposed to the 
primary antibody (1 in 2000 dilution) (either polyclonal antibodies against human DHPR 
or E. coli DHPR) in 100 ml of TTBS containing 1 % gelatin with gentle agitation from 5-
15 h. The membrane was washed with TTBS (tw·ice) to remove unbound first antibody. 
The membrane was then exposed to the second antibody, goat anti rabbit-alkaline 
phosphate conjugate (1 in 3000 dilution; Bio Rad) in 100 ml of TTBS containing 1 % 
gelatin and agitated gently for 2 h. Then the membrane was washed with TTBS for 5 min 
(2 times) and finally with TBS to remove residual Tween-20 detergent from the 
membrane surface. 
The alkaline phosphatase colour reaction Nas set up by separately dissolving 30 
mg of nitroblue-tetrazolium in 1 ml of 70% DMF, and 15 mg of bromochloroindolyl 
phosphate into 1 ml of DMF (separately). Just prior to use these two 1 ml solutions were 
mixed into 100 ml of carbonate buffer (0.1 M NaHC03, 1.0 mM MgCb, pH 9.8), and 
the membrane was immersed into it. The antigens were normally visible after 5-10 min of 
colour development. The membrane was immersed in 2 changes of water (10 min each) 
to stop the development. It was then photographed wet so as to enhance the purple 
coloured bands. 
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CHAPTER 4 
ATTEMPTS TO ISOLATE THE GE~NE ENCODING E. COLI 
DHPR BY COSMID CJ~ONING. 
4 .1 INTRODUCTION 
The limiting factor in the study of the catalytic properties and mechanism of action 
of an enzyme is often the amount of the active protein available. Although the 27-kD 
E.coli DHPR is a fairly abundant protein in the wild type organism, the final yield of 
pure protein starting from a 40 litres of culture was about 2-4 mg (see Chapter 2). 
Isolation of the gene that encodes E.coli DHPR is the first step towards producing richer 
sources of the protein. The cloning of the gene into a multi-copy plasmid expression 
vector such that it is placed downstream from an efficient promoter can result in a single 
protein constituting more than 50% of the total cell protein in the engineered organism 
(Dixon et al., 1988). Large amounts of protein produced by genetic engineering could 
ultimately assist in the solution of the X-ray crystallographic structure of this flavin 
containing dihydropteridine reductase. Since an in vivo function for the reductase is not 
known, isolation of the gene would also enable construction of mutants for genetic 
studies. The complete nucleotide sequence would allow the deduction of the primary 
amino acid sequence of E. coli DHPR which could be compared with the known 
sequences of human-liver DHPR (Dahl et al., 1987; Lockyer et al., 1987) and rat liver 
DHPR (Shahbaz et al., 1987). Such a primary structure comparison could comment on 
the nature of evolution of DHPR and identify t:1e functionally important amino acid 
residues within the sequence that are conserved. 
Some preliminary attempts were made in this work to obtain a strain that was 
deficient in dihydropteridine reductase using the tetrazolium-MTT dye, by assuming that 
the reductase may not be essential for growth of the organism. The method was similar to 
that used for the isolation and mapping of glutathione reductase-negative mutants of E. 
coli Kl2 using the compound 5,5'-dithiobis-(2-nitrobenzoic acid) (Davis et al., 1982). 
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The tetrazolium-MTT staining method was not successful however. It stained all colonies 
blue despite attempts to reduce the background by spraying the lysed colonies with 
Methotrexate. This was done to inhibit dihydrofolate reductase which also forms the 
insoluble formazan with the MTT indicator. 
Given the current status of molecular biological techniques, the cloning of the gene 
from E. coli should in theory be trivial. Elegant methods such as the use of synthetic 
oligonucleotide probe to isolate the gene (Ullrich et al., 1984) were overlooked in favour 
of the cosmid cloning strategy (Hohn and Collins, 1980). The attractive feature of this 
method was that there was a high probability of obtaining the complete DHPR gene (-
0.8.kb based on the molecular weight of the protein) because of the large insert fragments 
(35-45 kb) that can be cloned into the cosmid vectors. In this chapter, I describe the 
construction of a cosmid library of the genome of E. coli strain D3-157 (Singer et al., 
1985). The genomic DNA from this strain was chosen because it isfolA. It was hoped 
that overproduction of E.coli DHPR could complement the DHFR mutation in the strain 
D3-157, thus enabling selection of recombinants on minimal nutrient plates containing no 
folate-dependent end-products such as methionine, glycine, thymidine, adenine and 
pantothenate. However this screening method could not be used because the strain D3-
157 was found to be resistant. After using a suitable strain for transfection, 300 
recombinants, each bearing 35-45 kb DNA fragments in the cosmid vector pHC79 (Hohn 
and Collins, 1980), were purified. Their cell-free extracts were individually prepared and 
screened directly for increased DHPR specific activity compared with that from the 
background strain. Two cosmid clones thus obtained were studied in further detail. 
4.2 RESULTS AND DISCUSSION 
4. 2 .1 Cosmid cloning 
Cosmids are plasmids that contain the cos sequence (cos stands for cohe~ive site) 
from bacteriophage A DNA required for packaging DNA into the A capsid (Hohn and 
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Murray, 1977). The cosmid vector pHC79 (Hohn and Collins, 1980) used in this study 
is a derivative of the plasmid vector pBR322 (Bolivar et a/.,1977). The pHC79 vector 
contains an,.., 2-kb DNA fragment containing the bacteriophage cos sequence inserted in a 
non-essential region of pBR322 ( 4.4 kb). The cosmid vector has features of pBR322 
such as the tetracycline and ampicillin resistance genes, several unique cloning sites and 
an origin of replication (ori ) which is similar to that of Col El (see Figure 4.1). 
The chromosomal DNA used for the construction of the cosmid library was 
isolated from thefolA strain D3-157 (Singer et al., 1985) as described in Section 4.5.1. 
Large DNA fragments for cloning into cosmid vectors are normally generated by partial 
digests of the genomic DNA with an appropriate restriction endonuclease. In this study 
the restriction endonuclease Sau 3A was used for the partial digests of chromosomal DNA 
from strain D3-157. This enzyme recognises a four base sequence -N-G-A-T-C-N-, 
which occurs frequently (about once every 256 bps assuming restriction endonuclease 
sites are distributed randomly) in any given DNA sequence. Another feature that makes 
Sau 3A a suitable candidate for generating large fragments for cloning into the cosmid 
vector is that the 5' overhang sequence that it produces is complementary to that produced 
by the restriction endonuclease Barn Hl, which recognises the six base sequence -G-G-
A-T-C-C-. The cosmid vector pHC 79 has a unique Barn Hl site located within the tet 
resistance gene. 
Trial partial digests of the chromosomal DNA with Sau 3A were carried out to 
optimize the conditions required for obtaining fragments ranging from 35 to 45 kb (see 
Section 4.5.2). The result in Figure 4.2 indicates that 0.016 units of Sau 3A digested 
0.5 µg of DNA under the conditions used to generate fragments of the required size 
range. This partial digest was scaled-up appropriately to digest 60 µg of chromosomal 
DNA. After the reaction was terminated by adding EDT A (pH 8.0) to a final 
concentration of 20 mM, the digest was fractionated according to size by sodium chloride 
gradient centrifugation, and the contents of the tubes were distributed into 10 Eppendorf 
tubes (see Section 4.5.2). Electrophoresis of samples (10 µl) from each fraction on a 
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Figure 4.1 ' The stucture of cosmid vector pHC79(-6.4 kb) 
showing its restriction enzyme cleavage sites (Hohn 
and Collins, 1980). 
The direction of transcription of the ampicillin (Amp1') and tetracycline 
(Tetr) resistance genes, and the origin of replication (ori) are indicated by 
thin arrows within the circle. The thick line on the circle (flanked by the 
pBR 322 coordinates) contains the cos sequence from A DNA. 
Figure 4.2 Establishing the conditions for partial digestion of 
chromosomal DNA from strain D3-157, with Sau 3A. 
The experimental details for the partial digestion are described in Section 4.5.2. 
The samples were analysed by agarose gel electrophoresis (0.3% w/v at 40c for 
15h), 'a' A DNA cut with Xho I is the known size marker. Lanes 'b' to 'j' 
contain 1 µg of DNA digested with 2 to 0.08 units of Sau 3A at 370c for 20 min. 
Lane 'k' is undigested chromosomal DNA. The conditions for lane 'i' were 
scaled up for the large scale digestions. 
Figure 4.3 Agarose gel electrophoresis of samples after NaCl 
gradient centrifugation of large-scale partial digestion, 
as described in Section 4.5.2. 
Lane 'a' and 'l' are A DNA (cut with Xho I) size markers. Lanes 'b' to 'k' are 
samples from the fractions collected after the gradient centrifugation. Fraction 'i' 
was used for making the cosmid library. 
SO kb~ 
33kb~ 
15k~ 
a bcdef9h 
abcdef9hijk I 
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0.3% (w/v) agarose gel (see Figure 4.3) showed that fraction "i" contained the ideal-size 
fragments required for the construction of the cosmid library. Fractions "j" and "k" 
contained fragments that were < 35 kb, which might form non-contiguous inserts with 
fragments from two different regions of the E.coli chromosome (Old and Primrose, 
1985). 
After dialysis against TE, half the volume of fraction "i" (,.., 1 µg DNA) was co-
precipitated with 2 µg of pHC79 (that had been previously digested with Bam HI and 
dephosphorylated to remove its 5' terminal phosphates; a gift from Dr N. E. Dixon) by 
addition of ethanol. The vector DNA was dephophorylated to prevent self-ligation and a 
2: 1 ratio of vector DNA to insert DNA was used so that the formation of hybrid 
concatenated molecules would be favoured. This mixture was ligated with the joining 
enzyme T 4 DNA ligase. 
The ligation mixture was packaged in vitro (see Section 4.5.9). During in vitro 
packaging the concatemeric DNA (ie. a DNA fragment flanked by lefthand and righthand 
vector) is nicked at the cos sites by an endonuclease which is a product of gene A of 
bacteriophage A. These nicks are on the opposite strands of the righthand and lefthand 
vectors. They form the cohesive termini (or sticky ends) which allow the concatenated 
molecule to circularise upon adsorption and injection into a suitable host by the 
transducing phage particle. The in vitro packaged extract was used to transfect the host 
strain D3-157 rec A (see Section 4.5.11 for details of construction of the rec A strain) as 
described in Section 4.5.10. It was important that the host strain was rec A to prevent 
the large insert fragments from undergoing homologous recombination into the 
chromosome of the host. The strain D3-157 rec A was selected as the host because it 
was shown in this work to grow poorly on LB plates containing 100 µM Methotrexate. 
It was argued that recombinants that carry the gene coding for DHPR would show better 
growth as a result of complementation of the DHFR mutation of this strain. The basis for 
this argument is that homogenous preparations of E. coli DHPR show dihydrofolate 
reductase activity (see Section 3.2.1). If the transfection had been successful, it was 
89 
t 
\ 
intended to plate the transfected cells on LB plates containing ampicillin and Methotrexate 
(100 µM) to give an arbitrary size selection of the colonies. However, this was not 
successful because there were no recombinants when the transfected cells were plated on 
LB-plates containing ampicillin. This was later shown to be due to the A resistance of the 
host strain (the strain grew across a A Ch 28 streak). The host strain in cosmid cloning 
has to be A sensitive so that the transducing phage particles can adsorb and its DNA be 
injected into the cell. 
An alternative host strain DM7111 recA (a gift from Dr N. E. Dixon) which was 
known to be A sensitive (confirmed by streaking across A Ch 28 and observing no 
growth along or after the A Ch 28 streak) was transfected with the in vitro packaged 
mixture (only 1/5 of the original packaged extract was used for each transfection). In the 
former case (i.e. with D3-157 recA as host) only the large colonies were going to be 
selected and screened directly for increased DHPR specific activity. With DM7111 recA 
as the host, it was theoretically determined (based on the size of the insert in the cosmid 
vectors and the size of the E. coli chromosome -4600 kb) that screening at least 300 
recombinants should yield at least two that had the complete gene encoding DHPR. 
DM7111 recA transfected with the packaged extract was suspended in 500 µl of 
LB broth and plated on LB plates containing ampicillin (250, 150, 100, 50 and 25 µl per 
plate). There were> 1000 recombinants on the plate spread with 150 µl of the transfected 
cell suspension. The steps involved in cloning using the cosmid vector are presented 
schematically in Figure 4.4. One thousand colonies were toothpicked (sterile) on to LB 
plates containing ampicillin (100 per plate) and incubated at 370c overnight. About 95% 
of these colonies were ampicillin resistant. From these, 300 colonies were purified for 
singles on four-sector LB plates containing ampicillin. The single colonies were streaked 
on 8-sector plates and a loopful from each sector was suspended in 1.5 ml-capacity glass 
screw-cap vials containing 1 ml LB medium and 77 µl DMSO (sterile). Two hundred and 
ninety-seven recombinants (WA101-WA397) were stored at-700C. WA101-WA397 are 
DM7111 recA bearingpWA101-pWA397, respectively. 
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Figure 4.4 The Scheme of events for cloning large DNA 
fragments from strain D3-157 into the cosmid vector 
pHC79 and screening for DHPR clones. 
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4.2.2 Screening directly for increased DHPR specific activity 
The screening for increased DHPR specific activity was carried out in batches of 
30 (see Section 4.5.12). The cell-free extracts were individually assayed for DHPR 
activity (i.e. quinonoid 6-methyl-dihydropterin dependent oxidation of NADH; see 
Section 2.5.1.1) and their protein concentrations were determined by the method of 
Bradford (1976). The cell-free extract from the host strain without any plasmids, had a 
DHPR specific activity of 0.052 U/mg ( + 0.05 U/mg). This value was similar to that 
observed in other E. coli strains that were investigated in this study (e.g. see specific 
activity of cell-free extract from E.coli strain H 712 in Table 2.4). Thus the wild-type 
level of DHPR specific activity is generally about 0.055 U/mg. The cell free extracts 
from most of the recombinants also showed DHPR specific activity that varied ( + 0.02 
U/mg) around this value (see Table 4.1), except for WA 265 and WA 266 which were 
0.234 U/mg and 0.292 U/mg, respectively. The requirement for quinonoid 
dihydropterin-dependent oxidation of NADH by cell-free extracts prepared from WA 265 
and WA 266, showed the enhan9ed level of DHPR activity to be real (see Table 4.2). 
Although the plasmid replicon in pHC 79 has a copy number of about 50 copies 
per cell (similar to ColEl) in the recombinant cosmids the copy number during normal 
growth is often as low as five copies per cell (Hohn and Collins, 1980). This may 
account for the 5 to 6-fold increase in DHPR specific activity observed in strains WA 265 
and WA 266. However, even at this level of increased DHPR specific activity, the 
extracts from the two strains were distinctly yellow in colour. Since DHPR purified from 
E. coli had been shown to contain tightly bound flavin, the yellow colour of the two 
extracts was attributed to increased expression of the 27-kD flavoprotein. The two clones 
were rechecked from the strains stored in DMSO to ensure that they possessed increased 
DHPR specific activity. They were also checked to see that they were derivatives of the 
parent strain DM 7111 recA. The parent strain has the genotype p-, cys B trp E pur F 
recA, srl ::Tn 10. Minimal plates that were supplemented with cysteine, trytophan and 
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Table 4.1: Direct screening of cosmid clones for increased DHPR activity 
at 30°C in Tris/HCI at pH 7.4. 
S/No. SIA S/No. SIA S/No. SIA S/No. SIA. S/No. SIA 
0/YA) Ulmg 0/YA) Ulmg 0/YA) Ulmg (YVA) u/mg 0/YA) U/mg 
101 0.052 134 0.057 167 0.058 200 0.055 233 0.055 
102 0.056 135 0.052 168 0.057 201 0.052 234 0.055 
103 0.056 136 0.057 169 0.055 202 0.055 235 0.055 
104 0.052 137 0.055 170 0.052 203 0.055 236 0.052 
105 0.058 138 0.052 171 0.052 204 0.058 237 0.055 
106 0.052 139 0.052 172 0.055 205 0.055 238 0.055 
107 0.055 140 0.052 173 0.055 208 0.055 239 0,052 
108 0.055 141 0.057 174 0.048 207 0.052 240 0.057 
109 0.053 142 0.055 175 0.052 208 0.048 241 0.057 
110 0.055 143 0.064 176 0.057 209 0.043 242 0.052 
111 0.057 144 0.051 177 0.057 210 0.052 243 0.052 
112 0.057 145 0.055 178 0.052 211 0.061 244 0.055 
113 0.057 146 0.057 179 0.045 212 0.053 245 0.048 
114 0.057 147 0.057 180 0.058 273 0.058 246 0.052 
115 0.057 148 0.052 181 0.052 214 0.055 247 0.055 
116 0.052 149 0.052 182 0.052 215 0.057 248 0.058 
117 0.050 150 0.052 183 0.055 216 0.057 249 0.058 
118 0.057 151 0.050 184 0.036 217 0.052 250 0.057 
119 0.057 152 0.057 185 0.052 219 0.056 251 0.055 
120 0.035 153 0.057 186 0.057 219 0.052 252 0.055 
121 0.057 154 0.057 187 0.052 220 0.052 253 0.055 
122 0.057 155 0.057 188 0.052 221 0.048 254 0.055 
123 0.053 156 0.055 189 0.057 222 0.057 255 0.046 
124 0.055 157 0.057 190 0.055 223 0.057 256 0.052 
125 0.055 158 0.052 191 0.055 224 0.057 257 0.052 
126 0.052 159 0.073 192 0.055 225 0.052 258 0.052 
127 0.046 160 0.058 193 0.057 226 0.057 259 0.036 
128 0.055 161 0.096 194 0.055 227 0.057 260 0.052 
129 0.055 162 0.057 195 0.052 228 0.052 261 0.055 
130 0.057 163 0.062 196 0.057 229 0.052 262 0.053 
131 0.083 164 0.057 197 0.052 230 0.057 263 0.048 
132 0.053 165 0.058 198 0.055 231 0.052 264 0.055 
133 0.055 166 0.055 199 0.055 232 0.052 265 0.234 
continued-/ 
Table 4.1: Direct screening of cosmid clones for increased DHPR activity 
S/No. SIA SINo. SIA S/No. SIA S/No. SIA (WA) Ulmg (WA) Ulmg (WA) Ulmg (WA) u/mg 
266 0.292 299 0.057 332 0.058 365 0.058 
267 0.058 300 0.052 333 0.063 366 0.057 
268 0.057 301 0.052 334 0.062 367 0.062 
269 0.057 302 0.057 335 0.057 368 0.065 
270 0.052 303 0.052 336 0.055 369 0.062 
271 0.055 304 0.057 337 0.058 370 0.058 
272 0.055 305 0.052 338 0.057 371 0.060 
273 0.055 306 0.052 339 0.057 372 0.062 
274 0.055 307 0.057 340 0.057 373 0.058 
275 0.057 308 0.055 341 0.057 374 0.062 
276 0.057 309 0.055 342 0.056 375 0.065 
277 0.052 310 0.072 343 0.055 376 0.062 
278 0.057 311 0.055 344 0.058 377 0.060 
279 0.057 312 0.057 345 0.045 378 0.065 
280 0.057 313 0.057 346 0.055 379 0.058 
281 0.093 314 0.057 347 0.055 380 0.047 
282 0.055 315 0.057 348 0.055 381 0.063 
283 0.055 316 0.048 - 349 0.052 382 0.062 
284 0.049 317 0.057 350 0.057 383 0.062 
285 0.052 318 0.068 351 0.057 384 0.058 
286 0.055 319 0.052 352 0.057 385 0.058 
287 0.055 320 0.052 353 0.058 386 0.065 
288 0.038 321 0.055 354 0.057 387 0.062 
289 0.055 322 0.057 355 0.052 388 0.062 
290 0.058 323 0.057 356 0.052 389 0.058 
291 0.062 324 0.052 357 0.052 390 0.058 
292 0.076 325 0.055 358 0.057 391 0.058 
293 0.078 326 0.055 359 0.062 392 0.058 
294 0.058 327 0.055 360 0.058 393 0.060 
295 0.052 328 0.052 361 0.057 394 0.062 
296 0.052 324 0.057 362 0.065 395 0.060 
297 0.048 330 0.052 363 0.058 396 0.058 
298 0.052 331 0.550 364 0.058 397 0.058 
Table 4.2 Requirements of DHPR activity in cell-free extracts from WA 265 and 266 in Tris/HCI (pH 7.4) at 
2soc 
Omission 
None 
Cell free extract 
6-methyl-tetrahydropterin 
NADH 
Perioxidase/H202 
a . µmoles NADH oxidized per min per ml. 
WA265a 
5.26 
0.28 
0.32 
0.00 
0.38 
WA266a 
6.98 
0.30 
0.43 
0.00 
0.45 
uracil allowed the growth of WA 265, WA 266 and DM 7111 recA. When cysteine or 
uracil were omitted from the minimal plates, none of the three strains grew. The clones 
WA 265 and 266 were selected for further study. 
4.2.3 Comparison of plasmids p WA 265 and 266 
The cellular content of plasmids p WA 265 and p WA 266 from the recombinants 
WA 265 and WA 266 were amplified (by adding spectinomycin at mid-log phase during 
growth to inhibit protein synthesis) and the plasmids were isolated by caesium chloride 
gradient centrifugation. The two plasmids were digested with the restriction 
endonucleases Eco RI, Bam HI and Hind III, individually, and in combination. The 
digested DNAs were analysed on a 0.7% (w/v) agarose gel (see Figure 4.5). The 
suspicion that WA 265 and WA 266 were siblings that may have arisen before the initial 
recombinants were selected for ampicillin resistance, was confirmed by the restriction 
digest pattern of their respective plasmids. Although some of the digests had not gone to 
completion, the sizes of the smaller ( < 6.5 kb) fragments in the double and triple digests 
were identical for the two plasmids. Two unrelated plasmids with the gene of interest in 
an overlapping region would have been useful for sub-cloning the gene encoding the 
reductase. In this case, since the two clones were siblings, the strain WA 266 and its 
plasmid p W A266 were used for all further work .. 
4.2.4 Sub-cloning the gene for E coli DHPR 
It was argued that the 5 to 6-fold increase in specific activity observed in cell-free 
extracts prepared from WA 266 might be increased if the size of the insert in plasmid 
p W A266 (-35-45 kb) were to be reduced so that the pHC79 replicon may function at a 
higher efficiency. Six-fold increase in the specific activity of the reductase was already 
sufficient to distinguish the recombinant clone WA 266 from other cosmid containing 
strains due to the intense yellow colour of the colonies. It was surmised that the bright 
yellow colour could be used as the selection criterion during sub-cloning. Since the insert 
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Figure 4.5 
"' 
Agarose gel electrophoresis of restriction endonuclease cleavage fragments of plasmids 
pWA 265 (A) and pWA 266 (B). 
Samples were run on a 0.7% (w/v) agarose gel as described in Section 4.5.4. Lanes 'a', 'j', 'k' and 't', are the 
known size markers (A DNA digested with Hind III); 'b' and 'l' were digested Eco RI; 'c' and 'm' 
were digested with Bam HI; 'd' and 'n' were digested with Hind III; 'e' and 'o' were double digested with Eco RI 
and Bam HI; 'f and 'p' were double digested with Eco RI and Hind III; 'g' and 'q' were double digested with 
Bam HI and Hind III; 'h' and 'r' were triple digested with Eco RI, Bam HI and Hind III; 'i' and 's' were digested 
with Xho I. 
kb 
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in pWA266 had not been mapped, the sub-cloning strategy was to digest the large 
plasmid separately with several commonly used restriction enzymes that recognise a six-
base pair sequence, and ligate to the resulting fragments with a plasmid vector that had 
been digested with the same or compatible restriction enzyme. The plasmid vector pUC8 
(Vieira and Messing, 1982) was selected because it has several unique cloning sites in its 
poly linker region. This vector has also the strong lac promoter which can be manipulated 
to induce high level expression of genes products whose coding sequences (DNA) are 
downstream from it. 
The plasmid p WA 266 (2 µg per digest) was separately digested with the 
restriction endonucleases Eco RI, Barn HI, Hind III and Sal I and ligated with pUC8 
(0.2 µg per digest) which had been linearized with the respective enzymes and 
dephosphorylated. The ligation mixtures were used separately to transform DM 7111 
recA that had been made competent by CaCl2 treatment (see Section 4.5.16). The 
transformation mixtures were plated out on LB plates containing ampicillin and incubated 
at 37°C. The yield of transformants was low (about 20 colonies per transformation). The 
Sal I or Hind III digests of pW ~ 266 ligated with similarly-digested pUC8 did not yield 
yellow colonies. The transformants resulting from Barn HI and Eco RI digests of p WA 
266 ligated into pUC8 gave some yellow colonies which were of the same intensity as 
WA 266. The plasmids from the transformants were isolated by a rapid lysis method (see 
Section 4.5.14) and analysed on a 0.7% (w/v) agarose gel (result not shown). The white 
colonies from the above transformations contained reclosed pUC8 vectors and the yellow 
colonies contained very large plasmids. The plasmids from the yellow colonies of the 
above transformations were not studied any further. 
An alternative strategy, which if successful can result in the gene of interest being 
localised in a small fragment, was carried out. The method was essentially similar to the 
first step in the construction of the cosmid library, where a frequently-cutting restriction 
enzyme was used to generate fragments of the required size range. In this instance Sau 
3A was used in a trial partial digest of plasmid p W A266 to generate fragments ranging 
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Table 4.3 Direct screening of sub-clones for increased DHPI~ specific activity in Tris-HCI (pH 7.4) at 2soc. 
Strain 
AN 1459 (control) 
DM 7111 (control) 
I-IM 002 
HM004 
WA401 
I-IM 402 
HM012 
WA403 
,vA 404 
Specific activity 
(U/mg) 
0.052 
0.057 
0.11 
0.057 
0.19 
0.225 
0.049 
0.189 
0.196 
Strain 
I-IM 018 
HM023 
HM025 
I-IM 027 
HM028 
HM029 
WA405 
HM032 
WA406 
Specific activity 
(U/mg) 
0.131 
0.034 
0.057 
0.057 
0.052 
0.049 
0.086 
0.042 
0.252 
from 5 to 10 kb. The partial digest was scaled up appropriately to digest 4 µg of plasmid 
pWA266. One half of the Sau 3A partial digest was ligated with pUC8 that had been 
linearized with BamHI and dephosphorylated (with calf intestinal alkaline phosphatase to 
prevent reclosure ). The second half was reclosed by intramolecular ligation. The two 
separate ligation mixtures were used to transform E. coli strain AN1459 that had been 
made competent by calcium chloride treatment. ( The strain AN 1459 had been noted to 
have a high transformation efficiency; Dr N. E. Dixon, personal communication). The 
plasmid p W A266, partially digested with Sau 3A and ligated with Bam HI digested 
pUC8, gave several hundred transformants, but none was clearly yellow. The reclosed 
Sau 3A partial digests on the other hand yielded more transformants and about two dozen 
of them were bright yellow. A total of 36 transformants from the partial digest ligated 
with pUC8, were streaked on 8 sector plates. Plasmid DNA from these transformants 
was isolated by rapid lysis and analysed on a 0.7% (w/v) agarose gel (result not shown). 
More than 50% of the transformants were reclosed vectors, thus indicating that the 
dephosphorylation of the vector was not complete. The transformants with inserts from 
this experiment showed no increase in DHPR specific activity when their cell-free extracts 
were assayed. 
The yellow colonies obtained from transformation with the reclosed Sau 3A partial 
digest, together with some that were not intensely coloured, were also analysed following 
rapid lysis (see Figure 4.6). The yellow colonies in the plate containing the transformants 
from the reclosed partial Sau 3A digest fluoresced (see Figure 4.7) when viewed under 
short wavelength u.v. irradiation (after the colonies had been picked and streaked onto 8-
sector plates). The fluorescence was ascribed to the increased level of flavin prosthetic 
group due to increased level of the reductase. The direct screening for increased DHPR 
specific activity of some of the transformants from the reclosed Sau 3A partial digest (see 
Table 4.3) showed clones that had only 2 to 5-fold increase over the levels in 
thebackground strain (AN 1459). In the face of the earlier argument that the reduction in 
size of the insert in pWA266 might result in an increase in DHPR specific activity due to 
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Figure 4.6 Agaraose gel electrophoresis of rapid lysates of 36 
transformants from sub-cloning experiment. 
The undigested plasmid DNA obtained from 36 transformants ( that were 
purified and subjected to rapid lysis as described in Section 4.5.14), were 
analysed by agarose gel electrophoresis (0.7% w/v) together with undigested 
plasmids pUC 8 (2.6 kb), ori C (12.2 kb) and pBR 322 (4.36 kb), as size 
markers. Lane '33' is plasmid pWA 406 which was selected for further studies. 
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Figure 4.7 Yellow colonies fluoresce under u.v. light 
The yellow colonies which showed 2 to 6-fold increase in DHPR specific 
activity (in their cell-free extracts) appear as bright spots when viewed 
under short wave u.v. irradiation. 

more copies of the plasmid occurring in the recombinant, the above result cannot be easily 
explained. 
Plasmid DNA from three of the sub-clones WA401, WA403 and WA406 were 
isolated from large-scale preparations. The sizes of the plasmids pWA401, pWA403 and 
pWA406 from the sub-clones were estimated to be 12.5, 9 and 15 kb respectively, by 
summation of the sizes of fragments produced by several restriction endonucleases. 
Complete Sau 3A digests of the three plasmids were compared with those of pUC 8, pHC 
79 and pBR 322 by electrophoresis on an 1.5% (w/v) agarose gel (see Figure 4.8), to 
check for deletions within the vector sequence. The result indicated that in plasmid p WA 
406, the cosmid vector pHC 79 has lost a 665 bp Sau 3A fragment that contained an Eco 
RI site. 
4.2.5 Analysis of the gene product 
The only indication so far that the gene coding for E. coli DHPR had been 
isolated were the increased specific activity which is quinonoid dihydropterin-dependent 
(see Table 4.2) and the bright yellow colour of the colonies (ascribed to the flavin content 
of DHPR). It was possible that the reason for no significant increase in DHPR specific 
activity despite reduction of the size of the insert from 35 to 45 kb (in pWA266) and 8 to 
10 kb (in pWA406), may have been formation of the apoprotein. Perhaps the flavin 
biosynthesis in the organism may not have kept up with the high levels of DHPR 
produced in the clones. This hypothesis was investigated firstly by growing WA 266 and 
WA 406 in LB broth containing ampicillin and supplemented with riboflavin (100 µM). 
There was no significant increase in the specific activity of the reductase in the extracts 
prepared from WA 266 and WA 406 grown with riboflavin supplementation. Secondly, 
when the extracts of the clones were incubated with FAD (10 µM) at 370c for 0.5 h, 
neither showed any change in specific activity. These results suggested that apoprotein 
formation may not be the reason for the lack of increase in DHPR specific activity. 
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Figure 4.8 Agarose gel electrophoresis of complete Sau 3 A 
digests of plasmids pUC 8 (a), pBR 322 (b), pHC 
79 (c), pWA 401 (d), pWA 403 (e) and pWA 406 (f) 
The plasmids were digested completely with Sau 3A (37oc, 
2h) and electrophoresed on an agarose gel (1.2% w/v). The 
arrowhead indicates that the 665-bp Sau 3A fragment present in 
the plasmid vectors (a, band c), was missing from the plasmid 
pWA 406. 
a b C d e f 
The cell-free extracts of several strains be1ring plasmids that direct synthesis of 
proteins to give increase DHPR specific activity \Vere compared with those of the E.coli 
strain AN1459 (background level of DHPR specific activity) by 12% (w/v) SDS-PAGE 
analysis. Approximately equal amounts of total protein were applied to each track so that 
they could be compared after staining and destaining. It was expected that the clones 
showing 4 to 6-fold increase in specific activity \vould show a more intensely-staining 
protein band around 27 kD (molecular weight of \vild type DHPR). The result in Figure 
4.9 indicated there to be no obvious overproduction of the 27-kD DHPR in the clones, 
compared with the level in the background strain. There may be three possible 
explanations for the absence of any observable increase in the DHPR at the expected 
region on the SDS-P A gel: 
a) The levels of over-production of DHPR were not sufficiently high to 
differentiate visually between extracts from clones and the background strain by 
SDS-PAGE analysis. 
b) There may be a second previously-unidentified protein that can reduce 
quinonoid 6-methyl-dihyd_ropterin, which is responsible for the increased activity 
in WA 266 and the others that were derived from it during sub-cloning. 
c) The gene for DHPR may have fused with a second gene to produce a 
partially-active fusion protein of higher molecular weight. 
It was at first believed that the first explanation could not be true because the 
clones and their extracts were bright yellow in colour. If the colour were due to increased 
levels of the 27 kD flavoprotein identified in this s1udy as E. coli DHPR, then the protein 
should be visible as a more intense band in the SDS-PA gel. The second explanation 
might have been true except that when the reductase from E. coli was being purified, 
every attempt was made to look for possible isoenzymes in the membrane and soluble 
fraction to compare with the NADPH specific DHPR isolated from bovine and human 
livers (Nakanishi et al. , 1986a,b). Judging frorn the SDS-PA gel (see Figure 4.9), all 
the clones that gave yellow colonies and produced yellow cell-free extracts showed an 
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Figure 4.9 Polyacrylamide gel electrophoresis of cell-free extracts prepared from several E. coli strains. 
'Ihe cell-free extracts (100 µg each) from AN 1459, the wild type strain (a), WA 266, the primary cosmid clone; and 
WA 405 (c), WA 406 (d), WA 401 (e), WA 403 (f), HM 023 (g), HM 002(h) and HM 018 (i), which are strains that 
contain plasmids derived from p WA 266 with insert DNA of various sizes, . The arrowhead indicates the position of 
purified E.coli DHPR (27 kD). Pharmacia low molecular weight markers were also run concurrently. The extracts 
(b, c, d, e, f, h and i) which had enhanced DHPR specific activities, did not show any sign of overproduction of the 
27-kD protein, but they have an intense band aroun 45 kD which is absent in AN 1459. 
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intense band at about 45 kD (compared with the Pharmacia low molecular weight 
standards). It was more intense than the corresponding band from the extract of the 
background strain (AN 1459). This observation provoked the hypothesis that a gene 
fusion may have been formed inadvertently during the construction of the cosmid library 
with the consequent production of a higher molecular-weight fusion protein. Further 
support for this possibility came from the fact that the increased reductase activity present 
in the extracts prepared from W A266 or W A406 was rapidly lost during attempts to 
purify the protein responsible for the activity ( unlike that from the wild type strain 
discussed in Chapter 2). 
4.2.6 Protein synthesis directed by plasmid DNA 
Proteins that are synthesized under the direction of plasmids containing the cloned 
DNA fragments can be detected by in vitro transcription and translation (Pratt et al., 
1981) or by in vivo methods using mini-cells (Dougan and Kehoe, 1984) or maxi-cells 
(Sancar et al., 1979). In this study the mini-cell expression system was used to 
investigate the proteins that were synthesized under the direction of the plasmids p WA 
266 and p WA 406. Mini-cells are small, spherical and anucleate vesicles that continually 
bud-off from certain mutant E.coli strains. When these strains are transformed with 
plasmids that can occur as multiple copies, the mini-cells that bud-off from them often 
contain a copy of the plasmid. Hence the mini-cell producing strain DS 410 (Dougan and 
Sherrat, 1977) was made competent with calcium chloride and transformed separately 
with plasmids pWA 266, pWA 406 and the cosmid vector pHC 79. The transformants 
were cultured separately and mini-cells produced were isolated by sucrose gradient 
centrifugation. The purified mini-cells containing the plasmids pWA 266, pWA 406 or 
pHC 79 were allowed to synthesize proteins in the presence of 35S-methionine (to 
radiolabel the newly-synthesized proteins) and their products were subsequently analysed 
by SDS-PAGE and fluorography. Both plasmids pWA 266 and pWA 406 contained a 
gene that resulted in five to six-fold increase in DHPR specific activity in the cell-free 
extracts of strains trasformed with them [eg. strain WA 266 (DHPR specific activity is 
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Figure 4.10 Identification of proteins synthesized by plasmid DNA in vivo in the presence of 35S-methionine. 
(A) SDS-PA gel (12%w/v) of 'a' Pharmacia low molecular weight standards; 'b' human brain DHPR (25 kD); 'c' and 'd' E.coli 
DHPR (27 kD); 'e', 'f and 'g' are minicells containing plasmids pHC 79, pWA 266 and pWA 406, respectively (the experiment is 
described in Section 4.5.16). 
(B) The gel (A) was dried down and the proteins that were synthesized under the direction of the plasmids in the mini cells were 
visualised by fluorography, as described in Section 4.5.16. 'h' is the same as lane 'e' and shows the proteins that were encoded by 
pHC 79; 'i' is the same as lane 'f and shows the proteins encoded by plasmid pWA 266; 'j' is the same as lane 'g' and shows the 
proteins encoded by plasmid pWA 406. The 27-kD E.coli DHPR was not synthesized under the direction of plasmids pWA 266 
or p WA406, although both plasmid directed the synthesis of two proteins with molecular weights of about 45 Kd and 47 kD. 
A 
a b C d e f g 
' 
l 
B 
h • I • J 
......c:47K 
~45K 
~27K 
0.292 U/mg) which is DM 7111 rec A (DHPR specific activity is 0.052 U/mg) 
transformed with plasmid p WA 266]. However, the result (in Figure 4.10) indicated 
clearly that the 27-kD E.coli DHPR was not being synthesized from the plasmids pWA 
266 and pWA 406 in the minicells. When the vector-encoded proteins (mini-cell+ pHC 
79 ) were taken into account, the proteins at about 45 kD and 47 kD were the major 
products expressed from the inserts in plasmids p WA 266 and p WA 406. It was felt that 
either the 45 kD or the 47 kD protein might have been responsible for the increased 
DHPR specific activity because the SDS-PAGE analysis of cell-free extracts prepared 
from several strains, including WA 266 and WA 406 (Figure 4.9), also indicated that a 
protein of about 45 kD was being over-produced (in comparison with extracts prepared 
from wild type strain AN 1459). It was argued that the protein band on the SDS-PA gel 
that was approximately 45 Kd (Figure 4.9) might contain both the proteins ( 45 Kd and 47 
Kd, see Figure 4.10) that are encoded by the cloned DNA fragments (35 to 45 kb in pWA 
266 and about 10 kb in pWA 406). The over-expressed proteins were considered to be 
worthy of further investigation. 
4.3 SUMMARY 
A cosmid library was constructed by cloning 35 to 45-kb DNA fragments 
generated by partial digestion with Sau 3A into the Bam Hl site of the cosmid vector 
pHC79. Three hundred transfectants were selected and screened directly for increase in 
DHPR specific activity. Two clones WA265 and WA266 had DHPR specific activity of 
0.232 U/mg and 0.292 U/mg, respectively. These were 5 to 6-fold higher than the 
specific activity of the reductase in the extracts of the wild-type background strain. The 
plasmids p WA 265 and p WA 266 were identical when analysed by restriction 
endonuclease digestion. The plasmid pWA 266 was sub-cloned by Sau 3A partial digest 
followed by intramolecular religation to give plasmid pWA 406 which had a 9 to 10-kb 
--insert in the vector pHC 79 which was in turn missing a 632-bp Sau 3A fragment. SDS-
PAGE analysis of the extracts from strains bearing pWA 266 and pWA 406 indicated that 
a 45-kD protein was expressed in high levels. In vivo synthesis of proteins under the 
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direction of pWA 266 and pWA 406 produced two proteins that were 47 kD and 45 kD. 
The 27-kD E.coli DHPR was not synthesized by the plasmids. It was thought possible 
that one of the proteins (47 kD or 45 kD) might have been a fusion product of E. coli 
DHPR and a product of another gene (see however Chapter 5). 
4. 4 MATERIALS 
4. 4 .1 Enzymes, antibiotics and compounds 
The restriction endonucleases, T4 DNA ligase, and calf intestinal alkaline 
phosphatase were obtained from Boehringer-Mannheim, GmbH, W. Germany. 
Tetracycline was from Sigma Chemical Co., St. Louis, Mo. U.S.A. Spectinomycin 
hydrochloride (Trobicin) was obtained from Upjohn Co., Kalamazoo, U.S.A. and 
ampicillin was from Beecham Research Laboratories, Victoria, Australia. L-[35S]-
methionine, a-[32P]-deoxyadenosine triphosphate and y-[32P]-adenosine triphosphate 
were obtained from from Amersham Australia Pty. Ltd. 
4.4.2 Media used for growth of bacteria 
LB media and plates were prepared as described in Section 2.5.4. Antibiotics 
were filter sterilised and used at the following final concentrations: 15 µglml tetracycline, 
and 50 µglml ampicillin. The minimal medium 56 was essentially as described by Monod 
et al. (1951) and contained (per liter): 
10.6g Potassium hydrogen orthophosphate 
6. lg Sodium dihydrogen orthophosphate 
0.2g Magnesium sulphate 
2.0g Ammonium sulphate 
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The medium was prepared as a five-time; concentrated stock with chloroform 
added to 0.05% (v/v). 
4.5 METHODS 
4. 5 .1 Preparation of chromosomal DNA 
E.coli strain D3-157 cells (Singer et al., ~. 985) from a 500-ml culture (LB+ 50 
µg/ml thymine, 0.2% (w/v) glucose, 100 µg/ml streptomycin sulfate) were harvested (at 
OD6oo - 1.0) by centrifugation at 6000 rpm for 10 min at 4°C (in a Sorvall RC-2B 
Centrifuge with a GS3 rotor). The pellet was rinsed with 20 ml of 50 mM Tris-Cl pH 7.4 
(containing 20% (w/v) sucrose, 1 mM EDTA and 2 mM DTT), and suspended in 10 ml 
of the same buffer. Note that~ the cell suspension could be stored at -70°C without 
serious damage to them. Lysozyme (2.5 ml of a :LO mg/ml solution in the above buffer) 
was added with swirling on ice for 5 min followed by 2.5 ml of 0.5 M EDT A pH 8.5. 
After a further 5 min, 15 ml of Triton X-100 solution (0.1 % (v/v) Triton X-100, 62.5 
mM EDTA, 50 mM Tris/Cl pH 8.0) was added. 1he mixture was kept for 15 min on ice. 
The lysate (36 ml) was added to 34.2 g of CsCl and 3.6 ml of ethidium bromide (10 
mg/ml). The mixture was gently shaken under subdued light to dissolve the CsCl and 
transferred equally to two polyallomer ultracentrifuge tubes (Beckman). The tubes were 
filled to the top with TE (10 mM Tris/Cl, pH 7.8 and 1 mM EDTA) containing 0.95 g/ml 
CsCl sealed, and centrifuged at 39 k rpm for 40 h at 150c in a Beckman L8-70 
Ultracentrifuge in a vertical Ti-50 rotor. The chr.omosome band was briefly visualized 
with a long-range u.v. light source and drawn from the tube with a pasteur pipette after 
the top of the tube was carefully cut with a sterile ~;calpel. The DNA was transferred into 
a second polyallomer ultracentrifuge tube with 0.~5 ml of ethidium bromide solution and 
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TE containing 0.95 g/rnl CsCL The tubes were sealed and centrifuged at 35 k rpm for 36 
h at 150c in a fixed-angle 50 Ti rotor in a Beckman L8-70 Ultracentrifuge. The 
chromosome band was visualized and isolated as above. The ethidi um bromide was 
removed after six extractions with NaCl-saturated isopropanol (50:50 mixture of 
isopropanol and 5 M NaCl in TE). The colourless aqueous phase was dialysed overnight 
against TE (2 x IL) at 40c. The concentration of DNA (stored at 4°C) was 100 µg/rnl 
( on the assumption that a 50 µg/rnl DNA solution will give an absorbance of 1.0 at 260 
nm). 
4.5.2 Sau3A partial digests of bacterial DNA 
A trial partial digest was carried out as follows: 135 µl of stock DNA (10 µg) and 
15 µl of 10 x Sau3A buffer (final concentration 7.5 mM Tris/Cl pH 7.4, 15 mM MgCh, 
60 mM NaCl and 6 mM 2-mercaptoethanol) were mixed in a 1.5 ml Eppendorf tube. 
This was portioned out into 9 tubes (that were labelled Tubes 1-9). The mixture (30 µl) 
was transferred into tube 1 and 15 µl into each of the remaining 8 tubes. Four units of 
Sau3A were added to tube 1 a~d mixed well. Thus, in tube 1, 2 units of enzyme was 
used to digest 1 µg of DNA. By working rapidly, 15 µl were transferred from tube 1 to 
tube 2 and mixed well. This two-fold serial dilution was continued to tube 9. The tubes 
were transferred from the ice-bath to a 370c water bath and incubated for 20 min. The 
reaction was stopped by adding 0.5 M EDTA (pH 8.0) to a final concentration of 20 mM. 
To each tube was added 5 µl of gel loading buffer (see Section 4.5.4) and the samples (20 
µl) were loaded in order into the wells of a 0.4% (w/v) agarose gel. Bacteriophage A 
DNA digested with Xhol and undigested chromosomal DNA were included as markers. 
Scale up of the partial digest was carried out by using the optimum conditions 
determined in the trial. The scale up (ten-fold) was performed under exactly the same 
conditions as the above trial experiment keeping volume, temperature and time of digest 
constant. The large fragments (35-45 kb) required for the cosmid cloning experiment 
were further purified by NaCl gradient centrifugation. After the partial digest was 
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stopped, 0.5 ml of the mixture was carefully layered onto a SW 41 polypropylene 
centrifuge tube (Beckman), containing 5-25% NaCl in TE (10 ml; the gradient was 
formed using a gradient mixer). The tubes were mounted into detachable buckets of the 
SW41 swing-out rotor and centrifuged at 35K rpm for 3 hat 12°c in a Beckman model 
L8-70 ultracentrifuge. After centrifugation the polypropylene tubes were punctured at the 
bottom with a sterile 18-gauge needle (with care being taken not to introduce any 
bubbles), 0.5-ml aliquots were withdrawn and placed in 1.5 ml Eppendorf tubes. Small 
aliquots of these fractions were analysed by agarose gel electrophoresis (0.4% w/v). The 
fractions of interest were dialysed vs. TE, DNA was recovered by ethanol precipitation. 
4.5.3 Restriction endonuclease digestion of DNA 
DNA (0.5-10 µg) was digested, with the appropriate restriction endonuclease, in 
the buffers prescribed by the manufacturers, or in the general buffers: "low salt buffer" 
(ie. 10 mM Tris-Cl pH 7.5, 10 mM MgC!i and 1 mM DTT); "medium salt buffer" (as in 
"low salt buffer" + 50 mM NaCl) and "high salt buffer" (50 mM Tris-Cl pH 7 .5, 10 mM 
MgCl2, 1 mM DTT and 100 _mM NaCl). The buffers were made up as 10-fold 
concentrates, sterilised by filtration and stored at -2ooc. The digestions were normally 
set up in a volume of 20 µl where the DNA solution, in a sterile Eppendorf tube was 
made up to 18 µl with sterile H20 and 2 µl of the appropriate 10 x buffer was added. The 
restriction enzyme (1 µl of a stock ranging in activity from 5-10 U/µl) was added last; 
reactions were mixed well and incubated at 370c for 2-4 h. If the digested DNA was to 
be analysed by agarose gel electrophoresis, 6 µl of gel-loading dye (see Section 4) was 
added and the mixture was loaded into a gel slot. The digestion reaction was stopped by 
addition of 0.5 M EDTA (pH 8.0) to a final concentration of 10 mM or by heating the 
mixture at 700c for 5 min. 
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4.5.4 Agarose gel electrophoresis 
Agarose gels were cast in horizontal gel tanks (180 cm long and 140 cm wide). 
Wells (3-6 mm deep and 5 mm wide) formed with combs immersed in the melted agarose 
were used for loading samples. Agarose gels, which were generally 0.7% (w/v), were 
made by melting 1.4 g agarose in 200 ml ( + 10 ml to allow for reduction in volume 
during melting) TBE (Tris-borate buffer contains 0.089 M Tris-borate, 0.089 M boric 
acid and 2 mM EDT A) in a microwave oven. Upon cooling to ..... 5ooc, ethidium bromide 
solution (final concentration of 0.5 µg/µl) was added to the clear agarose. The agarose 
was then cast in the horizontal gel tank with comb in place to form wells. The tank was 
filled with TBE containing 0.5 µg/ml ethidium bromide until the buffer covered the gel by 
1-2 mm (to prevent dehydration). The loading buffer for agarose gels was 0.25% 
bromophenol blue in 40% (w/v) sucrose dissolved in water (6 x concentrate). The gels 
were normally run at 50 volts until the dye reached the anode region. The gels were 
photographed (Polaroid camera; Polaroid Type 57 film) using a transilluminator to 
transmit u.v. light through the gel. 
4.5.5 Dephosphorylation of DNA 
The 5' terminal phosphate of DNA was removed using calf intestinal alkaline 
phosphatase (CIP). The DNA in a minimum volume of TE (3-6 µl) was mixed with 5 µl 
of 10 x CIP buffer (0.5 M Tris-Cl, pH 9.0, 10 mM MgCl2, 1 mM ZnCl2 and 10 mM 
spermidine) and made up to 48 µl with sterile water. CIP (2 µl, 5-10 U/µl) was added 
and the mixture incubated at 370c for 30 min. A second aliquot of CIP was added and 
incubation was continued for a further 30 min before the reaction was stopped by addition 
of 5 µl of 10% (w/v) SDS and heating at 700c for 15 min. The DNA was purified by 
phenol extraction (see Section 4.5.6 ) and precipitated with ethanol (see Section 4.5.7). 
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4.5.6 Phenol extraction of DNA 
Plasmid DNA isolated by rapid lysis (see Section 4.5.14) was further purified by 
phenol/chloroform extraction as described in Maniatis et al. (1982). The aqueous DNA 
sample was mixed with an equal volume of phenol (equilibrated with O. lM Tris-Cl pH 
8.0 containing 0.1 % (w/v) hydroxyquinoline and 0.2% (w/v) ~-mercaptoethanol) and 
centrifuged in an Eppendorf Microfuge for 3 min. The aqueous layer was removed with a 
Pipetman tip (discarding the interface and lower organic phase) and placed in a fresh 
Eppendorf tube. An equal volume of a 1:1 mixture of phenol (as above) and chloroform 
(24.1 (v/v) mixture of chloroform and isoamyl alcohol) was added and mixed by 
vortexing before centrifugation in a Microfuge for 3 min. The aqueous layer was 
removed as above and mixed with an equal volume of chloroform (as above) to remove 
traces of phenol from the previous steps. The aqueous layer was separated by 
centrifugation in a Microfuge for 3 min and the DNA was precipitated with ethanol as 
described in the following Section). 
4.5.7 Ethanol precip~tation of DNA 
DNA was precipitated from aqueous solutions (100-300 µl) by adding 3 M 
sodium acetate (1110th of the volume of aqueous solution) and absolute ethanol (2 times 
the volume of aqueous solution) in 1.5 ml Eppendorf tubes. The contents were mixed 
well and stored in ice or at -70°C for 30 min (if nano gram quantities were being 
precipitated the tubes were left overnight) and then centrifuged in a Microfuge for 5 min. 
The supernatant was discarded and 1 ml of 70% (v/v) ethanol (stored at -200C) was 
added to the tube without resuspending the pellet. After two or three careful inversions, 
the tubes were centrifuged for 5 min in a Microfuge. The supernatant was aspirated off 
and the pellets were dried in vacuum desiccator for --10 min. The pellet was resuspended 
in the appropriate solution or stored at -2ooc until required. 
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4.5.8 Ligation of DNA 
Ligations were generally done in a total volume of 20 µl. The compositions of 
blunt-end ligation buffer (10 x concentrate) and the sticky-end ligation buffer (10 x 
concentrate) are given below. The fragments of DNA to be ligated were placed in an 
Eppendorf tube and made up to 18 µl with sterile H20. The appropriate "ligation buffer" 
(2 µl of 10 x concentrate) was mixed with the DNA solution, 1 µl of T4 DNA ligase (1 
U/µl) was added and the reaction was allowed to proceed for 12-20 hat about 14°C. 
10 x Blunt end buffer 10 x Stick~ end buffer 
Tris-Cl pH 7.4 250mM 500mM 
MgCl2 50mM lOOmM 
DTI 50mM lOOmM 
Spermidine 2.5mM lOmM 
ATP lOmM lOmM 
Hexamine cobalt chloride lOmM 
BSA 0.1 mg/ml 1 mg/ml 
Buffer concentrates were sterilis~d by filtration and stored in 50 µl aliquots at -70°C. 
4.5.9 Packaging in vitro of concatemers into bacteriophage A 
particles 
The ligation of large Sau3A fragments (generated by partial digestion) with 
BamHI-digested cosmid vector pHC79 (dephosphorylated) results in high molecular 
weight concatameric DNA. The phage particles for the packaging were obtained as 
freeze-thaw lysates and sonicated extracts (gifts from Dr Barbara van Leeuwen, JCSMR). 
The freeze-thaw lysate was prepared from an induced lysogen with an amber mutation in 
gene E that prevents formation of the phage head and the sonicated extract was prepared 
from an induced lysogen with an amber mutation in gene D that results in accumulation of 
phage in the pre-head stage. When the two extracts are mixed with the concatemers, 
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genetic complementation occurs, and the DNA is packaged into A particles (Hohn and 
Murray, 1977). 
The freeze-thaw lysate (10 µl) was carefully placed by the side of a 1.5-ml 
Eppendorf tube that contained 5 µl of ligated mixture at the bottom. The sonicated extract 
(15 µl) was dropped directly onto the ligated mixture and, using the same Pipetman tip, 
the freeze-thaw lysate was mixed in without introducing bubbles. Note that bubbles tend 
to reduce drastically the packaging efficiency. The mixture was set aside at room 
temperature for 1 h, and 500 µl of SM buffer (which contained per liter: 50 ml of lM 
Tris-Cl (pH 7.5), 5.8g NaCl, 2g MgS04 and 5ml of 2% gelatin) was added to it prior to 
storage at 40c. 
4.5.10 Tran sf ection of packaged extract 
The strain to be transfected was grown in LB medium (30 ml) supplemented with 
maltose (10 mM) at 370c, overnight. The cells were harvested by centrifugation (6000 
rpm, 10 min) and suspended in 5 ml of LB medium containing 10 mM MgS04. The 
packaged extract (100 µl) was diluted with 100 µl of SM buffer in a 1.5-ml Eppendorf 
tube. The cell suspension (200 µl) was mixed with the diluted packaged extract and 
incubated at 370c. After 20 min, 1 ml of LB medium was added and the incubation was 
continued for a further hour to allow for expression of drug resistance. The transfected 
cells were pelleted by centrifugation in a Microfuge and suspended in 100 µl of LB. 
Various amounts of this were spread on LB plates supplemented with ampicillin and 
incubated at 370c. 
4.5.11 Construction of the recA derivative of E. coli strain D3-157 
The Pl lysate used in the above experiment was a kind gift from Dr C. M. Elvin 
and was made by growing bacteriophage Pl on E.coli strain NK 5304 (srl-1300 :: TnJO 
recA56). 
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Strain D3-157 (25 ml cultures in LB broth) was grown to an OD595 -0.6 and 
transferred (5 ml each) to 4 screw-capped tubes. They were centrifuged at 3200 rpm for 
10 min in a bench-top centrifuge and the supematants were discarded. The following 
additions were made to the 4 tubes: 
Tube 1 Tube2 Tube 3 Tube4 
LB broth 0.5 ml 0.5 ml 0.5 ml 0.5 ml 
CaCl2(50 mM)/MgCl2(30 mM) 0.5 ml 0.5 ml 0.5 ml 0.5 ml 
Pl lysate 0.5 ml 0.1 ml 0.02 ml 
LB broth 0.4 ml 0.48 ml 0.5 ml 
The tubes were incubated at 37°C for 20 min, then the cells were pelleted by 
centrifugation at 3200 rpm for 10 min in a bench-top centrifuge. The cell pellets were 
suspended in minimal salts medium (diluted two-fold) and pelleted by centrifugation (the 
wash step was repeated). The pellets were suspended in 50 µl of LB broth, spread on LB 
plates containing 15 µg/ml tetracycline, and incubated at 37°C overnight. There were no 
colonies from Tube 4. Transductants from Tube 3 were screened for the presence of the 
recA allele by checking for sensitivity to u.v. irradiation. This was carried out by 
streaking the colonies on LB plates containing tetracycline and exposing the plate for 30 
sec to short wavelength u.v. source followed by overnight incubation at 370c. The recA 
strains were sensitive to the u.v. irradiation, whereas the rec+ strain (D3-157) used as a 
control survived the 30 s exposure. 
4.5.12 Direct screening for increased DHPR specific activity 
The recombinants that were being screened for increased DHPR specific activity 
were grown overnight in 30 ml of LB medium supplemented with ampicillin. The cells 
were pelleted by centrifugation in SS-34 tubes using the SS-34 rotor in a Sorvall RC-SC 
centrifuge at 6000 rpm for 10 min at 40c. The cells were suspended in 50 mM Tris-Cl, 
pH 7.4, containing 1 mM EDTA and 200 mM KCl (0.8 ml) and transferred into 1.5-ml 
capacity TLA-100 (Beckman) tubes. Chicken egg-white lysozyme (200 µl, 20 mg/ml in 
107 
the above buffer) was added and mixed in well with a 1-ml Pipetman tip. The suspension 
was kept at ooc for 1 hr and then frozen in liquid N2. This was allowed to thaw at 4°C 
and centrifuged at 75 000 rpm with a TLA-100 rotor in a Beckman model T-100 benchtop 
ultracentrifuge at 40c for 30 min. The cell-free extract (0.75 ml) was removed and stored 
in labelled glass vials. Aliquots were taken to assay for DHPR activity (Section 2.5.1.1) 
and protein concentration was determined as desc1ibed in Section 2.5.2. By this method, 
thirty recombinants were screened at a time. 
4.5.13 Preparation of plasmid DNA 
The preparation of amplifiable plasmid was essentially as described by Silhavy 
et al. (1984). An overnight culture (5 ml) of the plasmid-bearing strain in LB broth 
containing 50 µg/ml ampicillin was used to inoculate 1 L of minimal medium 
supplemented with 0.5% (w/v) casam1no acids, 40 mM glucose; other growth 
requirements and ampicillin (or appropriate antibiotic). Growth at 370c with aeration in a 
gyratory environmental shaker was monitored by measuring OD590. When the OD590 
was -0.7, spectinomycin hydroc_hloride (0.3 g/L) ·was added to inhibit protein synthesis. 
Cultures were grown for a further 12-16 h for plasmid amplification. The cells were 
pelleted by centrifugation (as in Section 4.5.1) and resuspended in 20 ml of 25 mM Tris-
Cl pH 8.0 containing 50 mM glucose and 10 mW EDTA (at 40C). Lysozyme (50 mg) 
was added whilst swirling and the mixture left on ice for 5 min. NaOH-SDS solution (40 
ml, 0.2 M NaOH and 1 % SDS) was added, mixe:i in well by inverting the capped tube 
until the cell suspension was clear and left on ice for 5 min. Potassium acetate solution 
pH 4.8 (30 ml; 3 M potassium acetate and 3 M glacial acetic acid) was added to the tube 
with mixing. A white precipitate was formed while standing on ice for 15 min. The 
supernatant (75 ml) was collected after centrifugation at 10 000 rpm for 30 min in a 
Sorvall RC-SC centrifuge with a GSA rotor and the DNA was precipitated by adding 
isopropanol ( 45 ml). The mixture was frozen in ~ dry ice-ethanol bath, thawed and the 
DNA pellet was separated by centrifugation at 11)000 rpm for 30 min. The pellet was 
rinsed with cold 70% (v/v) ethanol and dried in a desiccator attached to a water pump for 
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10 min. The pellet was suspended in TE containing CsCl and ethidium bromide (8 ml TE 
+ 8 g CsCl + 1 ml of 10 mg/ml ethidium bromide) and transferred into a polyallomer tube 
(Beckman) to fit the fixed angle Ti-50 rotor and centrifuged at 39 000 rpm for 36 h at 
150c in a Beckman L8-70 Ultracentrifuge. The supercoiled plasmid band (well separated 
from the band of relaxed DNA) was visualised under long-range u.v. light and withdrawn 
from the tube with a sterile disposable 5-ml syringe attached to an 18-gauge needle. The 
ethidium bromide was completely removed after three extractions with aqueous NaCl-
saturated isopropanol and the aqueous layer was dialysed overnight (4°C) against TE (2 x 
1 L). The DNA yield by this method was usually about 500 µg/L of culture 
4.5.14 Rapid small scale isolation of plasmid DNA 
Strains containing plasmids were streaked on 8-sectored LB plates containing 
ampicillin (50 µg/ml) and incubated overnight (at 370C). A loopful of cells was scraped 
from a sector and transferred to a 1.5-ml Eppendorf tube containing 1 ml of LB broth. 
The cells were pelleted by centrifugation in an Eppendorf Microfuge for 5 min. The 
supernatant was discarded and the tubes were stored on ice. The cell pellet was 
suspended in 200 µl of lysozyme solution (25 mM Tris-Cl pH 8.0, 50 mM glucose, 10 
mM EDTA and 5 mg/ml lysozyme) using a Pipetman tip and incubated on ice for 5 min. 
NaOH-SDS stock solution (0.3 ml, 0.2 M NaOH and 1 % SDS) was added to the tube 
and mixed in well by inverting the capped tube several times. The clear cell suspension 
was chilled in ice for 5 min. Potassium acetate pH 4.8 (0.3 ml; 3 M potassium acetate 
and 3M glacial acetic acid) was added to the tube. The contents were mixed gently by 
inversion and frozen in dry-ice for ...... 5 min. This was then thawed to room temperature 
and centrifuged for 10 min in a Microfuge. The supernatant (0.75 ml) was carefully 
removed (making sure not to transfer any of the white precipitate) and transferred into a 
fresh 1.5-ml Eppendorf tube. Isopropanol (0.45 ml) was added to the supernatant and 
mixed well. After 20 min at room temperature, the precipitated DNA was pelleted by 
centrifugation in a Microfuge for 10 min. The supernatant was discarded and 1 ml of 
70% (v/v) ethanol was added carefully without resuspending the pellet. The tubes were 
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centrifuged for a further 10 min in a Microfuge and the supernatant was aspirated off 
using a drawn-out Pasteur pipette. The pellet was dried in a vacuum desiccator (-10 min) 
until it became translucent, then suspended in 50 µl of TE containing 20 µg/ml RNaseA 
using a Pipetman tip. After incubated at 370c for 15 min and then at 700c for 15 min, 
the plasmid DNA was stored frozen at -2ooc. 
A large number of transformants can be analysed for insertions by the above 
method. The size of the plasmid DNA from the above rapid lysates was analysed by 
mixing 5 µl of the RNaseA-treated solution with 10 µl of TE and 5 µl of loading buffer 
and subjecting them to agarose gel (0.7-1.0% (w/v)) electrophoresis (see Section 4.5.4). 
The plasmid DNA prepared as described above could also be used for transformation of 
competent cells. For restriction enzyme analysis, the plasmid DNA samples were further 
purified by phenol extraction (see Section 4.5.6). 
4.5.15 Transformation of competent cells with plasmid DNA 
The transformation procedure was carried out essentially as described by 
Lederberg and Cohen (1974). Cells were grown overnight in 10 ml of LB medium. A 
sub-culture was grown by adding 200 µl of overnight culture to 20 ml of LB medium, 
followed by growth at 37°C to an OD595 -0.7. The medium containing the cells was 
chilled on ice then centrifuged at 6000 rpm for 10 min at 4°C. The cell pellet was 
suspended in an equal volume of cold 0.1 M MgS04. The cells were pelleted by 
centrifugation, suspended in 10 ml of cold 0.1 M CaCl2 and kept on ice for 30 min. This 
was followed by centrifugation to pellet the cells, which were suspended in 1 ml of cold 
0.1 M CaC!i and left standing on ice for 40 min. These cells were competent for 
transformation. The plasmid DNA or ligation mixture (made up to 200 µl with TE) to be 
used for the transformation was chilled on ice and 200 µl of competent cells were added. 
The mixture was allowed to stand on ice for 30 nrin and then heat shocked for 2 min at 
42°C. LB medium (1 ml) was added to the mixture, which was then incubated for 1-2 h 
to allow time for expression of drug resistance. The cells were pelleted by centrifugation 
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in a Microfuge for 3 min and suspended in 100 µl of LB medium. Aliquots were spread 
on selective medium and incubated for 1-2 days at 37°C. 
4.5.16 Mini-cell isolation and in vivo protein synthesis 
The strain DS410 (Genotype : minA, nzinB, thi, lac; Dougan and Sherrat, 
1977)was transformed with plasmids p WA 266, p WA 406 or vector pHC 79 and were 
grown separately overnight at 370c in a 1:1 mixture of LB:56 media (500 ml total) 
containing 0.4% glucose and ampicillin (50 µg/ml). The cells were chilled on ice and 
harvested by centrifugation at 8000 rpm for 15 min at 4°C with a GS-3 rotor in a Sorvall 
RC-SC centrifuge. The pellets containing the whole cells and the mini-cells were 
suspended in 10 ml of RM medium (described later) and shaken vigorously for 2 hat 
40c. The cell suspension (5 ml per gradient) was layered on a sucrose gradient (Dougan 
and Kehoe, 1984) which was formed by freezing 30% w/v sucrose (in RM medium) in 
clear SS 34 Centrifuge tubes (40 ml per tube) and allowing it to thaw slowly at 4°C. 
Tubes were centrifuged at 6000 rpm at 4°C for 20 min using a HB-4 rotor (swing-out) in 
a Sorvall RC-SC centrifuge. The mini-cells which formed an opaque band around the 
middle of the tube were well separated from the whole cells which pelleted at the bottom 
of the tube. The mini-cell band (-5 mls) was collected with a Pasteur pipette and pelleted 
by centrifugation at 13 000 rpm at 40c for 10 min. The mini-cell pellet was resuspended 
in RM buffer and the sucrose gradient centrifugation procedure was repeated. The pellet 
was suspended in 3 ml of RM buffer and kept on ice. This preparation was checked for 
contamination with parent cells by viewing through a phase-contrast microscope 
(magnified 400x). There was about 1 parent cell per 10 fields viewed at that 
magnification (Note: 1 cell per field viewed at 400 x magnification indicates a 
concentration of -1 x 106 cells/ml which is about 10 times more than is acceptable for in 
vivo expression studies). The mini-cells were pelleted by centrifugation, suspended in 
RM buffer containing 30% glycerol to an OD595 of 2 and stored as 200 µl aliquots at 
-70°C (after instant freezing in liquid N2) until required. 
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For in vivo protein synthesis, 20 µl of the stored mini-cells were collected by 
centrifugation in 1.5-ml Eppendorf tubes and then resuspended in 20 µl of RM medium 
containing vitamins, nucleotides and 19 amino acids (omitting methionine). After 
preincubation for 1 hat 370c, 25 µCi of 35S-methionine (1,390 Ci/mmol) was added 
and the mixture was incubated for a further hour, followed by a 15 min chase with 
unlabelled methionine (100 µM). The mini-cells were pelleted by centrifugation and 
suspended in 30 µl of "SDS cracking buffer" (300µ1 of 50% aqueous glycerol, 100µ1 of 
0.4% aqueous bromophenol blue, 200µ1 of 0.5 M DTT, 400µ1 Of 2 M Tris-base, 30µ1 of 
aqueous 10% SDS and 200µ1 of water), heated at 100°C for 3 min and electrophoresed 
on a 12% SDS-PA gel. The gel was stained with Coomassie Blue and destained (see 
Section 2.5.3) to visualise the Pharmacia low molecular weight standard markers and the 
purified E.coli DHPR. 
In order to detect the 35S-methionine labelled proteins, the gel was soaked in water 
to remove residual acid from the destaining step and then impregnated with 0.8 M sodium 
salicylate (Chamberlain, 1979) by soaking for 40 min. The gel was washed briefly with 
distilled water before it was dried onto Whatman 3 MM paper at 6QOC using a BioRad 
#483 slab gel drier, and exposed to Kodak XAR-5 film for 2-4 days. 
RM salts (10-fold concentration): 10g Nf4Cl + 15 g KCl dissolved in 100 ml water 
57.1 g Na2HP04 + 24.9 g KH2P04 were added 
Brought to 1 liter with water and autoclaved. 
RM-medium: RM salts (lOx) 5ml 
containing: Glucose solution (20%; 1 ml), water (43 ml), lM MgS04 (0.5 
ml), (0.5ml), O.lM CaCh (0.05 ml), 0.01M FeCl3 (0.01 ml), 
D-Cycloserine (lOmg/ml; 0.1 ml), and all other amino acids (ommitting 
methonine at 50µg/ml each .. Vitamins: thiamine (B 1) and pantothenic acid 
each at 0.001 % w/v. Nucleotides (ATP, OTP, CTP and TTP) each at 
5mM. 
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CHAPTER 5 
IDENTIFICATION AND CHARACTERIZATION OF THE TWO 
MAJOR PROTEINS SYNTHESIZED UNDER THE DIRECTION 
OF PLASMIDS pWA266 AND pWA406 
5 .1 INTRODUCTION 
The in vivo expression of proteins under the direction of the plasmids p W A266 
and pWA406 clearly showed that two proteins with relative molecular weights of 47 000 
and 45 000 were synthesized in fairly large amounts. The 27 kD E.coli DHPR was not 
apparently being synthesized under the direction of the plasmids. Since much effort had 
been invested in obtaining the primary cosmid clone (Chapter 4), it was decided that the 
six-fold increase in D HPR specific activity in the cell-free extracts prepared from strains 
W A266 and W A406 required further investigation. Several scenarios were envisaged for 
the increased DHPR activity (discussed in Chapter 4). It was reasoned that the most 
probable of these was that a gene fusion may have occurred inadvertently during the 
construction of the cosmid library to give rise to a higher molecular weight protein. It 
was suspected that fusion between the 5' region of the gene that encodes DHPR and the 
3' part of the tet gene of the cosmid vector pHC79 may have taken place. The reason for 
this was that the large DNA fragments generated by Sau 3A partial digest for the 
construction of the cosmid library were inserted into the Bam HI site which occurs within 
the tet gene of the vector. The loss of the termination codon of the gene that codes for 
DHPR (during the partial digestion with Sau 3A to obtain large DNA fragments for 
cosmid library construction) could then have resulted in the formation of an extended 
reading frame. If this were the case, then part of the DHPR gene would be on one end of 
the plasmid p W A266. It was reasoned that if the occurrence of the fusion could be 
established, then the complete gene encoding DHPR could be readily isolated from a new 
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cloning experiment by using a radiolabelled fragment from the cosmid clone as a 
hybridization probe. 
This chapter describes attempts to purify the protein responsible for the increased 
DHPR activity in the extracts prepared from the recombinant strains W A266 or W A406. 
A purification method for E.coli DHPR, which is a 27-kD flavoprotein, has been 
established in this study (see Chapter 2). However the rapid loss of reductase activity 
during the early steps in the attempted isolation of the protein responsible for the increased 
enzyme activity did not permit purification of the protein to homogeneity. Partial 
purification was achieved by using steps similar to those summarised in Table 2.3. Two 
proteins with relative molecular weights of about 45 000 and 47 000 that co-purified 
through the three purification steps were studied further because one them was suspected 
to be responsible for the increased DHRP specific activity in the strain W A266. Since the 
N-terminal amino acid sequence of DHPR from E.coli has been determined, it was felt 
that sequencing the N-termini of the two proteins would be one way to confirm the fusion 
protein hypothesis. The amino termini of the two proteins were determined by 
microsequencing using the method of Vanderkerckhove et al., (1985). The 45-kD 
protein, which in all probabilitY- is the source for the increased DHPR activity proved to 
be a natural haemoprotein in E. coli whose N-terminal amino acid sequence was 
significantly homologous with haemoglobin from the filamentous myxobacterium 
Vitreoscilla (Wakabayashi et al., 1986). The 47-kD protein on the other hand was serine 
h ydroxymethy ltransf erase. 
5.2 RESULTS AND DISCUSSION 
5. 2 .1 Partial purification and identification of 45-kD and 47-kD 
polypeptides 
Procedures similar to those used for the purification of E.coli DHPR described in 
Chapter 2 were followed to purify the suspected fusion protein from the cell-free extract 
prepared from WA 406. After some initial work it became clear that the protein 
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responsible for the increased DHPR activity was behaving very differently from the 27-
kD E. coli DHPR. The reductase activity in the extracts prepared from WA 266 was 
similar to that from WA 406. Since the decrease in the size of the insert from 35 to 45 kb 
in pWA 266 to about 10 kb in pWA 406 did not increase the level of DHPR in the strain 
WA 406, there was no apparent advantage in purifying the fusion protein from it. Also it 
was argued that purification of the suspected fusion protein from WA 266 would directly 
establish that fusion occurred during the cosmid cloning; however further evidence would 
be required to confirm this if the the protein was i~olated from WA 406. In the latter case 
it could be argued that a fusion may have resulted during sub-cloning and not during the 
original cosmid library construction. Therefore it ,vas decided that the protein responsible 
for the increased DHPR activity had to be purified from extracts made from WA 266. 
The increased DHPR specific activity present in the cell-free extract prepared from 
the strain WA 266 was stable in 50 mM Hepes-KOH (pH 7.4) containing 200 mM KCl 
and lmM EDTA at 4°C for 1-2 days. The activity was also stable to storage for several 
months at -20°C. Repeated thawing of the extracts to 4°C and freezing to -20°C did not 
affect the reductase activity. Hqwever, when the e"~tract was fractionated with ammonium 
sulfate, the 35-45% saturation fraction which normally separated more than 80% of the 
total DHPR activity in strains H-712 and D3-157 (compare with Table 2.4), contained 
less than 15% of the total activity that was present in the initial extract. The supernatant, 
after the extract was brought to 45% saturation with ammonium sulfate had about 15% of 
the activity contained in the original extract. There was almost no DHPR activity in the 0-
35% ammonium sulfate saturation fraction. This shows that the increased DHPR specific 
activity was lost during the ammonium sulfate fractionation. In the light of the fact that 
ammonium sulfate fractionation is normally employed as the first step in isolation of 
proteins because of its stabilization effects and ability to give some degree of purification 
when starting from a cell free extract, the loss of DHPR activity could not be readily 
explained. Moreover the reductase isolated and characterised as DHPR in this study has 
been shown to be stable to ammonium sulfate precipitation during the purification. Thus 
this phenomenon was investigated further. 
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The extracts from strains WA 266 and D3-157 were saturated to 0.4 M ammonium 
sulfate and incubated at 25°c. At this level of saturation there was no protein 
precipitation. The extract from WA 266 lost DHPR activity rapidly with time. More than 
80% of the activity present in the original extract was lost in three hours. During the same 
period, the extract from WA 266 incubated under identical conditions without ammonium 
sulfate, lost about 40% of reductase activity. The (lower level of) DHPR activity in D3-
157 was stable when in ammonium sulfate ( 10% of saturation) and compared under the 
same conditions as for WA 266 (see Figure 5.1). Dialysis of the extract from WA 266 
containing ammonium sulfate against 50mM Hepes-KOH did not restore the reductase 
activity. Also, dialysis of the starting extract against 50mM Hepes-KOH (pH 7.4) 
resulted in the loss of more than 80% of DHPR activity . Unsuccessful attempts were 
also made to reactivate the reductase by adding freshly-prepared cell-free extract from 
strains D3-157 or WA 266 to investigate if unknown factor(s) were being removed during 
the fractionation. The reason for the loss of DHPR activity is not yet clear, but the 
anomalous behaviour was taken as further support that a fusion protein may have been 
formed. 
At this stage of the work it was decided that it is more important to isolate the two 
major proteins (45-kD and 47kD) that were synthesized under the direction of the plasmid 
DNA, even if it is at the expense of the reductase activity, and to characterise them by N-
terminal amino acid sequencing. The ammonium sulphate fractionation of extract from 
WA 266 was carried out rapidly (about 1 h) so that some idea of the distribution of the 
DHPR activity into different fraction could be ascertained. Working quickly was an 
important criterion because the reductase activity seemed to be lost in a time dependent 
manner after the addition of ammonium sulfate (see Figure 5.1). About 65% of the total 
reductase activity that was present in the starting extract appeared in the 45-60% 
ammonium sulfate saturation fraction and only about 20% of the activity remained in the 
35-45% saturation fraction. DHPR activity in the 45-60% saturation fraction was very 
unstable and all the enzyme activity was lost within 3-5 h while standing in ice. On the 
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Figure 5.1 Effect of ammonium sulfate on DHPR activity in cell-free extract prepared from strain WA 266 at 25°C 
The DHPR activity of samples were measured as described in Section 2.5.1.1. 
(a) cell-free extract from WA 266 + 0.4 M saturated ammonium sulfate was incubated at 25°C, and aliquots were removed for enzyme 
activity assay at 30 min intervals. 
(b) as in (a), except that no ammonium sulfate was added. 
(c) cell-free extract from strain D3-157 + 0.4 M saturated ammonium sulfate was carried out as described for (a). 
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other hand the reductase activity in the 35-45% saturation fraction was stable. This 
indicates that the product of the cloned gene which has DHPR activity appears in the 45-
60% ammonium sulfate saturation fraction and the wild type DHPR (27-kD) is contained 
in the 35-45% saturation fraction as established in Chapter 2. 
The 45-60% ammonium sulfate fraction was desalted using a Pharmacia PD-10 
gel filtration column and the protein fraction was eluted with 50mM Hepes-KOH (pH 
7.4) buffer. The eluate was rapidly chromatographed through the f.p.l.c. Mono-Q ion-
exchange column followed by chromatofocusing using the Mono-P column, after buffer 
exchange into the appropriate starting buffer. The purification characteristics of the 
protein responsible for the increased DHPR specific activity in strain WA 266 were 
different from that of the wild-type DHPR at every stage. Whereas the 27-kD E. coli 
DHPR normally eluted with about 100 mM NaCl during separation by ion-exchange 
chromatography, the "active" fraction from WA 266 was eluted with 60 mM NaCL The 
"active" fraction contained <5% of the starting reductase activity and it was yellow in 
colour. The yellow colour was used to indicate the fraction of interest after the separation 
by chromatofocusing because all the reductase activity was lost by this time. The 
isoelectric point of the 27-kD E. coli DHPR is 5.3. The yellow-coloured fraction, 
however, eluted at pH 6.5 in the chromatofocusing step. A different buffer system to that 
used in Chapter 2 was employed to generate a suitable pH gradient to elute the yellow-
coloured fraction at this pH value. 
The SDS-PAGE analysis (see Figure 5.2) of the fractions containing the yellow 
colour at different stages during purification showed that the 45-kD and 47-kD proteins 
co-purified through all the steps. Since the purification of the two proteins was based on 
diminishing DHPR activity and the yellow colour, the similarity of their molecular 
weights with those of the two major plasmid-encoded proteins observed in the in vivo 
transcription and translation system (see Chapter 4, Figure 4.10), was taken as support 
for the notion that one of them may be the suspected fusion protein. The partially-purified 
proteins were separated on a 12% (w/v) PA gel and electroblotted onto a polybrene 
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Figure 5.2 Polyacrylamide gel electrophoresis of proteins. 
(a) Pharmacia low molecular weight standards; (b) purified E.coli DHPR (27 kD); (c) cell free extract from WA 266; 
(J) 0 - 45% ammonium sulfate saturation fraction of extract from WA 266; (e) 45 - 60% ammonium sulfate fraction 
of the extract from WA 266; (t) and (g) show fractions after Mono-Q anion exchange chromatography and (h)is the sample 
after Mono-P chromatof ocusing. 
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Figure 5.3 Polybrene glass blot of partially purified proteins from strain WA 266, stained with fluorescamine. 
The sequence of the 47 Kd and 45 Kd proteins were obtained by microsequencing in an Applied Biosystem 477 A Protein Sequencer. 
The arrowhead indicates the position of E. coli DHPR (27Kd). The N-terminal amino acid residues of the 47 Kd and 45 Kd proteins 
are presented and are different from that obtained for the 27 Kd E.coli DHPR (compare with Table 3.3) 
47 K · protein 
/M LKCEMNIADYDAELEQ 
~45 K protein 
~-~i~~ MLDAQTIATVKATIPLLKET 
' 
30 K protein 
No sequence obtained 
(quarternized ammonium polybase)-coated glass fibre sheet . The protein bands were 
visualised under u.v. light after staining with fluorescamine (see Figure 5.3), where the 
intensity of the fluorescamine stain is dependent on the number of reactive primary amino 
groups available on the immobilized protein. Traces of an ,.... 30-kD protein that was not 
observed in the Coomassie-stained protein bands in Figure 5.2 were seen with the 
fluorescamine stain. 
The 45-kD protein (bands from four tracks were carefully excised with a scalpel 
and mounted into the reaction chamber of the Applied Biosystems 477 A sequenator) was 
subjected to microsequencing. The N-terminal sequence of the first 20 amino acid was 
readily obtained with an average amino acid repetitive yield of 90%. The initial yield of 
about 45 pmol (the lower limit for sequencing with this machine is about 10 pmol) of 
protein enabled confident identification of the amino acid residues. The N-terminal 
sequence was not similar to that of the 27-kD reductase. The N-terminal 17 residues of 
the 47-kD protein, obtained by microsequencing, also showed no similarity with the 
sequence of the 27-kD DHPR. The 30-kD band did not give any sequence data. The 
earlier suspicion that a fusion protein may have been formed and that one of the two major 
proteins products of the plasmid DNA may contain the N-terminal region of E.coli DHPR 
is not true. If a fusion protein had been formed (by the fusion of the gene that codes for 
the 27-kD DHPR and the tet gene) then its N-terminal amino acid would have been the 
same as that of the 27-kD E.coli DHPR (see Figure 5.3). 
Two other approaches that were concurrently undertaken with the protein 
sequencing approach to hasten the isolation of the complete DHPR gene were also 
unsuccessful. One of them involved obtaining about 1 kb of DNA sequence data in the 
region where the gene fusion was suspected to have occurred (see the restriction map of 
plasmid pWA 406 in Figure 5.6). There was no open reading frame which corresponded 
to that of the gene encoding the 27-kD DHPR as predicted from its N-terminal amino acid 
sequence (data not shown). The second approach was involved insitu hybridization of 
more than 1000 recombinants (from the comid library prepared in this study) replicated 
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onto nitrocellulose membranes, with the radiolabelled Sall-Barn HI fragment (Sal I partial 
digest to isolate the 2.6-kb fragment followed by a Bam HI digest) indicated on the 
restriction map of pWA 406 (see Figure 5.6). This method was performed essentially as 
decribed in Maniatis et al. (1982). It was felt that if part of the gene that codes for DHPR 
were within the region of DNA used as a probe, then some of the colonies with which it 
would hybridize should contain the complete gene for DHPR. Sixty colonies that 
hybridized with the probe were grown from the master plates and directly screened for 
increased DHPR activity but without any success (data not shown). 
The N-teminal sequences of the 45-kD and 47-kD proteins were compared with 
those of other protein sequences stored in the National Biomedical Research Foundation 
Protein Data Bank to determine if they corresponded to any known E.coli proteins. The 
45-kD protein was found to be highly homologous with haemoglobin from the 
filamentous myxobacterium Vitreoscilla (Wakabayashi et al., 1986). Of the 20 amino 
acid residues that were compared, 14 residues occurred in identical positions as the 
haemoglobin from Vitreoscilla and 3 of the remaining residues were conservative 
substitutions involving valine-iso}eucine changes in two of the postions and valine-leucine 
change in the remaining position (see Figure 5.4). The 47-kD protein was identical at 15 
positions (of the 17 that were compared) with serine hydroxymethyl transferase, the glyA 
gene product from E.coli (Stauffer et al., 1981, Plamann et al., 1983). The amino acid 
residue at position 4 of the 47-kD protein was preliminarily assigned as cysteine. 
However, arginine has been predicted to occur at this position from the DNA sequence of 
the glyA gene (Plamann et al.,1983). The PTH-derivatives of both cysteine and arginine 
are known to escape detection by h.p.l.c., therefore it is likely that cysteine may have 
been wrongly assigned at this position in the first instance. The amino acid residue at 
position 16 was analysed as glutamate whereas the predicted residue for serine 
hydroxymethly transferase is tryptophan. 
The molecular weight of the 47-kD protein obtained by SDS-PAGE comparison 
with Pharmacia low molecular weight standard is in close agreement with the published 
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Figure 5.4 Comparison of N-terminal sequences of the 47-kD and 45-kD proteins with known proteins 
The N-terminal amino acid sequences of the 47-kD and 45-kD proteins were compared with sequences of other proteins in the 
National Biomedical 
Research Foundation Protein Data Bank (see text) 
47 K 
SHMT 
45 K 
VHb 
MLKCEMNIADYDAELEQ 
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M L D Q Q TI N I I K A -riv P V L K E H 
molecular weight of E. coli serinehydroxymethyl transferase (45 300) which was 
calculated from the predicted amino acid sequence of the glyA gene (Plamann et al., 
1983). The indirect evidence for the presence of the glyA gene in plasmids pWA 266 and 
p WA 406 was confirmed by carrying out genetic complementation experiments using a 
glyA mutant strain GS245 (Stauffer et al., 1981). When this mutant strain made 
competent by calcium chloride treatment was transformed with plasmids p WA 266 or 
pWA 406, it was able to grow on minimal plates that did not contain serine and glycine, 
whereas strain GS245 on its own or when transformed with the cosmid vector pHC79 
did not grow in this medium. 
Since the subunit weight of the 47-kD protein (measured by SDS-PAGE) is 
actually 45 300, then that of the 45-kD protein must be about 44 000. The subunit 
molecular weight of the Vitreoscilla haemoglobin is 15 800 (Wakabayashi et al., 1986). 
There has been no previous report of any haemoglobin like protein in E.coli. Although 
there is strong homology in the N-terminal amino acid sequence of the two proteins, the 
higher molecular weight of the protein from this study needs to be accounted for. The 
joining of non-contiguous DNA fragments during the construction of the cosmid library 
has not been considered before because the selection of the insert was carried out with 
great stringency. The coincidence that the sum of the molecular weights of the 
haemoglobin protein from Vitreoscilla and E. coli DHPR is about 44 000, led to the 
suspicion that a fusion due to joining of non-contiguous regions of the chromosome 
during the cosmid library construction may have occurred. Other evidences such as the 
loss of DHPR activity during the purification of the protein and the yellow colour which 
may be due to the flavin prosthetic group in E. coli DHPR, favour the fusion protein 
arguement. In any event, it was decided that the 44-kD protein meritted further 
investigation because it appeared to be novel. 
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5.2.2 Restriction mapping of plasmid pWA 406 
The restriction mapping of the plasmid pWA 406 was carried out so that the 
gene(s) responsible for the coding of the 44-kD protein could be isolated. The plasmid 
DNA or fragments isolated from it, were analysed by single, double or triple digests with 
commonly used restriction endonucleases (for example see Figure 5.5a). The restriction 
digests of plasmids pWA 401 and pWA 403 were also carried out (see Figure 5.5b) to 
support the location of some of the sites on p WA 406. 
The Sal I digest of p WA 406 gave 4 fragments (8 kb, 6 kb, 2.1 kb and 0.6 kb) 
which indicated that there must be 4 such restriction sites. One of the Sal I sites was 
located within the vector pHC79 (compare with Figure 4.1). The 8-kb and 6-kb Sal I 
fragments were isolated, reclosed by intramolecular ligation and separately transformed 
into AN 1459. The rationale here was that only the reclosed vector containing the 
complete vector DNA would yield recombinants. The reclosed 6-kb fragment gave 
recombinants on a LB plate containing ampicillin. This information was used to locate the 
second Sal I site(*) on the map of pWA 406. Since the size of the vector in pWA 406 is 
about 5.7 kb, the second Sal I site was placed such that a 6-kb fragment would contain 
most of the vector DNA (see Figure 5.6). The remaining two Sal I sites were located by 
comparison with the Sal I restriction pattern of plasmids pWA 401 and pWA 403. The 
Eco RI digest of pWA 406 generated 2 fragments of about 10 kb and 8 kb. Both sites 
must have been in the insert because the Eco RI site of the vector was lost in the 665 bp 
fragment that was deleted during the sub-cloning (see Figure 4.7). The first Barn HI site 
that occurred within the 0.6-kb Sal I fragment was formed fortuitously during the cosmid 
construction because the ligation of a Barn HI cut 5' overhang with a sau 3A cut 5' 
overhang had a 25% probability of forming a new Barn HI site. The second Barn HI site 
that occurs at the junction where the 665-bp fragment has been deleted was formed by 
intramolecular ligation of two Sau 3A generated 5' overhangs. However the T nucleotide 
residue at position +4045 of the vector (from the DNA sequence of pBR322; Sutcliffe, 
1979) will not form a Barn HI recognition sequence. Deletion of two further 36-bp and 
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Figure 5.5 Agarose gel electrophoresis of plasmid DNA 
(A) Plasmid pWA 406 was digested with Sal I (b), Eco RI (c), Pvu II (d), Bam HI (e) 
Xho I (f), Hpa IT (g), Sma I (h), Sal I - Xho I (i), Eco RI + Xho I G), BamHI + Xho I (k) 
BamHI + Eco RI (1), Sal I + Pvu II (m), and Eco RI + Sma I (n). A 1.6-kb Pvu II fragment '1 
isoltaed from p WA 266 was digested with Sma I, Xho I, Eco RI and Sal I respectively 
('o' - 'r'), to check for the presence of these restriction sites. The lanes marked (a) contain A 
DNA digested with Hind III, and were run as known size markers. 
(B) Plasmids pWA 401 (b - h), pWA 403 (i - o) or pWA 406 (p - v) were digested with 
Pvu II + Eco RI, Pvu II + Sal I, Eco RI +Sal I, Pvu II+ Eco RI + Sal I, Eco RI and Sal I, 
respectively. Lanes marked 'a' contain A DNA digested with Hind III, size markers. 
A 
abcdef 9h i jka a lmn o pq r a 
B 
Figure 5.6 Restriction map of plasmid p WA 406. 
The double arrowhead (within the -2.3 kb Sal I - Barn HI fragment) indicates the region that was used as probe DNA in the in situ 
hybridization and the small arrows indicate the regions that were sequenced in the attempt to identify an open reading frame for E.coli DHPR 
gene (explained in the text). The position of glyA gene and pHC 79 vector DNA are also indicated. 
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17-bp Sau 3A fragments however, would result in a new Bam HI site. The deletion of 
these two small fragments could not be resolved in Figure 4. 7. It was reasoned that any 
further deletion would result in inactivation of the bla gene which in turn would result in 
loss of ampicillin resistance. 
The restriction map of plasmid p WA 406 shows that the g lyA gene is on the 8-kb 
EcoRI fragment. However, when Stauffer et al. (1981) cloned the glyA gene it was 
shown to be within a 13-kb EcoRI fragment. Comparison of the restriction maps of 
plasmid pWA 406 in this work and pGS29 (Stauffer et al., 1981) enabled the correct 
placement of the glyA gene. The earlier assumtion that the 10-kb insert DNA fragment in 
plasmid p WA 406 must be contiguous in comparison with its occurrence in the 
chromosome of strain D3-157 may be incorrect because comparison of the restriction 
maps of plasmids pWA 406 and pGS 1 (from Stauffer et al., 1981) with the complete 
physical map of the E.coli genome around minute 55 (see Figure 5.7; Kohara et al., 
1987) shows that plasmid p WA 406 has further deletions in the insert that may have taken 
place during the sub-cloning, or more likely due to restriction site polymorphism D3-157 
vs W3110. 
5.2.3 Oligonucleotide probing and DNA sequencing of 5' region of 
the gene responsible for coding the 44-kD protein. 
Three mixed oligonucleotides containing sequences that were complementary to 
the N-termini of the 44-kD protein and the 27-kD E.coli DHPR were synthesized (see 
Figure 5.8) using the preferred codon usage catalog for E.coli (Grantham et al., 1981). 
The y-32P-labelled oligonucleotides D27-1 and D27-2 (containing sequences that are 
complementary to those predicted to encode amino acid residues 1 to 6 and 14 to 20 of the 
27 Kd DHPR respectively) did not hybridize with any bands on the nitrocellulose filter 
which contained fragments of plasmids pWA 266 and pWA 406 obtained by separate 
digestion with several restriction endonucleases. This result indicates that the increased 
DHPR specific activity in the cell free extracts of strains bearing plasmids pWA 266 and 
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Figure 5.7 Comparison of restriction map of p WA 406 (3) with the physical map of E. coli chromosome around 
the 55 min region. 
The physical map of the entire E.coli genome was obtained using Bam HI (a), Hind III (b), Eco RI (c), Eco RV (d), Bgl I(e), Kpn I 
(f), Pst I (g) and Pvu II (h) by Kohara et al. (1987). The map around the 55-min region which contains the -13-kb Eco RI fragment 
in plasmid pGS 1 (Stauffer et al., 1981) is shown in the figure. The position of glyA is also indicated. By comparison, in the 
restriction map of pWA 406, the - 10-kb insert DNA of the plasmid may not be contiguous in the chromosome [as indicated by the 
break in (3)]. 
'E' is Eco RI; P is Pvu II; filill is the mnemonic for guanine and me is the mnemonic for RN Aase. 
1 
gua 
(53·9) y 
' ' 
I ,.... 
2650 ' ' 
' 2700 ' 
rnc 
(55·4) y 
___ __... _____ ....__ _________ ....__
 ______ --.... _ _......L.L.. ______ a 
-------.....-------.---..---------..------.,,.-------.----.,IJ.----'---1..__...1 b 
. . .. 5 
--------~-----..-- 1 
n I tr I r• "t 1 1 f 1 1 1 r I Sh:, 1 1 A I j 1 • 1; 1 ii j .. : r. 
~x4 
---~ 2 
E 
t 
p 
f 
p p E p 
j I I i .. .. 
~A p p E p 
} ~ i f . I I 
3 
l 
Figure 5.8 The sequences of the synthetic mixed oligonucleotides predicted 
from the N-terminal amino acid sequence of E. coli DHPR (D27-1) 
and D27-2; compare with Table 3.3) and 45-kD protein (D45-1; 
compare with Figure 5.3) (N = G, A, T and C). 
027-1 
5'- ATG GAC ATC ATC TGC GT -3' 
T T T T T 
A A 
D27-2 
5'- TTT CAT NGC ATC AAA NGC TTT -3' 
G G 
D45-1 
5 ~ - GC AAT AGT CTG NGC ATC CAG CAT - 3 ' 
G G T G 
p WA 406 may be due to another protein that is capable of oxidizing NADH in a 
quinonoid dihydropterin-dependent reaction or that the 5' region of the gene that codes for 
E.coli DHPR may be missing in the clones. 
The gene that codes for the 44-kD polypeptide was localised in a 3.2-kb Pvu II 
fragment by hybridization with y32_p labelled mixed oligonucleotides that were 
complementary to the 5' region of the gene as predicted from the protein data (see Figure 
5.9). The probe also hybridized with a 3.2-kb Pvu IT fragment of chromosomal DNA 
from E.coli strain ND82 that was completely digested with the restriction endonuclease 
(see Figure 5.10). This implies that the Pvu IT fragment containing the gene for the 44-
kD polypeptide is most probably a contiguous DNA fragment found in the chromosome. 
The 3.2-kb Pvu IT fragment (-2 µg) was isolated after pWA 406 (-10 µg) had been 
digested completely with the restriction endonuclease Pvu IT. This fragment was in turn 
digested completely with the restriction endonuclease Sau 3A and ligated with the 
sequencing vector M13 mp18 (100 ng; Viera and Messing, 1982) digested with Barn HI. 
The E. coli strain JM 101 was transformed with the ligation mixture and 48 clear plaques 
were selected to identify a M13 clone bearing the 5' region of the gene encoding the 44-
kD protein by dot blot hybridization with y32_p labelled mixed oligonucleotide D44-1. 
One of the Ml 3 clones containing the Sau 3A-generated fragment hybridized with the 
probe. Also the 3.2-kb Pvu IT fragment and on M13 clone containing the fragment also 
hybridized with the radiolabelled oligonucleotide (see Figure 5.11). The size of the insert 
in the ss DNA prepared from the M13 clone containg the Sau 3A fragment could not be 
estimated by comparison with the ss DNA from the M13 vector on 0.6% agarose gel (data 
not shown). It was felt that the small insert in the M13 clone should be sequenced to 
confirm that the gene encoding the 44-kD protein is responsible for the hybridization 
signal with the mixed oligonucleotide probe. The complete sequence of the insert which 
is 163 base pairs long was obtained by the M13 dideoxy sequencing (Sanger et al.,1977) 
using 35s detection (see Figure 5.12). 
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Figure 5.9 Southern blot hybridization of plasmid DNA. 
(a) A DNA digested with Eco RI and Hind III; (b) Plasmid pWA 406 digested with 
Pvu II; (c) ,.., 10-kb Bam HI fragment from plasmid pWA 406, digested with Pvu II; 
and (d) ,.., 8-kb Eco RI fragment from plasmid pWA 406 digested with Sal I. The 
samples were separated on a 0.7% (w/v) agarose gel and transferred onto a 
nitrocellulose filter by Southern blotting, as described in Section 5.4.5. The DNA was 
baked on the filter and hybridized to 5'-labelled mixed oligonucleotide probe D45-1. 
The autoradiograph shows the,.., 3.2-kb Pvu II fragment hybridized strongly with the 
labelled probe (in lanes 'b' and 'c'). In 'd' an ,.., 5.5-kb Sal I fragment also hybridized 
with the probe because it contained most of the 3.2-kb Pvu II fragment (compare with 
the restriction map of p WA 406 in Figure 5.6). The,.., 8-kb Eco RI fragment was not 
digested completely with Sal I, hence the large fragment also hybridized with the probe. 
Figure 5.10 Southern blot hybridization of chromosomal DNA from strain 
ND 82 digested with a variety of restriction endonucleases. 
The chromosomal DNA from strain ND 82 was digested completely with Bam HI (b ), 
Eco RI (c), Hind III (d), Pvu II (e) or Sal I (f), and electrophoresed on a 0.7% agarose 
gel followed by Southern blot transfer onto a nitrocellulose filter. The DNA was baked 1 
on the filter and hybridized with the labelled mixed oligonucleotide D45-1. The 
autoradiograph indicated that the,.., 3.2-kb Pvu II fragment hybridized with the probe 
DNA. 
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Figure 5.11 Screening for Ml3 clones containing the 5'-region of the gene that encodes the 45-KD protein. 
The 3.2-kb Pvu II fragment (-2 µg) from plasmid pWA 406 was isolated as described in Section 5.4.2 and digested completely 
with Sau 3A. The fragments were cloned into M13mp18 cut with Bam m and transformed into a suitable strain (JM101). 48 
clear plaques (Ml3 clone #01-48) were selected and analysed by dot blot hybridization with the labelled mixed oligonucleotides 
D45-1. The autoradiograph indicated that one M13 clone [#13( * )] hybridized strongly with the probe. The probe also 
hybridized with a M13 clone containing a 3.2-kb Pvu IT fragment (A2,**) and the denatured 3.2-kb Pvu IT (B2, ***) fragment 
that was included as a positive control. 
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Figure 5.12 Dideoxy nucleotide sequencing of M13 clone # 13. 
The preparation of template DNA and the sequencing using 35S detection was 
carried as described in Section 5.4. 7. The figure shows the complete sequence 
of the non-coding strand of the 163-bp fragment derived from plasmid pWA406. 
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The nucleotide sequence 5'-GCGATTGGTT ....... on the non-coding strand 
starting from position ,..., 154 is identical at 22 out of the 23 bases with one of the species 
of the mixed oligonucleotide D44-1, (5'-GCRATRGTRTGNGCRTCCAGCAT). The 
sequence of the 163 bases are likely, therefore, to be from the non-coding strand of the 
gene that encodes the 44-kD protein. The information was used to predict the amino acid 
sequence of the N-terminal region. Except for the lysine residue at position 18 of the 
preliminary N-terminal amino acid sequence (of thie first 20 amino acid resisues) obtained 
for the 44-kD protein (in this study), it was identical with the corresponding region of the 
amino acid sequence predicted from the DNA sequence (N-terminal 52 residues). This 
confirmed that the DNA sequence obtained is the 5' region of the gene that codes for the 
44-kD protein that was being investigated. 
The predicted N-terminal 52 amino acid residues of the 44-kD protein showed 
extensive homology with the sequence of the Vitreosscilla haemoglobin (Wakabayashi et 
al., 1986). The sequences are identical in 23 positions (43%) and conservative 
substitutions occur at 8 of the remaining positions (15%; see Figure 5.13). The complete 
primary structure of haemoglobins from several species is known and the comparison of 
these sequences indicate that only two residues are common to all. One is the histidine 
(helix position F8) that forms a covalent link v,ith the haem iron and the other is a 
pheny !alanine that occurs in position 1 of the loop made by helices C and D which is 
responsible for wedging the haem molecule into its pocket. Most haemoglobins also 
contain a histidine that is distal to the haem (helix position E7), which can form a 
hydrogen bond with the bound oxygen. In Vitreoscilla haemoglobin, a glutamine residue 
occurs in the place of histidine at this position. However it is suggested that the amino 
group of glutamine could form the hydrogen bor d with the bound oxygen in the same 
way as the imidazole from histidine (Perutz, 1 q86; Perutz et al. , 1965; Phillips and 
Shoenborn, 1981). 
The phenylalanine residue at position 33 of the available sequence for the 44 kD 
protein occurs in the same position in Vitreoscilla haemoglobin. The sequence alignment 
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Figure 5.13 · The predicted sequence of the N-terminal region of the 45-KD protein designated as HMP 
(haemoprotein) is compared with the corresponding region of Vitreoscilla haemoglobin. 
The shaded box indicates the matched residues and the clear box shows the residues that are conservative 
substitutions. Phenylalanine at position 31 (*) is conserved in all haemoglobins ( compare with Figure 5.14). 
1 11 2 1 
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Figure 5.14 Comparison of the N-terminal 52 amino acid residues of the 
45-KD haemoprotein with other haemoglobins. 
Human haemoglobin chains (HHba and HHbP ), Sperm whale 
myoglobin (SWMb), Glycera ha.emoglobin (GHb), Lupin 
leghaemoglobin (LLb), Vitreoscilla haemoglobin (VHb) and the 
45-KD haemoprotein (Hmp) from this study. All the sequences, except 
for that of Hmp, were alligned by Wakabayashi et al. (1986). 
HAEMOGLOBIN 
Residue Helix 
no. ( R l posn ( H ) HHba HHb/3 SWM b GHb LLb YHb Hmp 
1 V G 
2 NAl V H V G A 
3 NA2 L L L L L 
4 Al s T s s T 
5 A2 p p E A E 
6 A3 A E G A s 
7 A4 D E E Q Q 
8 A5 K K w R A 
9 A6 T s Q Q A M M 
10 A7 N A L V L L L 
11 A8 V V V I V D D 
12 A9 K T L A K Q A 
13 AlO A A H A s Q Q 
14 All A L V T s T T 
15 Al2 w w V,.,' w w I I 
16 Al3 G G A K E N A 
17 Al4 K K K D E I T 
18 Al5 V V V I F I V 
19 Al6 G E A N K K 
20 ABl A A G A A A 
21 N 
22 D 
23 Bl H N D N N T T 
24 82 A V V G I V I 
25 83 G D A A p p p 
26 84 E E G G K 
27 85 y V H V H 
28 86 G G G G T 
29 87 A G Q K H V L 
30 88 E E D D R L L 
31 89 A A I C F K V 
32 BIO L L L L F E E 
33 811 E G I I I H T 
34 812 R R R K L G G 
35 813 M L L H V V p 
36 814 F L F L L T K 
37 815 L V K s E I L 
38 816 s V s A I T T 
39 Cl F y H H A T A 
40 C2 p p p p p T N 
41 C3 T w E E A F F 
42 C4 T T T M A y y 
43 cs K Q L A K K D 
44 C6 T .R E A D N R 
45 C7 y F K V L L M 
. 
46 CDl F F F F F F F 
47 CO2 p E D G s A T 
48 CD3 H s R K H 
49 CD4 F F F F F H N 
50 CDS G K s L p p 
Sl CD6 D D H G K E E 
52 CD7 L L L G V L 
53 CD8 s s K R K 
54 01 T T T 
55 02 p E s p E 
56 03 D A A E L I 
57 D4 A E s V F F 
58 05 V M p D N 
59 D6 H M K Q M M 
6Q 07 G G A N G s 
61 El s N s D N R N 
62 E2 A p E p p Q Q 
6J E3 Q K D A E E R 
64 E4 V V L V L s Q 
65 E5 K K K A Q L G 
66 E6 G A V D A E D 
"' 67 E7 H H H L H Q 
68 E8 G G G G A p 
69 E9 K K V A G K 
70 EIO K K T K K A 
71 E 11 V V V V V L 
72 E12 A L L L F A 
73 El3 D G T A K M 
74 El4 A A A E L T 
75 EIS L F L I V V 
76 E16 T s G G y L 
77 E17 N D A V E A 
78 El8 A G I A A A 
79 E19 V L L V A A 
80 E20 A A K s I Q 
81 EFl H H K H Q N 
81 V L L L I 
8J E E 
of Vitreoscilla haemoglobin placed this phenylalanine residue at the position CDl (see 
Figure 5.14). Only further sequencing will tell if the remaining two crucial amino acid 
residues are also present in the 44-kD protein. 1'1ost known haemoglobin subunits are 
about 13-15 kD, thus the size of the 44-kD protein requires further explanation. 
At this stage further information was necessary to establish if the protein was 
naturally 44 kD or the suspected fusion product. I-fowever this doubt was dispelled when 
the 162-bases-long nucleotide sequence was cornpared with the European Molecular 
Biology gene data bank. The first 36 bases (see Figures 5.12 and 5.15), except for the T 
residue at position 3 which generates the Sau 3A recognition sequence were identical 
with the corresponding 5' sequence of an unknown geneX whose product was also 
reported to have a molecular weight of 44 000 (Plamann and Stauffer, 1983). This gene 
is situated adjacent to the glyA gene but is transcribed in the opposite direction (see Figure 
5.15). The in vitro transcription-translation of the plasmid pGS 1, which carries the E. 
coli glyA gene and other genes on a 13-kb Eco RI DNA fragment, as well as that of 
several other derivatives bearing smaller DNA fragments, directed the synthesis of two 
proteins with relative molecular weights of about 46 500 and 45 500 (Plamann and 
Stauffer, 1983). This is in agreement with the independent observation (made in this 
study) that the inserts in plasmids pWA266 and pWA 406 direct the synthesis of two 
polypeptides of similar molecular weight in the in vivo transcription-translation 
experiment using minicells (see Figure 4.10). Plarnann and Stauffer (1983) identified the 
protein that is coded by the glyA gene by inactivating the gene using the transposable 
element Tn5, and showed that the 46.5-kD protein was not being made in an in vitro 
transcription-translation system. The concoffitant loss of serine hydroxymethyl 
transferase activity confirmed that the larger of the two proteins detected in SDS-PA gels 
of the in vitro transcription-translation products was the glyA gene product. 
The nucleotide sequence of the transcription and translation control regions for 
glyA and geneX that codes for the 44-kD protein (Plamann and Stauffer, 1983; Figure 
5.15) clearly shows that the two genes are being transcribed in opposite directions. It is 
125 
Figure 5.15 The first 36 bp at the 5' end of the sequence obtained for the gene that encodes the 45-KD protein 
compared with the available sequence of gene 'X' 
The sequence of the control region of glyA and gene 'X' ( identified as haemoprotein gene in this study) was obtained by 
Plamann and Stauffer (1983). 
I-TAC TGT ACC GAT GGT TIC AC( CT( AAC CAT 
TAC. T<."T AGC GA T CCT nc AGC GT( AAG CAT 
ATG ACA TCC CTA CCA MC TCC CAC TIC GTA 
Val T~r Ala ll~ Tbr Gln Ala A•p lA-u tkt 
All:. A TC J 
ATCGTcncc rr 111 TI GCATCTIAATfGATGTATCTCAAATGCATCTTATMMAATAG(CCTGCAATGTMATGGTICmG<;TGm 
TACCAGAAGG~CGTAGMTTMCTACATAGAGTTTACGTAGAATATIIIIIAlCGCGACGTTA(.;ATTTACCAAGAAACCACAAA 
Shine-Oala•rno 
aequrnce 
aene X -22i. P,,bnow 
box 
-3~ Reaiun 
TTCAGAMGM TGTGA T GAAGTCAMAA mccA TCACAAAC(TGAAAA(~AAA TCCGITf CCGGTTGCAAGCT(TTT A TT(TCCAMGCCTTGCGT A(;(( lGAAGGT AA TCGmGCGT AAA TTCCTITGTC 
AACTcmcnACACTACTTCACTITTTAMCClAGTGTTT~GACITf&'(T"fTAUiCAMGGCCMCGTICGA~AMlMGA<;GTliCGCMCGCATCGGACTI"CCA'fTAGCMACGCAmMG<;AMCAC 
-)~ •~110• 
Pribnow 
boa •• &ly_A 
!jhinr-l>•IK•rno 
af!,IUf'IH r 
Mr\ l.f'u I.ya Ara& Glu t1rl A•p 
M'-AC(T~TIATCGCACMTGATTCGG'nATA(lGTICG(t:GTitlt:CMCAGGA(CGCCTArAAAGG((AMAATT1-fATTliTTAGCTGALllAli(iAliATGc<;c.; AHi TI'A MG C~T GM ATG AAC 
- - .. . - - -
TICTGGACAATAGCGTGTIACTMGCCMTATGACAAGCGGCMCAGGTIGTCClGGCGGAIAlTICCGGfl I rlAMAIMCAA'fCGA(TCAGTCCTlTACGCC TAC MT TIC GCA CTT TAC TIC 
interesting that in the in vitro transcription-translation studies carried out by Plamann and 
Stauffer (1983) and in the in vivo transcription-translation experiments carried out in this 
work, the major products detected by SDS-PAGE are the 44-kD and 45-kD proteins. 
This is despite the fact that the insert in the plasmid templates contains (based on its size) 
several other genes that code for other proteins. This suggests that their transcriptional 
regulators, such as the -35 region and the Pribnow box in the promoter region, are 
amongst some of the stronger promoters in E.coli. In this respect Plamann and Stauffer 
(1983) have indicated that the -35 region of geneX is homologous at five residues to the 
six residues that form the consensus -35 RNA polymerase recognition sequence -
TTGACA-. The Pribnow box sequence is also homologous at four residues compared 
with the six residues of the consensus sequence -TATAAT- (see Rosenberg and Court, 
1979, for discussion on regulatory sequences involved in the promotion of transcription). 
Both the -35 region and the Pribnow box are believed to be involved in the binding of the 
RNA polymerase. On the translation side, the sequence obtained by Plamann and 
Stauffer (1983) shows a putative ribosome binding site (Shine-Dalgarno sequence) that is 
4 bases ahead of the AUG start codon. This sequence is complementary at 6 residues to 
the 7 residues at the 5' end of 16S rRNA (AGGAGGU) involved in mRNA binding. In 
summary, the strong transcriptional and translational regulation sequences must account 
for the high level of synthesis of the 44-kD protein in the in vivo transcription-translation 
system. Preliminary results from the attempts to obtain high levels of expression of the 
44-kD protein by cloning the gene into a strong expression vector supports the above 
argument that the natural promoter of the the gene that codes for the 44-kD protein is 
efficient (N.E. Dixon and S.G. Vasudevan, unpublished results). The implication from 
the result so far is that the 44-kD protein is not a fusion product. The gene that codes for 
the 44 Kd protein is provisionally designated as hmp (for haemonrotein) and is located in 
the plasmid pWA 406 (see 5.16). 
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Figure 5.16 Restriction map of plasmid pWA 406 showing the positions of glyA and hmp genes. 
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5.2.4 Characterization of the 44-kD protein by absorption spectroscopy. 
The extensive homology of the N-terminal amino acid sequence of the 44-kD 
protein with Vitreoscilla haemoglobin (Wakabayashi et al., 1986) was investigated by 
visible absorption spectroscopy to show the presence of the haem group and determine its 
structure. Briefly, the characteristic features of visible absorption spectra of haem 
containing proteins are the a, P and y bands which are due to the metalloporphyrins. The 
a and p bands are the lower energy transitions and generally occur between 500 and 600 
nm. The y band, also known as the Soret peak, is an intense band that occurs around 380 
and 420 nm. These bands are thought to originate from 7t to 1t* electronic transitions of 
the metalloporphyrins (Gouterman, 1978). 
The room temperature difference spectra of the dithionite reduced minus oxidized 
cell free extract of WA 266 or AN1459 (kindly carried out by Professor R.K. Poole, 
Kings College London) are shown in Figure 5.17. The intensity of y band at 435 nm is 
about 16 to 20-fold more intense for the spectrum of the extract from WA 266 compared 
with the same band centred around 420 nm in the spectrum of the similarly prepared 
extract from AN1459. The enhanced intensity of they band in the soluble extract from 
WA 266 indicates that plasmid pWA 266 is directing the synthesis of a soluble haem 
containing protein. Assuming that no other haemoprotein is encoded by the plasmid, this 
is evidence that the 44-kD protein contains a haem group. The broad symmetrical y-band 
(at 435 nm) and the single broad band in the a-P region at 560 nm is indicative of "high-
spin" reduced b-type haem. These types of "high-spin" reduced b-type haems are 
characteristic of haem-containing proteins such as myoglobin (reviewed by Wood, 1984). 
The "high-spin" state refers to the ferrous ion in the haemoprotein, where four of the five 
3d orbitals in its valence shell contain one unpaired electron each (Cotton and Wilkinson, 
1980). The broad band at 560 nm has been assigned as the p band because there is a 
weak shoulder at 590 nm which is the a band. In this respect the the spectrum of WA 
266 closely resembles that of the soluble haemoprotein b -590 from E.coli (Poole et al. , 
1986). However the a-band is more distinct in haemoprotein b-590 and its subunit 
127 
Figure 5.17 Reduced (dithionite) minus oxidized (ammonium persulfate) difference absorption spectra of soluble 
extracts of WA 266 (a) and AN 1459 (b) recorded at room temperature. 
The ·spectrum of an oxidized sample was stored in a digital memory of a Johnson Foundation dual wavelength 
spectrophtometer, with 500 nm as reference, and was subtracted from subsequent spectral scans. The oxidized minus 
oxidized baseline was featureless (not shown). The protein concentration of (a) was 4 mg/ml and (b) was 3 mg/ml. The 
pathlength was 1 cm, the scan rate 2. 9 nm s-1 and spectral bandwidth was 4 nm. 
435 
' 
400 
/ I l>A 0.04 
""16 A 0.01 
450 500 550 
WA VELENG1l-l (nm) 
560 
~ I l>A 
/ 590 
~ 
600 
(a) 
0.01 
0.02 
(b) 
Figure 5.18 CO-reduced minus reduced difference absorption spectra of soluble extract of WA 266 recorded at 
room temperature. 
The spectrum of the reduced sample was stored in a digital memory of a Johnson Foundation dual wavelength 
spectrophtometer and used to generate a featureless baseline. The sample was bubbled with a thin stream of CO for 2 min and 
the difference spectrum was recorded. The protein concentration was 4 mg/ml. The pathlength was 1 cm, the scan rate 2.9 
nm s-1 and spectral bandwidth was 4 nm. 
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molecular weight as determined by SDS-PAGE is about 75 000 which is considerably 
larger than that of the 44-kD protein being investigated in this study. Therefore the 44-kD 
protein appears to be distinct from any previously characterised haem-containing protein 
in the cytoplasm of E.coli. 
The carbon monoxide-bound difference spectrum of the extract from WA 266 has 
a y-peak at 420 nm (see Figure 5.18). This is identical to the peak position observed in 
similsr spectra of haemoglobin from Vitreoscilla, which also contains b-type haem and is 
"high spin" in the reduced state (Georgiou and Webster, 1987). In c-type haems they-
peak is typically in the region of 411-418 nm (Wood, 1984). The bands that appeared as 
peaks and shoulders in the reduced minus oxidized spectrum of the extract from WA 266 
(see Figure 5.17) are observed as troughs in the CO+reduced minus reduced difference 
spectrum (see Figure 5.18). The bands at 570, 533 and 420 nm are the a, p and ypeaks 
respectively of the CO-bound complex. 
The haemoglobin from Vitreoscilla was previously believed to be a soluble 
cytochrome oxidase, the final enzyme in the aerobic respiratory chain (Webster and Liu, 
197 4 ). However the laser flash photolysis characteristics of this protein (Orii and 
Webster, 1986) and the strong homology of its primary sequence with lupin 
leghaemoglobin (Wakabayashi et al., 1986) indicated it to be more akin to haem-
containing proteins that are involved in oxygen storage or transport. Georgiou and 
Webster (1987) have recently isolated and identified a membrane-bound terminal oxidase 
from Vitreoscilla that has different spectral properties (for example the y peak of the CO-
bound spectrum is at 416 nm). In the case of E.coli, the major terminal oxidases are the 
b-type cytochrome o and cytochrome d. Both the terminal oxidases are membrane-
bound (reviewed by Ingledew and Poole, 1984). 
The absorption spectra (shown in Figures 5.17 and 5.18) indicate that the haem 
type in the 44-kD protein is similar to that in the haemoglobin from Vitreoscilla and 
distinct from the terminal oxidases that occur in E.coli. However, this does not imply that 
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they carry out the same function. An in vivo function for the Vitreoscilla haemoglobin is 
still in the area of speculation but a recent report suggested that the heterologous 
expression of Vitreoscilla haemoglobin gene improves the growth properties of 
recombinant E. coli (Khosla and Bailey, 1988)! The authors found that E. coli strain 
JM101 containing the plasmid vector pUC9 showed lower cell yield than one that 
contained a plasmid pRED2 which expressed Vitreoscilla haemoglobin. 
With the view of investigating whether the expression of the gene encoding the 
44-kD haemoprotein from this study has any effect on cell yield, the strains DM7111, 
WA 266 and WA 101 were grown under aerobic and anaerobic conditions (by bubbling a 
constant stream of nitrogen) in rich medium. Strain DM7111 is the background for WA 
266 and WA 101 which contain plasmids pWA 101 and pWA 266. The rationale for 
using WA 101 was that the gene encoding the 44-kD haemoprotein is not present in 
plasmid p WA 101. Both plasmids p WA 101 and p WA 266 contain about 35-45 kb of 
insert DNA (cloned into BamHI site of cosmid vector pHC79). The growth yields (as 
judged by wet weight) of DM7111, WA 101 and WA 266 were similar for aerobically 
grown cells. In the oxygen depleted cultures, the wet weight of cells were also similar for 
the three strains (data not shown). Khosla and Bailey (1988) showed that the cell yield 
when Vitreoscilla haemoglobin was expressed in E. coli was twice that of E. coli strain 
containing plasmid vector pUC9. However, the preliminary results in this study indicate 
that overproduction of the 44-kD haemoprotein does not result in an increase in cell yield, 
in spite of the facts that it contains a similar haem type, and shows extensive N-terminal 
homology with the Vitreoscilla haemoglobin (Wakabayashi et al., 1986). 
Lamba and Webster (1980) showed that under optimal growth conditions the 
haem content in Vitreoscilla can be increased. When the oxygen concentration in the 
growth medium was below 10% of atmospheric, an increase in Vitreoscilla haemoglobin 
level was observed (Wakabayashi et al., 1986). Whole cells of he strains DM7111 and 
WA266 that were grown under aerobic and anaerobic conditions were compared by 
absorption spectroscopy to see if the levels of the 44-kD haemoprotein were enhanced in 
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the anaerobically grown cells. The reduced minus oxidized whole cell spectra of DM7111 
and WA 266 grown aerobically and anaerobically (spectra were kindly obtained by 
Professor Robert Poole whilst on study leave in Canberra) are compared in Figures 5.19 
and 5.20. Since the whole cell spectrum is complex and includes all the cytochromes and 
haemoproteins in E. coli, this discussion will be limited to the two main spectral features 
due to the 44-kD haemoprotein, which are they-peak around 434 nm and the broad~ 
peak centred around 560 nm. 
In the spectra of DM7111, the anaerobically grown cells show a prominent 
shoulder at about 434 nm in y band compared with the aerobically grown cells (see Figure 
5.19). This shoulder, however, has contributions from cytochrome b595 and 
haemoprotein b590 (Poole et al., 1986). There is no clear evidence of broadening of the 
base of the peak around 560 nm that can be assigned to the ~ band due to the 44-kD 
haemoprotein. Hence anaerobic growth of DM7111 does not show any spectroscopically 
observable increase in the levels of this new haemoprotein. Spectra of WA 266 cells have 
a shoulder around 434 nm and a broad ~ band which is centred around 560 nm for both 
the aerobically and anaerobically grown cells (see Figure 5.20). There is a trough around 
578 nm which may be accentuated due to the increased levels of the 44-kD haemoprotein 
which overlaps the b-595 component of the cytochrome bd complex (R. K. Poole, 
personal communication). This trough is not present in the spectra of DM7111. 
If the function of the 44-kD haemoprotein discovered in this study is similar to that 
of the Vitreoscilla haemoglobin, then one would expect to see some of its spectral features 
in wild type E. coli grown under anaerobic conditions. DM7111 showed no indications 
of its presence. In WA 266 the 44-kD protein was synthesized under aerobic and 
anaerobic conditions but there is no indication of higher levels of the protein in the 
anaerobically grown cells. It is clear that further spectral characterizations must be carried 
out before a specific function can be assigned to the 44-kD haemoprotein. The complete 
DNA sequence of the gene will permit comparison with the Vitreoscilla haemoglobin and 
determine if the position of the distal histidine and proximal histidine or glutamine are 
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Figure 5.19 Reduced rr,,inus oxidized difference absorption spectra of whole cells of strain DM 7111 grown under 
aerobic (A) and anaerobic conditions, recorded at 77K. 
The spectra was measured using a Aminco dualwavelength spectrophotometer. The protein concentration was 13 mg/ml in 
(A) and 7.5 mg/ml in (B) [determined by the method of Markwell et al. (1978)]. 
434 
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Figure 5.20 Reduced minus oxidized difference absorption spectra of whole cells of strain WA 266 grown under 
aerobic (A) and anaerobic conditions, recorded at 77K. 
The spectra was measured using a Aminco dualwavelength spectrophotometer. The protein concentration was 9 mg/ml in 
(A) and 7.5 mg/ml in (B) [determined by the method of Markwell et al. (1978)]. The characteristic broad peak centred 
around 560 nm observed in the extract prepared from WA 266, is present. 
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conserved at the same positions in the haemoprotein. It will also establish the point at 
which the two sequences diverge and may assist in accounting for the function of the C-
terminal region of the new haemoprotein. 
The sequence of the N-terminal 52 amino acid residues of the 44-kD haemoprotein 
was compared with the corresponding regions of the recently published sequence of 
subunits I and II of the membrane-bound cytochrome d terminal oxidase from E. coli 
(Green et al., 1988). Except for the first three residues which are Met-Leu-Asp in subunit 
I, there was no other homology. When the sequences of the two subunits of cytochrome 
d were compared with the Vitreoscilla haemoglobin, the phenylalanine residue (residue 33 
in Vitreoscilla haemoglobin and the 44-kD haemoprotein from this study) which is 
conserved in all haemoglobins was not present (the sequence comparisons are not 
shown). These data suggest that the 44-kD haemoprotein from E. coli is more like the 
haemoglobins than the cytochromes. 
5.2.5 Is the increased DHPR specific actr.vity in WA 266 due to the 
44-kD haemoprotein? 
It is clear that the increased DHPR specific activity in the cosmid clone WA 266 is 
not due to the 27-kD E.coli DHPR that was purified and characterised in this study. The 
27-kD reductase was not synthesized under the direction of plasmid p WA 266 as 
evidence by the in vivo minicell expression experiment (Chapter 4). Moreover, 
polyclonal antibodies raised in this work against E. coli DHPR did not inhibit the 
increased DHPR specific activity in the extract prepared from WA 266 as strongly as the 
enzyme activity observed in the extract prepared from DM 7111. Comparison of the two 
extracts by Wes tern blot detection did not show c\ny strong antigenic signal around the 
44-kD region above the background levels (data not shown). 
However, it is known that the glyA g,~ne product senne hydroxymethyl 
transferase (which catalyses the interconversion of serine and glycine) requires 5, 10-
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Figure 5.21 Western blot analysis of protein sample from WA 266 
The 45 - 60% ammonium sulfate saturation fraction (in track a and b) was 
electrophoresed in a SDS-PA gel (12%w/v) and transferred onto a 
nitrocellulose filter as described in Section 3.4.16. The nitrocellulose filter 
was sent to Mr Ian Jennings(The Murdoch Institute), who carried out the 
probing with the antibodies. 
(a) was probed with pre-immune serum. 
(b) was probed with the anti-idiotype antibody NS-6. The protein 
band identified as SHMT and HMP were of molecular weights of about 
47 000 and 45 000 (respectively) as judged by molecular weight 
markers that were run concurrently (not shown). 
a b 
~SHMT 
~HMP 
methylentetrahydrofolate for its function (Scrimgeour and Huennekens, 1962; Mudd and 
Cantoni, 1964). This indicates that serine hydroxymethyl transferase must also have a 
pterin binding site. It was felt that the presence of serine hydroxymethyl transferase 
would serve as good internal control to investigate if the 44-kD haemoprotein possessed a 
pterin-binding site by using the anti-idiotype antibody (pterin analogue). Some 
preliminary evidence from Western blot detection using anti-idiotype antibody NS-6 
suggests that both serine hydroxymethyl transferase and the 44-kD haemoprotein which 
are present in high levels in extracts prepared from WA 266 contain pterin binding sites. 
The Western blot (kindly carried out by Mr. Ian Jennings, The Murdoch Institute, Royal 
Melbourne Children's Hospital) was carried out on the 45-60% ammonium sulfate 
saturation fraction of the extract from WA 266 (see ·Figure 5.21). Other proteins were 
recognised as well and this may have been due to non-specific interactions of the anti-
idiotype antibody with proteins that bind substrates that bear some similarity with the 
pterin nucleus, e.g. flavin and other purine-derived molecules. Attempts to visualise the 
increased DHPR specific activity in the extracts of WA 266 by activity staining of non-
denaturing polyacrylamide gels were unsuccessful because of high background caused by 
the presence of NADH oxidases. 
5.3 SUMMARY 
Partial purification of the proteins from the cell-free extract of WA 266 was 
achieved by monitoring the residual DHPR enzyme activity and the yellow colour. Two 
proteins of molecular weights around 47 000 and 45 000 were present after the final 
purification through a chromatofocusing column. N -terminal amino acid 
microsequencing identified the slower moving band on a SDS-PA gel as serine 
hydroxymethyl transferase, the glyA gene product (Plamann et al., 1982). The faster 
moving band on the other hand is a new protein discovered in this work and its N-
terminal amino acid sequence (52 residues) shows significant homology with the 
haemoglobin from the filamentous myxobacterium Vitreoscilla. 
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The presence of the glyA gene in plasmid pWA 406 was confirmed by restriction 
endonuclease mapping. Also, the plasmids p WA 266 and p WA 406 were able to 
complement the glyA mutation in E. coli strain GS 245. The 16 to 20-fold enhancement 
of the characteristic Soret band in the cell-free extract prepared from WA 266 and the 
nucleotide sequence of a 163-bp fragment derived from plasmid pWA 406 is evidence 
that the gene that encodes the 44-kD haemoprotein is also present in the plasmids pWA 
266 and p WA 406. Except for the substitution by a T residue for the C residue 4 bp 
upstream from the A TG start codon, the nucleotide sequence of the first 36 bp of the gene 
that encodes the 44-kD haemoprotein matched all the reported sequence of an unknown 
geneX which is transcribed in the opposite direction to glyA and present immediately 
adjacent to it (Plamann and Stauffer, 1983). The N-terminal 52 amino acid residues 
predicted from the nucleotide sequence show strong homology with the Vitreoscilla 
haemoglobin (Wakabayashi et al., 1986). The phenylalanine residue at position 33 in the 
44-kD haemoprotein is conserved in all haemoglobins. The absorption spectra of the 
protein indicated that it contains ab-type haem which is "high spin" in the reduced state 
similar to the Vitreoscilla Hb and myoglobins (Wood, 1983). This protein is probably 
not the haemoprotein b-590 isolated from the cell free extract of E. coli (Poole et al., 
1986) due to the fact that their molecular weights are different and also because the a-
peak in the reduced spectrum of the 44-kD protein is less prominent than that of the 
former protein. The 44-kD protein is provisionally designated E.coli haemoprotein. 
An anti-idiotype antibody which mimics the pterin nucleus appears to recognises 
both serine hydroxymethyl transferase and the haemoprotein identified in this study. 
Further work is required to ascertain if either of these two proteins is responsible for the 
increased DHPR specific activity in the extracts prepared from WA 266. 
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5. 4 EXPERIMENT AL METHODS 
5. 4 .1 Partial purification of protein from WA 266 extract. 
The ammonium sulfate fractionation, DEAE-Fractogel or Mono-Q anion-exchange 
chromatography, and the Mono-P chromatofocusing, were carried out essentially as 
described in Section 2.6, except that for the chromatofocusing step, the start buffer was 
25 mM Bis-tris/Iminodiacetic acid (pH 7.1) and the eluent buffer was 10% Polybuffer 
TM 74/Iminodiacetic acid (pH 4.1). 
5.4.2 Isolation of DNA fragments from agarose gel. 
When fragments of DNA were required, either for sub-cloning DNA sequencing 
or for confirming the presence of restriction sites contained within, they were isolated 
from agarose gels. The DNA that has been digested with the appropriate restriction 
endonuclease was mixed in the sample loading buffer (see Section 4.5.4) and applied to 
slots (20 mm wide, 6 mm deep) in a 0.7% agarose gel. The gel and the running buffer 
contained ethidium bromide (0.5 µg/ml) to allow visualization of bands under long-range 
u.v. light during electrophoresis. When the fragment of interest was sufficiently 
separated from others, a scalpel was used to make a cut ahead of the band or the area 
around the band was cut out completely and inserted in another area of the gel. A strip of 
NA45 paper (DEAE membrane; Schleicher and Schuell D-3354, Dassel, W. Germany) 
was placed in the slit ahead of the band and electrophoresis was continued. Long range 
u.v. light was used to monitor the migration of the DNA fragment onto the NA45 paper. 
The paper which retained all the DNA was removed from gel, rinsed with TE buffer and 
placed in a 1.5 ml microfuge tube containing 0.45 ml of NaCl (1 M) and arginine 
(50 mM). The paper was completely immersed in the buffer and the tube was placed in a 
heating block at 100c for 1 h. The NaCl dissociates the DNA bound to the NA45 paper 
and the arginine competes for the negative charge on the paper thereby displacing the 
DNA into the solution. The paper was removed and 0.9 ml of ethanol was added to the 
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tube. The DNA was precipitated by leaving the tube at -700C (3-15 hrs) and later 
centrifuging it in an microfuge for 10 min to pellet the precipitated DNA. The pellet was 
rinsed with cold 70% (v/v) ethanol by centrifugation and dried at a water vacuum pump 
for 10 min. The DNA was resuspended in TE buffer and stored at -2ooc until required. 
5.4.3 Preparation of synthetic oligonucleotides. 
The synthetic oligodeoxyribonucleotides used in this study were prepared using an 
Applied Biosystems 380B DNA synthesizer (by Mr Garry Mayo, Medical Molecular 
Biology Group, JCSMR). The synthetic oligonucleotides were deblocked by treating 
with 2 ml of ammonium hydroxide for 6 hat room temperature followed by heating at 
650C overnight. When required for probing DNA fragments, one drop of the 
oligonucleotide mixture ( ...... 30-50 µl) was placed on a clean watchglass and allowed to 
evaporate to dryness. The residue was dissolved in a total of 60 µl of 80% acetic acid and 
allowed to stand at room temperature for 30 min. Diethyl ether (1 ml) was added to the 
tube, which was allowed to stand for a further 30 min before the white precipitate was 
collected by centrifugation in a microfuge for 10 min. The precipitate was dried in air and 
dissolved in water ( 1 ml). The absorbance at 260 nm was used to quantify the 
oligonucleotide (1 OD ...... 20 µg), and the solution was diluted appropriately to give a stock 
concentration of about 50 ng/µl. 
5.4.4 End-labelling of oligonucleotide with [y.32p]ATP. 
The oligonucleotide mixture (500 ng) was made up to 15 µl with the 
phosphorylation buffer (66 mM Tris-HCl pH 7.8, 10 mM MgCl2 and 10 mM P-
mercaptoethanol). To this was added 4 µl of [y-32P]ATP (1.4 Mbq; 370 Mbq/ml; 2000 
Ci/mmol) and 1 µl of phage T4 polynucleotide kinase ( ...... 20 units). The reaction mixture 
was incubated at 370c for 1 h and the reaction was terminated by adding 7 µl of 
formamide loading buffer (80% (v/v) formamide, 50 mM Tris-borate pH 8.3, 1 mM 
EDTA, 0.1 % (w/v) xylene cyanol, 0.1 % (w/v) bromophenol blue). 
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The labelled oligonucleotide was separated from unincorporated [y-32p]ATP and 
smaller oligonucleotide (In the synthesis of oligonucleotide mixture, up to 5 percent of the 
oligonucleotides were smaller than the required length) by electrophoresis through a 16% 
(w/v) acrylamide gel using the sequencing gel plates (40 cm long by 18 cm wide) with 
0.8 mm thick spacers and a comb that formed wells that were 1.5 cm deep and 1.5 cm 
wide. The 16% (w/v) acrylamide gel was made by mixing 40 ml of the 20% acrylamide 
stock for DNA sequencing with 10 ml of stock urea mix (see later). To this mixture was 
added 0.8 ml of 10% (w/v) ammonium persulfate and 75 µl TEMED. After mixing well, 
the mixture was poured between two sequencing gel plates (that were sealed by taping 
three sides) held at about 300 inclination. The comb was inserted and the gel was allowed 
to polymerize (-1 h). The bottom tape was then removed and the gel was subjected to 
pre-electrophoresis for 2 hat 1500 volts, using TBE as running buffer. The comb was 
removed from the gel and the wells were thoroughly flushed with TBE. The 
oligonucleotide mixture containing the formamide dye loading buffer was heated at 90°C 
for 3 min and loaded in the well using a drawn-out pipette tip. The mixture was 
electrophoresed through the gel at a constant voltage of 1500 volts for 3-4 h. 
After the electrophoresis, one of the glass plates was removed carefully. The plate 
retaining the gel was covered with Saran wrap, and the position of the oligonucleotide 
within the gel was visualised by exposing the gel to a Kodak XAR-5 film for 2 min and 
marking the orientation of the gel on film. The film was developed using a Kodak M20 
X-Omat processor. The developed film was used as a guide to position the 
oligonucleotide within the gel. (The oligonucleotide of interest was usually the slowest 
moving DNA band, which gave very high counts, indicating maximum incorporation of 
label). The gel was cut out carefully and sliced into smaller pieces in a 1.5 ml Eppendorf 
tube, after which 1 ml TE was added. The tube was briefly vortexed and incubated at 
65°C for 3-6 h to allow the oligonucleotides to leach out into the TE buffer, which was 
removed by using a 1 ml Pipetman tip. The labelled mixed oligonucleotides were used 
for hybridizations. 
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5.4.5 Southern blot transfer of DNA 
The Southern blot transfer of DNA was carried out essentially as described by 
Southern (1975). The electrophoresis of the appropriate restriction endonuclease-digested 
DNA was carried out on agarose minigels (8 cm long and 4 cm wide) using TBE 
containing 0.5 µI/ml ethidium bromide as running buffer, until the blue dye marker 
reached the anodic end. The gel was photographed before the sides of the gel and the 
region around the wells were trimmed using a scalpel so that the gel face was flat. The 
gel was then placed in a tray containing 200 ml of 0.25 M HCl to allow depurination (this 
step is only necessary when transferring large fragments of DNA,>10 kb). As soon as 
the blue dye in the gel turned greenish yellow ( -5 min), the gel was rinsed with water and 
immersed in a dish containing the denaturation buffer (0.5 M NaOH,.1 M NaCl) for 30-
40 min. After a brief rinse in water the gel was immersed in 200 ml of neutralization 
buffer (1 M Tris-HCl pH 8.0, 0.6 M NaCl) for 30 min (this step was repeated). 
A 5 mm thick glass plate 10 cm by 5 cm was wrapped with Whatman 3 MM paper 
and placed in a tray. The transfer buffer (20 x SSC; 3 M NaCl, 0.3 M sodium citrate) 
was poured into the tray so that it was about 4 mm deep, thus wetting the glass mount 
wrapped with Whatman 3 MM paper by capillary action (it is important not to submerge 
the paper in the buffer). The gel that had been treated as above was placed on the wet 
Whatman 3 MM paper and smoothed out by rolling over the gel with a clean test tube to 
remove bubbles trapped between the gel and the 3 MM paper. The nitrocellulose 
membrane cut to the size of the gel (floated in 2 X SSC until the upper surface became 
uniformly wet; - 30 min) was placed on the gel surface and bubbles were smoothed out as 
before. Three sheets of Whatman 3 MM paper wet with 2 x SSC were placed 
individually over the nitrocellulose membrane. Adsorbent towels that were cut to the 
same size as the gel were stacked (5-8 cm thick) on top of 3 MM paper and a 1 kg weight 
was placed on top of these. The whole set was covered with Saran wrap and the transfer 
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of DNA fragments onto the nitrocellulose membrane was allowed to take place at room 
temperature overnight . 
The weight, towels and 3 MM paper were removed and the nitrocellulose 
membrane was placed between two sheets of dry 3 MM paper and baked at 80°C for 2 h 
in a vacuum oven. The compressed gel was routinely reswollen by soaking in 1 x TBE 
containing 0.5 µg/ml ethidium bromide and photographed in order to assess the efficiency 
of DNA transfer by comparison with a photograph of the preblotted gel. If not used 
directly, the nitrocellulose membrane was stored in a vacuum desiccator in a cool place. 
5.4.6 Hybridization of Southern and dot blot filters 
The hybridization procedure was carried out essentially as described by Maniatis et 
al. (1982). After baking, the nitrocellulose filter was floated on the surface of 6 x SSC 
until it was wet from beneath. It was then completely immersed in the solution for 2 min 
and transferred to a plastic dish (with lid) containing 30 ml of prehybridization fluid (6 x 
SSC, 0.5% SDS, 5 x Denhardt's solution and 100 µg/ml of denatured salmon sperm 
DNA; see below for contents of these solutions). The size of the dish was such that its 
base was completely covered by the 30 ml of prehybridization solution. The dish was 
covered and incubated in a water bath at 65°C (a weight was placed on the dish to keep in 
place) for 3-4 h with gentle agitation. The nitrocellulose filter was then transferred into 30 
ml of hybridization solution (6 x SSC, 0.01 M EDTA, [y-32p]-labelled mixed 
oligonucleotide probe, 5 x Denhardt's solution, 0.5% SDS and 100 µg/ml of denatured 
salmon sperm DNA) and incubated at 650C for 2-4 h in a water bath with gentle agitation. 
The temperature control of the bath was then adjusted so that the filter cooled to 37°C 
slowly to promote annealing. Hybridization was continued at 370c for 2 h (or 
overnight). 
The filter was transferred into a solution (100 ml) of 2 x SSC and 0.5% SDS at 
room temperature in a fresh tray. After 5 min the filter was transferred to another tray 
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containing a solution of 2 x SSC and 0.1 % SDS and incubated for 15 min at room 
temperature with gentle agitation. The filter was finally placed in a tray containing a 
solution of 0.2 x SSC and 0.5% SDS and incubated from 30 min to 2 h (as required) at 
370c with gentle agitation. A second change of the final wash step was carried out if the 
background radioactivity level was high. The filter was dried on a sheet of Whatman 3 
MM paper, wrapped with Saran Wrap and exposed to Kodak XAR-5 film in a Kodak X-
Omatic C-2 cassette with intensifying screen for 3-24 h, at -70°C. The film was 
processed using the Kodak M20 X-Omat processor. 
5.4.7 
Constitution of Denhardt's solution (50x) 
Ficoll 
polyviny lpyrrolidone 
BSA (Pentax Fraction V) 
water 
Dideoxy sequencing of DNA 
5g 
5g 
5g 
to 500 ml 
Nucleotide sequencing was carried out by the dideoxy chain-terminating method 
of Sanger et al. (1980), using [a-32p]-dA TP or [35s]-dA TP with a Dideoxy Sequencing 
Kit purchased from BRESA (Biotechnology Research Enterprises S.A. Pty. Ltd., 
G.P.O. Box 498, Adelaide 5001, South Australia). 
5.4.7.1 Composition of sequencing gels 
20% Acrylamide sock 
acrylamide 
methylene bisacrylamide 
urea 
5xTBE 
96.5 g 
3.35 g 
.233.5 g 
100ml 
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water to 500 ml 
Urea mix 
urea 233.5 g 
5xTBE 100ml 
water to 500ml 
The appropriate percentage sequencing gels were prepared by mixing the 
acrylamide stock and the urea mix. Routinely, 10% ammonium persulfate (0.4 ml) and 
TEMED (50 µl) were added to polymerize the gel. 
5.4.7.2 Inserting DNA into M13 bacteriophage replicative form 
The DNA fragments for sequencing were generated by the appropriate restriction 
endonuclease digestion and inserted into the complementary site in the poly linker region 
of the replicative form of bacteriophage M13 mp 18 or mp 19. The replicative forms of 
M13 mp 18 and M13 mp 19 are identical except that the polylinker region is reversed 
from one with respect to the other. When DNA fragments were generated with two 
different restriction endonucleases, insertion into M 13 mp 18 and mp 19 gave 
recombinant phage containing the fragment to be sequenced, in both orientations. This 
was useful so that both coding and non-coding strands of the DNA fragment could be 
readily sequenced. 
5.4.7.3 Transformation of E. coli strain JM101 with Ml3 phage 
replicative form 
E. coli strain JM101 was transformed with M13 phage replicative form ligated 
with fragments to be sequenced because the genetics of the strain allowed easy selection 
of recombinant phage. The host strain is normally maintained on minimal media so that 
the F episome it carries (which bears the lac pro region that has been deleted from its 
chromosome) will not be lost. The lac operon on the F episome contains two mutations 
which make it lac-. This strain was grown in minimal media (56 minimal medium 
containing 20 mM glucose, 1 mM MgS04 and 0.0001 % (w/v) thiamine (B 1)) and made 
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competent for transformation. The ligated M 13 phage replicative form was used to 
transform the competent cells (see Section 4.5). 
The transformation mixture (10-100 µl) was mixed with 3 ml of 0.7% (w/v) soft 
agar (-450C) containing 8 µl of 0.5 M IPTG (isopropylthiogalactoside), 40 µl of a 20 
mg/ml stock solution of X-gal (5-bromo-4-chloro-3-indolyl-~-D-galactoside) and 250 µl 
of a log phase culture of E.coli strain JM101. The soft agar was molten and by working 
rapidly, the mixture was poured onto LB plates and allowed to set. These were incubated 
at 370c overnight. 
The lac- host strain is complemented by Lacz' expressed by non-recombinant M13 
phage. In the presence of IPTG, infected cells make the ~-galactosidase enzyme which 
hydrolyses X-gal to free the chromogenic substance that renders the plaques blue. Host 
strains with recombinant Ml 3 phage however show colourless plaques because the 
insertion of DNA fragment into the poly linker region inactivates a factor that complements 
the lac mutation ( carried on the F episome) of the strain, i.e. these strains do not produce 
~-galactosidase. ~ 
5.4.7.4 Preparation of single stranded template DNA 
JM101 was grown overnight at 370c with shaking in the minimal medium 
described above. This overnight culture was diluted 1 in 50 into 2 x YT medium (1 % 
yeast extract, 1.6% tryptone, 0.5% NaCl) and 5 ml aliquots were dispensed into sterile 
screw-capped polypropylene tubes of 10 ml capacity. The clear plaques from Section 
5.4.7.3 were picked individually with a sterile Pasteur pipette and inoculated into these 
tubes. The tubes were placed in racks and incubated at 37°C in an air shaker for 4-6 h. 
The tubes were centrifuged at 6000 r.p.m. for 10 min at 4°C, using a SS34 rotor-
head with jackets (to hold tubes in position) in a Sorvall RC-5 centrifuge. The 
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supernatant ( 4 ml; the 1 ml close to the cell pellet was discarded) was mixed well with 0.8 
ml of 25% PEG 6000 (polyethyleneglycol) containing 2.5 M NaCl, in a Sorvall SE12 
tube and incubated at o0c for 1 h. The precipi:ated phage (viable at this stage) was 
pelleted by centrifugation (SE12 rotor, 15 000 r.~.m., 20 min, 40C). The phage pellet 
was suspended well in 550 µl of TE containing 0.5% sarkosyl and transferred into a 1.5 
ml microfuge tube. The tubes were centrifuged in a microfuge for 10 min and 0.5 ml of 
the supernatants were transferred into fresh microfuge tubes containing 0.1 ml of 25% 
PEG + 2 M NaCl. The tubes were mixed well and incubated in ice for 1 h before 
centrifugation for 10 min in a microfuge to pellet the phage. The supernatant was 
removed by aspiration with a drawn out pipette connected to a water pump. The tubes 
were centrifuged for a further 2 min to pack the pellet and any remaining supernatant was 
removed with a Pipetman tip (PEG can affect the quality of DNA sequence, so it must be 
removed as completely as possible). The pell~ts were suspended in 200 µl of TE 
containing 1 % SDS and extracted twice each with phenol, phenol-chloroform and 
chloroform. The single-stranded template DNA in the aqueous phase was precipitated 
with ethanol, suspended in 50 µl of TE and stored at -20°C until used as template for 
DNA sequencing. 
5.4.7.5 Annealing, polymerisation and gel-electrophoresis of 
sequencing reactions 
To 5 µl of single-stranded DNA (prepared as above) was added 1 µl of M13 
universal sequencing primer (2.5 ng/µl), 1 µl of i.O x annealing buffer (0.1 M Tris-Hcl, 
pH 8.0, 0.1 M MgCl2) and 2 µl of sterile water. The contents were mixed well in a 0.5-
ml capacity Eppendorf tube, placed in a beaker containing water at 7 5°C and allowed to 
cool to room temperature so that the annealing reaction could occur ( -30 min). The tubes 
were briefly centrifuged to bring down the condensation and 1 µl of labelled dA TP [ a-
32p or 35S] was added. A set of 'mastermix' tubes for each nucleotide reaction was made 
up depending on the number of templates being sequenced (using the protocol supplied 
with the BRESA DIDEOXY SEQUENCING KIT, BRESA, S. Australia). 2 µl of each 
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nucleotide mastennix were dispensed into the bottom of separate tubes marked G, A, T 
and C. 0.5 units of Klenow enzyme (large fragment of DNA polymerase I) was mixed 
with the annealed DNA and radionucleotide label mixture, and 2 µl aliquots were 
dispensed along the sides of the tubes G, A, T and C. The tubes were centrifuged in a 
microfuge for 2 min to allow the solutions to mix and were warmed at 37°C. After 15 
min the polymerisation reactions were chased with 1 µl of chase solution (0.25 mM each 
of dGTP, dA TP, dTIP and dCTP) and the reactions were continued for a further 10 min. 
The reactions were stopped by adding 4 µl of formamide dye loading mix to each tube 
and heated at 90°C for 5 min and placed in ice. 
Gel electrophoresis of sequencing reactions were generally carried out on 6% 
(w/v) acrylamide gels (15 mls of 20% stock acrylamide solution containing 35 ml of urea 
mix, 0.4 ml of 10% w/v ammonium persulfate and 50 µl of TEMED) using Bio-Rad 
Sequigen apparatus (the gels were 36 cm long, 17 cm wide and 0.25 mm thick). Sample 
wells were 4 mm wide and were made by using a "shark tooth" comb. The gels were 
pre-electrophoresed for 1 hr at a constant voltage of 1500 volts using TBE as running 
buffer. The wells were flushed with buffer using a 10 ml syringe attached to a 24 gauge 
needle and 2 µl of each sequencing reaction was loaded carefully into separate wells using 
drawn-out capilliary tubes. The gel was run at 1750 volts (the gel temperature was about 
45-500C) for 1.5 h for obtaining sequences close to the universal primer. Sequences of 
up to 500 bases could be obtained by double and triple loading of the sequencing reaction 
after 2 and 4 h following the first sample load. After sufficient electrophoresis, the gel 
was removed from one of the glass plates by placing a sheet of Whatman 3 MM paper on 
the gel and using a test tube to rub the surface of the papers so that the gel would adhere 
to the paper more strongly than to the glass plate. The paper with the gel adhering to it 
was carefully peeled off, covered with Saran Wrap and dried by heating at sooc under 
vacuum using a Bio-Rad model 483 slab-dryer. The gels were exposed at room 
temperature in a Kodak X-Omatic C-2 cassette without an intensifying screen when [a-
32PJ-dA TP was used or at -7QOC in a cassette with intensifying screen when 35S-dA TP 
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was used. They were usually developed after 12-24 h using the Kodak M20 X-Omat 
processor. The sequences were read by using a manual digitizer. 
5.4.8 Phage dot-blot hybridization 
The clear plaques obtained as described in Section 5.4.7.4 were individually 
picked using sterile Pasteur pipettes and inoculated into separate 1.5-ml Eppendorf tubes 
each containing 1 ml of E. coli strain JM101 in 2 x YT medium (an overnight culture of 
JM101 grown in minimal medium was diluted 1 in 50 into 2 x YT as described in Section 
5.4.7.4). The tubes were placed in a rack and shaken at 370c in an air incubator for 6-8 
hand centrifuged in a microfuge for 10 min. The supernatant (0.8 ml) was transferred 
into fresh Eppendorf tubes (taking care not to bring any of the pellet across) containing 
200 µl of 25% PEG 6000/2 M NaCL The tubes were mixed well and incubated on ice for 
30 min. The phage was pelleted by centrifugation in a Microfuge for 10 min and the 
supernatant was removed by aspiration. The phage pellets were suspended in 100 µl TE 
buffer and stored at 40c in labelled tubes. 
About 2 µl of each of the phage stocks were applied directly onto a dry sheet of 
nitrocellulose membrane placed on a 96 well tissue culture tray over a light box ( to guide 
the application of phage spot). The nitrocellulose membrane was dried in air and then 
baked at sooc for 2 h in a vacuum oven. Hybridization with radio-labelled 
oligonucleotide was carried out as described in Section 5.4.6. The phage stock that 
hybridized with the oligonucleotide was used for the preparation of M13 single-stranded 
DNA for sequencing as described in Section 5.4.7.3. 
5.4.10 Complementation of glyA mutation in GS 245 
E. coli strain GS 245 (pheA 905, araD 139, ,1/acU 169, L1glyA, strA, thi) was a 
generous gift from Professor George Stauffer, University of Iowa, U.S.A. The glycine 
requirement of GS 245 was checked by streaking the strain grown on rich medium onto a 
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minimal plate supplemented with 0.4% (w/v) glucose, 200 µg/ ml phenylalanine, 1 µg/ml 
thiamine, 10 µg/ml each of thymine and uracil. The strain GS 245 did not grow in this 
minimal medium. However the strain GS 245 grew well when the minimal agar plates 
were supplemented with 200 µg/ml of glycine and serine. 
The glyA complementation experiments were carried out by making GS 245 
competent and transforming it with plasmids p WA 266 or p WA 406. These cells were 
plated out on the minimal plate with all the supplements (except for glycine and serine) 
and ampicillin. GS 245 containing plasmids pWA 266 or pWA 406 grew on ampicillin-
containing minimal plates without glycine and serine supplementation. The negative 
control, GS 245 transformed with cosmid vector pHC 79, did not grow whereas GS 245 
competent cells plated on minimal plates with all the supplements, including glycine and 
serine, grew well. 
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CHAPTER 6 
IN SEARCH OF THE GENE THAT ENCODES THE 27-Kd 
DHPR FROM ESCHER/SCH/A COLI 
6 .1 INTRODUCTION 
In this study it has been shown that the subunit molecular weight of human DI-IPR 
and E. coli DI-IPR are about the same when their relative mobilities are compared on SDS-
PA gel. The open reading frame for the human DI-IPR gene is 732 bp long (Dahl et al., 
1987; Lockyer et al., 1987). Therefore, in the simplest case the gene encoding DI-IPR, 
including the transcription control regions, must be about 0.8 - 0.9 kb in length. The 
direct screening for increased DI-IPR specific activity (see Chapter 4) did not identify any 
clones that overexpressed the 27-kD protein, although one clone (WA 266) showed a 6-
fold increase in DI-IPR specific activity that is probably due to overproduction of the 44-
kD haemoprotein (see Chapter 5). The implication from the work in Chapters 4 and 5 is 
that the expression of the gene that encodes the 27-kD DI-IPR from E. Coli may be quite 
complex and perhaps it may be part of an operon. 
The work outlined in this chapter decribes how the presence of the hmp and glyA 
genes in cosmid pWA 266 (and the sibling pWA 265) was exploited to set up 
methodology for isolating the gene that encodes th~ 27-kD DHPR from cosmid pools (see 
later in this Chapter). Six cosmid strains who ~; e plasmids hybridized strongly with 
radiolabelled oligonucleotide D27-2 (synthetic r11ixed oligonucleotides that should be 
complementry to the 5' portion of the gene that encodes DHPR, as predicted from the 
protein sequence information) were selected for further study. The cell free extracts 
prepared from the six strains did not show significant increase in DI-IPR specific activity 
compared with the wild-type level. However, the strong hybridization reactions that were 
observed suggest that the gene may be present in these cosmids, but for some as yet 
unknown reason was not overexpressed. NucleotiJe sequencing however would confirm 
this preliminary observation that the DHPR gene v.,as present in the cosmid. 
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Table 6.1 The composition of the cosmid pools 
Cosmidpool Source strains [DNA]µg/ml Vol. used for DBHa 
A WA 100- 112 116 1 
B WA 113 - 124 102 1 
C WA 125 - 136 43 2.5 
D WA 137 - 148 15 6 
E WA 149 - 160 32 4 
F WA 161 - 172 22 5 
G WA 173 - 184 61 2 
H WA 185 - 196 45 2.5 
I WA 197 - 208 38 2.5 
J WA209-220 61 2 
K WA221-232 33 3 
L WA 233 - 244 22 5 
M WA 245- 256 39 2.5 
N WA 257 - 268 30 3.5 
0 WA269-280 18 5 
p WA 281 - 292 11 10 
Q WA 293-304 38 2.5 
R WA 305 - 316 92 1 
s WA 317 - 328 97 1 
T WA 329- 340 94 1 
u WA 341 - 352 78 1.5 
V WA 353 - 364 28 3.5 
w WA 365-376 115 1 
X WA 377 - 388 72 1.5 
y WA 389 - 393 26 4 
A to Yb 37 2.5 
a. Volume used for dot blot hybridization. 
b. 1.2µg of DNA from each pool was mixed to give the combined pool. 
6.2 RESULTS AND DISCUSSION 
6.2.1 Dot blot hybridization of cosmid pools 
The cosmid pools (see Table 6.1) used in this study were made by Ms A. Hassan, 
Research School of Chemistry, ANU, using the cosmid library WA101 - WA 397 that 
was constructed in this study (see Section 6.4.1). 
Preliminary dot blot hybridization was carried out to establish the methodology to 
identify new gene(s) from the cosmid pool using a radiolabelled mixed oligonucleotide 
probe that contained a sequence complementary to the gene predicted from the N-terminal 
protein sequence data. Since it was known that the cosmid pool N (p WA 257 - p WA 
267) should hybridize with the oligonucleotide probe D45-1 because the hmp gene was 
present on p WA 266 (and the sibling p WA 265), it was used as a positive control. 
Cosmid pools N, 0, P, Q, S and A - Y (mixture containing all the pools) were dot blot 
hybridized with D45-1 (method described in Section 6.4.2). Cosmid pool N showed a 
strong hybridization reaction whereas the cosmid pools 0, P, Q, S and A - Y did not 
hybridize with D45-1. Taking this a step further, strain GS 245 that was made competent 
by CaCl2 treatment, was transformed separately ,v1ith cosmid pools N, 0, P, Q, S or A -
Y. The transformation mixture was plated out on minimal plates containing the necessary 
supplements, but without glycine and serine, to select for glyA complementation. There 
were about 50 transformants in the plate where the strain GS 245 was transformed with 
cosmid pool N and none for the other plates from transformations with cosmid pools 0, 
P, Q, S or A - Y. This exploratory experiment clearly showed that dot blot hybridization 
with an appropriate oligonucleotide mixture was an ideal method for cloning new genes 
from the cosmid pool. Further, the complementation of the glyA mutation in the strain 
GS 245 by cosmid pool N confirmed that complernentation of genetic traits could be used 
as a selection criterion for isolating a gene of inter ~st. The cosmid pool designated A - Y 
did not hybridize with the oligonucleotide D4j-1 and had no transformants in the 
complementation experiment despite the fact that p WA 266 (and the sibling p WA 265) 
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Figure 6.1 Screening cosmid pools by dot blot hybridization with 32p labelled oligonucleotide D27-2 
The dot blot hybridization was carried out as described in Section 6.4.2. The autoradiograph shows that cosmid pools P, Q, W and E 
hybridized with the probe DNA. 
A B C · D F G H J K L M 
.. 
N 0 p Q R s T u V w X y 
E A•Y .. y 
#. 
was present in it. This suggests that the size of the cosmid pool (i.e. the total number of 
different plasmids within a pool) may be a crucial factor. 
Dot blot hybridizations of the 25 cosmid pools (from A to Y) were carried out as 
described in Section 6.4.2, using y-32P-labelled mixed oligonucleotide D27-2 which 
contained the complementary sequence to the gene that encodes DHPR as predicted from 
the amino acid residues starting from position 14 to position 20 (Lys - Ala - Phe - Asp -
Ala - Met - Lys; see Table 3.3). The cosmid pools E, P, Q and W (see Figure 6.1) 
hybridized with the probe DNA. 
The first approach that was adopted to identify the plasmids within the pools that 
hybridized strongly with the probe DNA was to use the genetic complementation method. 
The rationale for using this approach came from the discovery in this study that E. coli 
DHPR can reduce 7 ,8-dihydrofolate. Since the cosmid library was made from the DI-IFR 
minus (folA) strain D 3-157, none of the plasmid-; within the cosmid pools would code 
for active wild-type DI-IFR. If the con1plete gene Gncoding E.coli DHPR was present in 
a plasmid and the product of the gene were suffici .:ntly over-produced, then that plasmid 
may be able to complement the DI-IFR mutation in the recA derivative of strain D3-157. 
The recA derivative of strain D3-157 was made competent and transformed separately 
with cosmid pools E, P, Q or W and spread on minimal plates without any 
supplementation with folate dependent end-products such as methionine, glycine, 
thymidine, adenine and pantothenate. There were no transformants in any of the minimal 
plates, but there were >250 colonies when each tra;1: formation mixture was spread on LB 
plates containing ampicillin. Two positive controls were also carried out simultaneously 
by transforming the strain D3-157 separately with plasmids pJFM 8 or pR 67 [pJFM 8 
contains the gene for chromosome-encoded DHF~~ described by Rood et al. (1980) and 
pR 67 contains the gene for type II R-plasmid en oded DHFR described by Smith et al. 
(1979); both were kind gifts from Dr J. F. Morrisun]. Both these plasmids were able to 
complement the DHFR mutation, as judged by gr1)wth on minimal plates without folate 
dependent end products. However, the interesting implication from the positive controls 
is that the R-plasmid encoded DHFR which has a turnover number (catalytic efficiency) 
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Figure 6.2 Screening rapid lysates of strains that contributed to the cosmid pools E, P, Q and W, by dot blot 
hybridization. 
Rapid lysates of strains that contributed to the cosmid pools were denatured and spotted on nitrocellulose filters (A and B). The filters 
were baked and then hybridized separately with D27-1 (A) and D27-2 (B). The six plasmids selected for further study based on the 
results in (A) and (B) were prepared in large scale as described in Section 4.5.13 and subjected to dot blot hybridization with the 
labelled probe D27-2 ( C). 
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Figure 6.3 Agarose gel electrophoresis of plasmid DNA. 
The plasmids pWA 159 (b), pWA 281 (c) pWA 284 (d), pWA 292 (e), 
p WA 293 (f) and p WA 365 (g) were digested completely with Pvu II and 
electrophoresed on a 0.7% (w/v) agarose gel (A), with A DNA digested 
with Eco RI and Hind III, as size markers (a and h). (The size markers 
were end-filled in the presence of [a-32P]-dA TP, as described by Maniatis 
et al. 1982.) 
The agarose gel (A) was blotted onto a nitrocellulose filter as described in 
Section 5.4.5. 
(B) The nitrocellulose filter was baked and hybridized with labelled mixed 
oligonucleotides D27-2. The bands in (a) and (h) are the end-filled 
molecular weight markers. An - 1.4-kb fragment from plasmid pWA 159 
hybridized strongly with the probe DNA, and an -2.1-kb fragment from 
plasmid pWA 284 also hybridized significantly. 
A 
abcdefgh 
B 
21226 bp~ 
5146 bp ..., 
4268 bp .... 
3530 bp _____.--
2027 bp --
1904 bp-.. ------
1709 bp ~ _; 
1375 bp ~ 
947 bp - -
8 31 b p --------
564 bp 
abcdef g h 
Table 6.2 Direct screening of DHPR specific activitya,b 
Strain Specific activity 
DM 7111C 0.056 U/mg 
WA159 0.085 U/mg 
WA281 0.126 U/mg 
WA284 0.061 U/mg 
WA292 0.082 U/mg 
WA293 0.080 U/mg 
WA365 0.060 U/mg 
a. The DHPR assay was carried out as described in Section 2.5.1.1 at 250c in Tris/HCl pH 7.4 
b. Protein estimations were performed using the Bio-Rad method (Bradford, 1976). 
c. The background strain containing no cosmids. 
of 0.5 s-1 (J. F. Morrison, personal communication) was able to complement the DHFR 
mutation in D3-157. From the data presented in Table 3.1, it was calculated that the 
turnover number for the reduction of 7 ,8-dihydrofolate by E. coli DHPR is also about 0.5 
s-1. Although the catalytic efficiencies of these two enzymes appear to be similar in the in 
vitro situation, their efficiency in vivo may be dependent on several factors. 
The source strains for the cosmid pools E, P, Q and W (WA 149 - 160, WA 281 -
304 and WA 365 - 376) were grown on LB plates containing ampicillin. Small scale 
plasmid DNA preparations (as described in Section 4.5.14) of these strains were dot blot 
hybridized separately with the synthetic oligonucleotides D27-1 (predicted from the first 
seven N-terminal amino acid residues of E. coli DHPR; see Tabel 3.3) or D27-2. 
Plasmids pWA 159, pWA 281, pWA 284, pWA 292, pWA 293 and pWA 365 showed 
strong hybridization response with the probe D27-2 and only plasmid pWA 293 
hybridized significantly with the probe D27-1 (see Figure 6.2). It was felt from the onset 
that the probe D27-l may not be ideal because it was predicted from a short sequence 
where the assignment of two residues (at position 2 and 5) were uncertain (see Table 
3.3). However, large scale plasmid preparations of the plasmids pWA 159, pWA 281, 
pWA 284, pWA 292, pWA 293 and pWA 365 were made and dot blot hybridizations 
with D27-2 showed that all of them hybridized strongly even after more stringent washing 
procedures. The six plasmids were digested completely with the restriction endonuclease 
Pvu II and analysed on a 0.7% (w/v) agarose gel (see Figure 6.3A). The restriction 
pattern of plasmids p WA 281 and p WA 284 vv ere not clear because in the former, 
insufficient DNA was present (the DNA yield fro1n strain WA 281 was very low, hence 
an ethanol-precipitated fraction was used for the r~striction analysis without quantifying 
the DNA) and the latter may have been only partially digested. Plasmids p WA 292 and 
p WA 293 shared several bands in common but were not siblings. The fragments from 
the agarose gel were transferred onto a nitrocellulose filter and hybridized with the y-32p_ 
labelled probe D27-2 (see Figure 6.3B). A 1.4-kb Pvull fragment from pWA 159 
hybridized strongly with the probe and also another approximately 2-kb fragment from 
plasmid pWA 284 showed moderate hybridization. The result from the Southern blot 
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hybridization is quite ambiguous because none of the fragments from plasmids p WA 
292, p WA 293 or p WA 365 hybridized with the probe, whereas the plasmid dot blots 
showed strong hybridization signals (see Figure 6.2C). 
6.2.2 Direct screening for increased DHPR specific activity 
Cell free extracts were prepared from the strains that hybridized with the probe 
D27-2 and their DHPR levels were compared with the background level of DHPR in 
strain DM 7111, that was similarly prepared. The results (see Table 6.2) indicated that 
the DHPR specific activity in strain WA 281 is more than two fold higher than the 
background level and that of strains WA 292 and WA 293 were only marginally higher. 
Samples of the cell free extracts were analysed by SDS-PAGE to check if any apoprotein 
was being made (see Figure 6.4). There were no indications of high levels of protein 
around molecular weight of 27 000 being synthesized in any of the strains. 
6.3 Summary 
The strains that were identified as possible E. coli DHPR clones on the basis of 
strong hybridization signal with the y-32p labelled D27-2 probe, did not show any 
increase in DHPR specific activity. Neither the possible clone colonies nor the extracts 
prepared from them were yellow, as would have been expected in the event of increased 
expression of a protein containing a flavin prosthetic group. The N-terminal amino acid 
sequence of E. coli DHPR (position 14 to 20), which was used to predict the sequence 
for the oligonucleotide probe D27-2, were unambiguous assignments. Also the sequence 
of the amino acids (Lys - Ala - Phe - Asp - Ala - Met - Lys) was ideal for probe synthesis 
because of the limited codons that code for several of amino acid residues such as lysine, 
phenylalanine, aspartate and methionine (Grantham et al., 1981). Based on the 
experience with the probing and ultimate sequencing of the 5' region of the hmp gene 
(described in Chapter 5), it is felt that the gene that codes for E. coli DHPR may be 
present in some of the plasmids that hybridized strongly with the DNA probe. However 
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Figure 6.4 Polyacrylamide gel electrophoresis of cell-free extracts from 
strains AN 1459 (1), WA 159 (2), WA 281 (3), WA 284 (4), 
WA 292 (5), WA 293 (6) and WA 365 (7). 
Cell free extracts from the strains (100 µg each) were electrophoresed on a SDS-
PA gel as described in Section 2.5.3.1. The arrowhead indicates the position of 
the 27-kD E. coli DHPR (not shown). There is no sign of any significant 
increase in the levels of the 27-kD protein in the cell-free extracts of the strains 
whose plasmids hybridized strongly with the oligonucleotide probes, compared 
with the wild type strain AN 1459. 
1 2 3 4 5 6 7 
this can only be proved by nucleotide sequencing lti:"ter subcloning the plasmids identified 
in this study. 
6.4 METHODS 
6. 4. 1 Preparation of cosmid pools 
The preparation of cosmid pools was can·ied out by Ms A. Hassan and were a 
kind gift from Dr N. E. Dixon. 
The strains WA 101 - WA 393 that were stored at -700C in 7% DMSO, were 
streaked on 8-sectored LB plates containing amp~cillin. A loopful of colony from each 
sector was used to inoculate 20 ml of LB medium containing ampicillin and grown 
overnight. Cultures were pooled in groups of 12 and used to prepare plasmid DNA as 
described in Section 4.5.13. 
6. 4. 2 Dot blot hybridization of cosn1id pools 
The general method described in Section 5.4.8 was applied for the dot blot 
hybridization of the cosmid pools. About 1 µg of DNA from each pool (see the volumes 
used in Table 6.1) was made up to 10 ~Ll in TE and placed in a 96-well tissue culture plate 
(Linbro, Virginia, USA). The denaturation buffer (10 µleach; 1 M NaOH, 2 M NaCl) 
was added to each of the wells containing the individual cosmid pools and incubated at 
room temperature for 30 min. The denatured cosr::rid pools were spotted ( 4 µ1/spot) onto 
nitrocellulose sheet placed on a clean 96-well tissu,; culture plate over a light box to guide 
the spotting process. The nitrocellulose filter '>las dried and treated as described in 
Section 5.4.6. 
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6. 4. 3 Complementation of fol mutation in strain D3-157 
Competent cells of the recA derivative of D 3-157 were made by the CaCl2 
method described in Section 4 and transformed ,vith the appropriate test plasmids and 
control plasmids. The transformation mixtures were spread on minimal plates that 
contained the essential salts, 0.2% glucose, tryptophan, tyrosine, histidine, guanine (50 
µg/ml each) guanine and thiamine (10 µg/ml). The strain D 3-157 did not grow in this 
minimum plate but when plasmids pJFM 8 [Apr, I>HFR+ (chromosomal)] or pR 67 (type 
II R-plasmid DHFR+) were used to transform th~ strain, they were able to grow. The 
strain D 3-157 was able to grow when the above minimal agar was supplemented with 
methionine, glycine, thymidine (50 µg/ml each), adenine (20 µg/ml) and pantothenate (1 
µg/ml). 
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CHAPTER 7 
GENERAL DISCUSSION 
The work described in this thesis has shown that DHPR from E.coli is a 27 kD 
flavoprotein. Apart from the 27-kD enzyme, another protein present in the cell-free 
extract prepared from strain WA 266 showed quinonoid dihydropteridine-dependent 
oxidation of NADH. The results from the experiments carried out in this work imply that 
the 44-kD haemoprotein is probably the second r,rotein with DHPR activity. Although 
further work is required to confirm this, the reasons for the present belief will be 
discussed later. 
This is the first report of a DHPR with a flavin (FAD) prosthetic group. All the 
DHPRs that were characterised previously are oxido-reductases that carry out the 
reduction of quinonoid dihydropterin by transferring hydride from the pyridine nucleotide 
to position N-5 of the pterin ring. The physical and kinetic properties of the reductase 
from E.coli are somewhat different from those of the mammalian reductases and may 
account for the reasons why it did not bind to the naphthoquinone affinity column. The 
reductases that bind to the affinity column are believed to do so by interaction of the pterin 
binding site of the conformationally altered NADH-enzyme complex with the affinity 
adsorbent. However, in the case of the 27-kD flavoprotein, the catalytic reaction 
probably involves a mechanism where the conformational change may not take place after 
the binding of NADH, because its function is to reduce the FAD prosthetic group. Also, 
the Km for the pterin substrates are much higher (- 0.1 - 1.5 mM) for the E.coli DHPR, 
compared with the mammalian enzymes (which have values in the lower µM range). 
Hence the bacterial reductase does not associate strongly with the affinity ligand. The 
interaction between NAD(P)H and the flavoprotein is not very strong either and may 
account for the inability of the reductase to bind to the dye affinity columns. 
The active-site region of E.coli DHPR has not been studied in detail, but the fact 
that the reductase is inactivated by DTT suggests that there may be crucial redox-active 
disulfide bond(s) near the catalytic site or in such proximity as to affect this site. The 
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presence and the function of the disulfide bonds need to be investigated further in future 
work. 
It was pointed out in earlier chapters that the difference between the DHPR and 
DHFR reactions lies in the positions of the pteLn ring (N-5 and C-6 respectively) to 
which the hydride from the reduced pyridine nucleotide is transferred during the catalysis. 
The 27-kD flavoprotein, which is clearly the protein responsible for the quinonoid 
dihydropterin-dependent oxidation of NADH, apparently does not distinguish between 
the positions N-5 and C-6, hence it can carry out both DHPR and DHFR reactions with 
the appropriate substrates. Perhaps this flavoprotein may be the evolutionary precursor of 
DHPRs and DHFRs that do not possess any prosthetic. It is also tempting to suggest that 
if DHPR or DHFR (without any prosthetic group) is altered by introduction of a flavin 
moiety near its active site by protein engineering, f1en the resultant semi-synthetic protein 
will be able to carry out the reduction catalysed by both enzymes. In this respect, 
Kokubo et al. (1987) have shown that it is possible to convert a haemoglobin to a 
flavohaemoglobin, where the latter can perform a new catalytic function. 
The 27-kD DHPR from E.coli is similar to the reductase from P seudomonas 
species in several respects. Both showed similar kinetic parameters with various pterin 
substrates (with respect to NADH), except that the Pseudomonas enzyme was almost 
inactive with NADPH. In both the organisms, monapterin was apparently the naturally 
occurring pterin substrate. The DHPR from Pseudomonas carries out the known function 
t 
of recycling the pterin cofactor for phenylalan1oe hydroxylase which occurs in that 
organism. In the case of DHPR from E.coli, an in vivo function is still obscure because 
this microorganism does not have the aromatic an1ino acid hydroxy lases. However, the 
similarities between the two bacterial reductases suggest that DHPR from E.coli must be 
the enzyme that reduces quinonoid dihydropterins from as yet uncharacterised systems 
which use a tetrahydropterin cofactor. 
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Attempts to clone the gene that encodes the 27-kD DHPR resulted in the cloning of 
the glyA gene and the newly identified hmp gene. Serine hydroxymethyl transferase is 
the product of the first gene, and is a crucial enzyme in the one-carbon metabolic 
pathway. The physiological reaction catalysed by SHMT is the interconversion of serine 
and glycine with tetrahydrofolate serving as the one-carbon carrier. In addition, SHMT 
can also catalyse other reactions such as decarboxylation of aminomalonate, aldol 
cleavage of allothreonine and transamination of D-alanine, because it is a pyridoxal 
phosphate-containing enzyme (Shostak and Schirch, 1988). If SHMT were responsible 
for the 6-fold increase in DHPR activity in the extract from strain WA 266, then it is not 
clear why the activity was lost during the purification. The notion that the cofactor that 
was required for the reductase was lost during the purification was discounted because the 
addition of freshly prepared extracts did not restore the DHPR activity in the partially-
purified protein samples. 
The more favoured candidate that may be responsible for the enhanced DHPR 
activity in the extract from strain WA 266 is the 44-kD haemoprotein which is encoded by 
the hmpgene. The N-terminal amino acid sequence of this protein showed extensive 
homology with the corresponding region of the haemoglobin from Vitreoscilla. In 
addition to the sequence data presented in Figure 5.14, the 44-kD haemoprotein also has a 
glutamine residue at the corresponding helix position E7 (N.E.Dixon, personal 
communication). This provides further evidence that it is related to haemoglobin-like 
proteins. The glutamine residue at that position is though to hydrogen bond with the 
oxygen molecule as in the case of myoglobin (Phillips and Schoenborn, 1981). There is 
no direct evidence for a distinct function for the 44-kD haemoprotein as yet. However, it 
appears to have a pterin binding site and seems very likely to be responsible for the 
enhanced DHPR activity. SHMT on the other hand is a well characterised protein, and 
from the extensive knowledge of its mechanism of action it is difficult to see how it could 
act as a reductase. 
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The molecular weight and spectral properties of the 44-kD haemoprotein are 
similar to those of the oxygen-binding flavohaemoprotein from the hydrogen bacterium 
Alcaligenes eutrophus (Probst et al., 1979). The) ellow colour of the extract from strain 
WA 266 and the partially purified protein is an indication that the haemoprotein from 
E.coli may also contain FAD. This haemoprotein also resembles the flavohaemoglobin 
from the yeast Candida mycoderma in molecular weight and spectral properties. 
An interesting speculation at this point is that the 44-kD haemoprotein is a 
bifunctional protein. One half of the protein may be involved in the storage of oxygen, 
which is transported to the haeme site by a tetrahydropterin as a hydroperoxy group 
attached to the '4a' bridgehead position of the pterin ring (compare with Armarego, 
1984 ). After the removal of the hydroperoxy group, the pterin substrate becomes 
oxidised to the quinonoid dihydropterin which is recycled by the reductase portion of the 
haemoprotein. This hypothetical model requires rigorous experimental evaluation. It 
may shed light on the in vivo physiological role for the protein. Wood (1984) classified 
the haemoglobin from Vitreoscilla and the flavoha=moprotein from A.eutrophus, together 
with a few other haem-containing proteins with ~imilar spectral properties, as putative 
oxygen buffers. The 44-kD haemoprotein from E.coli may well have a similar function. 
The haemoprotein from this study is expressed at low levels in the wild-type bacteria and 
has escaped discovery despite exhaustive investigation. If this is meaningful, then it may 
well act as a biological switch for some unknown reactions. 
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